










The handle http://hdl.handle.net/1887/30776 holds various files of this Leiden University 
dissertation 
 
Author: Talens, Rudolf P. 
Title: Studies into epigenetic variation and its contribution to cardiovascular disease 
Issue Date: 2015-01-08 
Studies into epigenetic 


























































































Rudolf P. Talens  Studies into epigenetic variation and its contribution to cardiovascular disease
Cover_def.indd   1 5-12-2014   13:23:56
1
Studies into epigenetic 
variation and its 
contribution to 
cardiovascular disease  
Rudolf Talens
Binnenwerk_opmaak.indd   1 5-12-2014   13:18:33
2
PhD thesis with summary in Dutch
ISBN: 978-94-6295-048-1
Copyright 2014 R.P. Talens
All rights reserved. No part of this thesis may be reproduced, 
stored in a retrieval system or transmitted in any form by any 
means without permission of the author or, when appropri-
ate, of the publisher of represented published material.
Front cover and internal layout by R. Velds
Printed & published by: 
Proefschriftmaken.nl || Uitgeverij BOXpress, ‘s-Hertogenbosch
Binnenwerk_opmaak.indd   2 5-12-2014   13:18:33
3
Studies into epigenetic 





de graad van Doctor aan de Universiteit Leiden.
op gezag van Rector Magnificus prof. mr. C.J.J.M. Stolker,
volgens besluit van het College voor Promoties






Binnenwerk_opmaak.indd   3 5-12-2014   13:18:33
4
Promotiecommissie 
Promotoren:  Prof. Dr. PE Slagboom
   Prof. Dr. JW Jukema
Co-promotor:  Dr. BT Heijmans
Overige leden: Prof. Dr. H Putter
   Prof. Dr. H Pijl
   Prof. Dr. SM van der Maarel
   Prof. Dr. DI Boomsma
   Vrije Universiteit Amsterdam
   Prof. Dr. J Mill
   University of Exeter
The research described in this thesis was supported by 
a grant of the Dutch Heart Foundation (DHF-2006B083) . 
Financial support by the Dutch Heart Foundation for the 
publication of this thesis is gratefully acknowledged. 
Binnenwerk_opmaak.indd   4 5-12-2014   13:18:33
5
Chapter 1
Introduction to epigenetic research
on common diseases
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Coronary heart disease (CHD) is an ageing related 
common disease that was responsible for 83,941 
hospitalizations and 9,720 deaths in the Netherlands in 2012 
[1]. It is caused by a narrowing of the coronary blood vessels 
with a myocardial infarction (MI) being its most common 
manifestation. CHD is a disease of a complex multifactorial 
nature. An individual’s risk of CHD is determined by the 
lifelong interaction between genetic background and 
environmental exposures [2,3]. Genetic and environmental 
factors contribute equally to CHD etiology [4]. Investigations 
into genetic sequence variation have been a main focus 
of the past decade and have revealed many genes behind 
the heritable components of CHD and its risk factors (e.g. 
type 2 diabetes (T2D) complications, metabolic syndrome, 
or hypertension) [5]. Classical environmental risk factors 
of CHD (e.g. smoking, diet, low physical activity) are well-
established as contributors to its clinical pre-stages such as 
hypertension, lipid profile, and obesity [6]. The risk of CHD 
is strongly correlated with age [1,7], which may reflect an 
accumulation of environmental exposures and ageing-related 
(stochastic) processes that both result in a randomness in 
onset and etiology of CHD. Geographical and epidemiological 
BOX1: The Hunger Winter Families Study
We explored the potential for epigenetic changes due to prenatal adversity 
on participants of the Hunger Winter Families Study [11]. This study investi-
gates individuals who were exposed in utero to the Dutch Famine. The Dutch 
Famine was the consequence of a German imposed food and fuel embargo 
for the western part of the Netherlands in the winter of 1944–45, toward the 
end of World War II. The famine was a 6 month period of severity and ex-
treme stress. Official daily rations contained less than 700 kcal on average, 
and although the winter was average meteorologically, the fuel shortages 
would make it tough. As the civil infrastructure was maintained during the 
war, individuals who were either conceived or born during the Dutch Famine, 
could be tracked through their birth records at the institutions in which they 
were born (midwife clinics in Rotterdam and Amsterdam, university hospital 
in Leiden. These individuals were compared with their same sex older or 
younger siblings. This design achieves to isolate the prenatal exposure event 
as best as possible in human population studies, by controlling for childhood 
environment and social economic status, sex, post-natal experience of the 
Famine and genetic variation, as siblings still share half of their genome. 
This study focuses on insults during the important stages of gametogenesis, 
organ and tissue development and the late gestational period of fetal (and 
neonatal) growth, characterized by remarkable increase in size.
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studies showed that poor conditions at the beginning of life 
also contribute to risk and severity of CHD in later life [8,9]. 
A survey across studies on famine cohorts, amongst which 
the Dutch Famine of 1944-1945 [Box 1], reported consistent 
associations between prenatal famine exposure and a higher 
BMI, more adiposity, a less favorable glucose metabolism and 
a more adverse lipid profile [10]. 
While the identification of genetic risk factors of CHD 
has contributed insights in molecular pathways involved in 
its etiology, the molecular mechanisms that mediate the 
effect of environmental risk factors are less well understood. 
Intervention studies on animal models present evidence that 
changes in DNA methylation, a major epigenetic mark, may 
be mechanistically involved in the association of prenatal 
adversity and ageing-related disease phenotypes [12,13]. 
In humans changes in DNA methylation at the IGF2 locus 
were associated with exposure to the Dutch Famine during 
conception [14]. Changes in DNA methylation have been 
repeatedly found associated with lifestyle and environmental 
exposures [15]. Ageing has been repeatedly associated with 
stochastic changes in DNA methylation and other epigenetic 
marks such as histone modifications [16]. Thus, research on 
ageing related common diseases such as CHD has partly 
refocused its attention towards the involvement of epigenetic 
regulation, as a mediator of the interactions between genome 
and (prenatal) environment [17,18]. This general introduction 
will explain the biochemical basis of epigenetic mechanisms, 
explore current knowledge on its involvement in disease 
development, and describe the facilities and resources 
available to epigenetic research, and finally present an 
outline of this thesis.
 
Epigenetic mechanisms
The genome of multi-cellular organisms appears in a 
condensed state within the nucleus, forming a nine to thirty 
nanometer thick fiber of a DNA – protein complex called 
chromatin [19,20]. These chromatin fibers are formed by the 
coiling and packaging of its nucleosomes, which consist of 
147 base pair long stretches of DNA wrapped twice around a 
protein scaffold of eight different histone subunits. Classically 
the condensation state of chromatin is grouped in three 
structural categories, open (euchromatin), intermittent 
(bivalent chromatin), and closed (heterochromatin), although 
Binnenwerk_opmaak.indd   7 5-12-2014   13:18:35
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more distinct chromatin states were recently defined [21]. 
The amount of condensation at each genomic area is 
regulated by epigenetic mechanisms, the molecular basis of 
which is formed by several correlated layers of biochemical 
information on and around the nucleosomes (Figure 1.1). 
Figure 1.1  The different layers of epigenetic information, exemplified by the 
two extremes of the spectrum: transcriptionally inactive heterochromatin (left) 
and transcriptionally active euchromatin (right) with a selection of their associ-
ated epigenetic marks. The primary layer of chromatin structure constitutes the 
methylation of genomic DNA (Me) at cytosine bases in specific contexts, and 
the packaging of DNA into nucleosomes, which vary in histone composition (dif-
ferently colored pie slices) and modifications of the histone tails (indicated by 
colored dots). DNA in chromatin may remain accessible to DNA-binding proteins 
such as transcription factors (TFs) and RNA polymerase II (RNAPII) or may be 
further compacted. Chromatin can also organize into higher-order structures 
such as nuclear lamina-associated domains and transcription factories [21]. Im-
mage reprinted with permission from Macmillan Publishers Ltd: Nature Reviews 
Genetics Volume 12 (1); Zhou, Goren & Bernstein, pages 7-18; copyright 2011
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These epigenetic layers include the methylation of DNA at 
cytosine residues, the addition of small chemical groups (e.g. 
phosphate, acetyl, or methyl groups) to the various histone 
subunits, nucleosomal packaging; non coding RNAs; and 
nuclear localization [22–25]. 
The capacity of the transcription machinery to access 
a gene after receiving the correct cues decreases with 
increasing condensation of its chromatin. A further 
assortment of epigenetic modifications, mainly on histone 
tails, results in the attraction or repulsion of transcription 
factors (i.e. enhancers and repressors) that enables a more 
or less continuous spectrum of fine tuning for epigenetically 
regulated gene expression [21,26]. Epigenetic silencing of 
repetitive DNA is generally thought to protect our genomes 
against the potentially detrimental effects of random 
insertion of transposons, mobile elements of parasitic origin 
[27,28]. Further, through variation of the epigenetic state 
at a genomic locus, epigenetic mechanisms determine the 
gene expression potential of a cell without changes to its 
DNA sequence [29]. Extensive epigenetic remodeling during 
development and differentiation generates the multitude of 
our body’s cell types, each with its unique cellular phenotype, 
function, and response repertoire, that nonetheless all 
contain the same genotype as the zygote they ultimately 
derived from [30]. 
A textbook example illustrating the importance of 
epigenetically regulated gene expression is the mechanism 
of genomic imprinting [31,32]. Imprinted genes are 
epigenetically marked during gametogenesis so that they 
are expressed only from the paternally or maternally derived 
chromosome. Only about 0.3 % of our genes are imprinted, 
most of such genes reside in clusters, such as the GNAS locus 
which contains silenced genes of both maternal and paternal 
origin and at least one non coding RNA that regulates 
imprinting of the adjacent genes [33]. Most imprinted 
genes code for key players in the signaling pathways that 
coordinate growth and development with metabolism [34,35]. 
Their effect covers as diverse processes as the development 
of extra-embryonic tissues, fetal nutrient acquisition, 
neonatal suckling, and the control of appetite during life 
[33,34]. Incorrect establishment of imprinting marks leads to 
fetal lethality, growth impairments, insatiable appetite, and 
mental retardation [34], exemplified by imprinting disorders 
Binnenwerk_opmaak.indd   9 5-12-2014   13:18:37
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such as the antagonistic Prader-Willi_Angelman syndrome 
[36], and Beckwith-Wiederman_Silver-Russel syndrome [37]. 
In contrast with the genetic sequence, epigenetic marks 
are not permanently fixed in a differentiated cell, they are, 
however, usually maintained over longer periods of time, 
and are faithfully transmitted to its daughter cells. During 
cell division the DNA separates from its protein scaffold to 
split the duplex for replication. Although several mechanisms 
have been proposed [38], mitotic transmission of the various 
histone modifications is less well understood than that of DNA 
methylation. The methylation marks are directly transmitted, 
as the methyl groups are covalently bound to the old 
strands of DNA, each of which is passed to one daughter 
cell. DNA methylation is the most studied layer of epigenetic 
information. A high degree of DNA methylation is generally 
associated with heterochromatin (Figure 1.1) and was long 
considered an epigenetic mark specific for the repression of 
transcription [39], although recent results from genome-wide 
techniques show that its function depends on context of its 
location within the transcriptional unit [28]. 
In humans, most DNA methylation occurs at the 
cytosine residue of CpG sites (a cytosine directly followed 
by a guanine residue) [24], but this is not the only form 
of DNA methylation. In embryonic stem cells and induced 
pluripotent stem cells substantial DNA methylation has been 
observed outside a CpG context, which is removed during 
differentiation [40,41]. Two recent studies have discovered 
cytosine residues that had a hydroxy-methyl group (hmC) 
covalently bound instead of a methyl group (mC) in both 
a-mitotic cell types of the brain [42] and in embryonic 
stem cells [43]. In stem cells (i.e. embryonic, pluripotent, 
and induced) high levels of hmC are often observed at 
epigenetically poised loci involved in pluripotency and 
maintenance of differentiation potential. The finding that 
methyl CpG binding proteins have a reduced affinity for hmC 
compared with mC [44], suggests that during differentiation 
the conversion of mC to hmC may be a molecular mechanism 
for rapid epigenetic decisions [43,45]. Its proposed role as 
biochemical intermediate in the process of active and passive 
DNA de-methylation [43,45] further supports the importance 
of hmC in cell differentiation, but also holds that it is likely not 
retained during multiple cell divisions. In line with this, hmC 
was found to occur only in low to marginal levels in tissues 
Binnenwerk_opmaak.indd   10 5-12-2014   13:18:37
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relevant for CHD development [46]. Thus, most studies on the 
epigenetic contribution to CHD and other common ageing 
related diseases focus on the methylation of DNA at CpG 
sites in differentiated tissues.
The epigenetic contribution to diseases with an 
environmental component 
The regulatory role of epigenetic mechanisms in cellular 
gene expression has forwarded research on the epigenetic 
involvement in common diseases, to both complement and 
understand their genetic component [47], with promising 
results. Two recent longitudinal studies reported an 
association of developing obesity [48] or type 2 diabetes 
[49] with different DNA methylation levels in leukocytes at 
established genetic candidate loci. Both studies reported that 
the epigenetic differences were found to precede disease 
manifestation and had remained stable throughout disease 
development during the study, showing that the epigenetic 
variation was persistent [48,49]. The epigenome has a 
dynamic capacity to undergo changes in each individual cell. 
This potential changeability of epigenetic marks is another 
topic of interest in research on common diseases [50]. The 
most studied example of epigenetic changes involved in 
disease are those affecting tumor cells [51]. Tumor cells 
often display high DNA methylation at promoters of genes 
controlling cell cycle arrest, while the genes promoting cell 
division are unmethylated, and both changes have been 
associated with the uncontrolled growth that is typical of 
malignant tumors [52–54]. Epigenetic differences have also 
been observed in ventricular tissue affected by MI compared 
with unaffected tissue from the same individual [55,56]. 
Studies on monozygotic twin pairs that are discordant for 
Beckwith-Wiederman and Silver-Russel syndromes suggest 
that epigenetic changes can precede the manifestation of 
metabolic diseases [57], and a recent genome wide study 
reported associations of DNA methylation with calendar age 
and ageing related phenotypes [58]. These and other results 
showcase that epigenetic variation may be an important 
factor in the process of ageing and risk for its related 
common diseases [18,59].
Individuals may harbor persistent epigenetic differences 
due to, first of all, the genetic sequence, which may prevent 
or force the establishment of epigenetic marks [60,61]. 
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Next, epigenetic differences between newborn monozygotic 
twins [62] and isogenic littermates [63] indicated that the 
extensive developmental program of epigenetic remodeling 
[30] may induce stochastic epigenetic variation, as has been 
proposed [64]. Further, a wealth of intervention studies on 
animal models showed that prenatal adverse conditions 
can induce epigenetic changes [65,66]. In humans, prenatal 
famine [14], and smoking during pregnancy [67] were also 
found associated with persistent epigenetic differences. 
Early development may provide a period of specific 
vulnerability to environmental influences (Figure 1.2) after 
which the epigenetic differences may persist through faithful 
transmission during mitosis [68,69].
In differentiated cells, epigenetic information can change 
Figure 1.2  Contrary to genetic sequence variation, which is fixed for life after 
fertilization, epigenetic variation has a more changeable nature that involves 
different factors during phases of life. Two periods of prenatal life are proposed 
to be particularly vulnerable to stochastic and environmentally driven changes. 
First, the conditions in which both parents live prior to fertilization can disturb the 
extensive epigenetic remodeling during gametogenesis. Genetic sequence varia-
tion may form another source of epigenetic variation (e.g. polymorphisms affect-
ing CpG sites) in the zygote. Second, the epigenetic remodeling during tissue de-
velopment can be shaped by both stochastic factors (e.g. epigenetic differences 
in MZ twins), and by the intra-uteral environment, shaped by both internal physi-
ological factors (e.g. placental morphology) and external maternal environmental 
factors (e.g. smoking, nutrition). Cell type differentiation also involves epigenetic 
remodeling, especially during early post-natal growth, resulting in a potentially 
still increased susceptibility to childhood environmental exposure like nutrition. 
During adult life environmental factors (lifestyle, living conditions) are thought to 
be of equal importance to stochastic changes (due to imperfect epigenetic main-
tenance), while in old age the efficiency of epigenetic maintenance is thought to 
decrease [119]. Immage republished with permission of Annual Reviews from An-
nual Review of Nutrition, volume 27, pages 363 – 388: Epigenetic Epidemiology 
of the Developmental Origins Hypothesis; Waterland & Michels, copyright 2007; 
permission conveyed through Copyright Clearance Center, Inc.
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over time. Imperfect maintenance of epigenetic marks 
has long been proposed to result in stochastic changes 
without any environmental influence [50,70]. A recent study 
reported solid evidence for this by following two initially 
identical cell cultures growing separately under the same 
conditions for 300 generations [51]. Epigenetic information 
may further change under the influence of environmental 
exposures related to lifestyle and living conditions [15] 
(Figure 1.2). For instance, prolonged or repeated exposure 
in adulthood to tobacco smoke [71,72], traffic exhaust fumes 
[73] or low doses of arsenic [74] were found associated with 
differences in DNA methylation. Intrinsic cues such as chronic 
inflammation [75,76] or stress [77] were also found to induce 
postnatal epigenetic changes. 
Epigenetic changes due to environmental exposures could 
result from direct chemical damage, or from the incomplete 
(e.g. lack of methyl donors) or compromised (e.g. toxic 
interference) establishment of epigenetic marks. It is even 
conceivable that environmentally driven epigenetic changes 
may to some extent constitute an adaptive response [65], 
as repeated transcription of a locus has been suggested to 
change its epigenetic state [21,26]. Changing epigenetic 
marks could thus be an indicator of an active, or activated 
biological process, although their downstream biological 
effects remain to be revealed [15]. In conclusion, at birth 
epigenetic variation may be persistent, semi-heritable, 
and to a degree soma-wide [69]. Then, as uncorrected 
stochastic aberrations and environmentally driven epigenetic 
changes accumulate throughout life, this persistent level 
gradually changes in each cell individually [15]. It has been 
hypothesized that a build-up of uncorrected dysfunctional 
epigenetic perturbations may eventually result in a state 
called epigenetic dysregulation, which is implicated in ageing 
and its related diseases [58,59]. 
Technology, data resources, and biobanks in 
epigenetic research
The huge advance in DNA sequencing technologies 
of recent years (reviewed by Harrison & Parle-McDormott 
(2011) [78]) has enabled measurement of DNA methylation 
at individual CpG sites on both genome wide and high 
throughput platforms [Box 2]. Genome wide platforms 
are best suited for constructing epigenome maps and for 
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uncovering epigenetic candidate loci. However, these 
platforms still interrogate only a fraction of all CpG sites in 
the human genome and are biased towards CpG islands and 
promoter regions [79]. Medium-throughput platforms, like the 
Sequenom EPITYER platform, enable accurate quantitative 
measurement of methylation of a limited set of (nearby) CpG 
sites at any genomic (candidate) locus on large populations 
[80].
Following the technological aspect of measuring 
data, epigenetic research will need resources to facilitate 
interpretation of epigenetic associations. Parallel to genetics, 
these resources must include epigenome maps charting 
consensus epigenetic marks (DNA methylation and histone 
modifications), preferably for multiple cell types [88,89] and 
epivariome maps describing inter-individual variation in 
these marks [90–92]. Further, notwithstanding a few notable 
exceptions [93], the regulatory effect of DNA methylation in 
a cell population is commonly thought to rely on the status 
of multiple CpG sites within a genomic region [94], requiring 
data describing such potentially exploitable patterns within 
the normal variation (cf. linkage disequilibrium) [60,95]. 
Epigenetic databases, like those from the International 
BOX2: Measuring DNA methylation by sequencing 
bisulphite treated DNA
Most studies assess DNA methylation by sequencing DNA that is treated with 
bisulphite (BS), although more techniques exist (reviewed by Harrison & Parle-
McDormott (2011) [78]). BS treatment transforms unmethylated cytosines into 
uracils, while retaining the methylated cytosines, creating an artificial sequence 
variant that genetic sequencing tools and techniques can measure. However, BS 
based methods cannot distinguish between methyl-cytosine and hydroxy-meth-
yl-cytosine [81], an issue in stem cells and brain, but not in other somatic cells 
[46]. Determining the relative proportions of the artificial BS sequence variants 
on a representative number of DNA molecules, which requires a slight alteration 
of the protocols from genetics, forms a measure for the amount of methylated 
and unmethylated alleles in the tissue sample. The DNA sequencing technolo-
gies developed in recent years have been modified to enable sequencing of BS 
treated DNA, and thus measurement of DNA methylation at individual CpG sites 
on whole genome, genome-wide and locus-specific medium throughput plat-
forms (reviewed by Gupta et al. (2010) [82] and by Harrison & Parle-McDormott 
(2011) [78]). An example of a platform for whole genome BS sequencing is the 
powerful Illumina HiSeq platform (Illumina, San Diego, USA), which uses next 
generation sequencing technology to assess the methylation of over 90 % of 
the genomic total of 28 million CpG sites [83]. An example of a genome-wide 
platform is the Infinium BeadArray platform (Illumina), which has increased the 
amount of CpG sites it can interrogate from 1.500 in 2006 [84] to over 450.000 
in 2011 [85]. Examples of medium throughput platforms are the sequencing-by-
synthesis based Pyrosequencing platform [86] and the mass spectrometry based 
Sequenom MASSarray platform [87].
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Human Epigenome Consortium [96] (http://www.ihec-
epigenomes.org/) and the National Institute of Health (NIH) 
Epigenomics Roadmap [97] (http://www.roadmapepigenomics.
org/), are under construction, but will require much effort to 
be as effective as their genetic counterparts.
Epigenetic research will also require access to diverse 
biomaterial of human population or patient based studies 
that investigate ageing and its common diseases. Many of 
these studies have collected blood samples at baseline, 
subsequently storing the extracted DNA in biobanks for 
future investigation. Epigenetic studies on these biobanks are 
technically possible since DNA methylation is not affected by 
standard methods for DNA extraction and storage. However, 
these biobanks were originally set up for genetic research 
and often contain only DNA from blood obtained during a 
single round of sampling. Their use in epigenetic research 
may thus be limited, since their construction did not consider 
resampling to allow studies on a dynamic epigenome [94]. 
First, epigenetic marks are susceptible to environmental and 
physiological influences. This may impede cross-sectional 
epigenetic studies in distinguishing cause from consequence 
of disease [98,99], while prospective epigenetic research will 
require either longitudinal sampling [49] or another form of 
evidence that the epigenetic variation remained stable during 
the study. Second, the frequently described tissue differences 
in (genome wide) epigenetic patterns [100–102] may limit 
the relevance of epigenetic variation to the tissue that 
was assessed, which may confine most epigenetic studies 
into disease causes to the search for potential epigenetic 
markers of disease risk, and limit implicating an epigenetic 
mechanism in disease etiology to those diseases for which 
the relevant tissues are available. Third, and more pressing 
is the fact that inter-individual variation in the composition of 
the heterogeneous leukocyte population may confound the 
epigenetic variation in blood, since each different cell type 
may carry its own specific epigenetic marks [103]. Although 
not relevant for candidate gene studies, methods that 
address this issue through mathematical correction are being 
developed for genome wide investigations [104]. 
Unfortunately there will never be biobanks that contain 
repeated longitudinal DNA samples from disease related 
internal tissues (e.g. heart, brain), thereby dismissing the 
direct analysis of epigenetic marks on other than biosamples 
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obtained during post mortem examinations [105] or repeated 
sampling of peripheral tissues. However, loci at which 
epigenetic marks are set early in development, for instance 
imprinted loci, are commonly thought to harbour a similar 
epigenetic information throughout the soma. Thus, at such 
loci epigenetic variation in peripheral tissues is proposed 
to also inform on internal tissues [106]. Although not often 
collected, other peripheral tissues than blood can be obtained 
with minimal (e.g. buccal cells, or epidermis) [107,108] 
or moderate invasiveness (e.g. fat, or muscle biopsies) 
[109,110], which may be useful in elucidating similarities of 
epigenetic variation across tissues. In recent years a few 
projects have been launched to establish biobanks designed 
for epigenetic research that for now mostly contain cross-
sectional samples from multiple peripheral tissues [62,111]. 
However promising the emergence of such projects, it will 
take time for many more of them to emerge. Thus, if the 
clinical biobanks with all their limitations can still provide 
meaningful answers to some epigenetic research questions, 
Table 1.1: Candidate loci investigated in the various
studies of this thesis
Locus Chromosome Gene function Studied in chapter2 3 4 5 6
IL10 01q32.1 Anti-inflammation x x x
NR3C1 05q31.3 Stress response x x
TNF 06p21.33 Pro-inflammatory x x
IGF2R 06q25.3 Growth/Apoptosis x x
GRB10 07p12.2 IIS inhibitor x x
LEP 07q32.1 Metabolism x x x x
CRH 08q13.1 Stress response x x x
ABCA1 09q31.1 Cholesterol transport x x x x
IGF2a 11p15.5 Early growth x x x
INSIGF 11p15.5 (Embryonic) Growth x x x x
KCNQ1OT1 11p15.5 Imprinting control region x x x
MEG3 14q32.2 Growth suppressor x x
FTO 16q12.2 Development x x
APOC1 19q13.32 Metabolism x x
GNASAS 20q13.32 Growth/Lypolytic signal x x x x
GNAS A/B 20q13.32 Growth/Lypolytic signal x x
 
a:  The susceptibility of DNA methylation to prenatal  
conditions was observed previously at the IGF2 locus [14,120].
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they will present an unmatched source of patient based DNA 
samples, due to their combined size, disease repertoire, and 
detail of participant information gathered during the (long) 
follow up period.
Outline of thesis
Epigenetic marks can be persistently or dynamically 
altered from gametogenesis until death by a combination 
of influences from exposure to the external environment, 
from internal physiological processes, and from uncorrected 
stochastic perturbations. These sources of epigenetic 
variation cannot be readily isolated for investigation, 
particularly not in humans, nor will it be possible to capture 
a lifetime’s accumulation of causes and consequences 
of epigenetic variation in one study. However, careful 
formulation of specific research question and subsequent 
selection of appropriate study designs, may still promise 
meaningful epigenetic research on ageing and its related 
diseases [112]. In this thesis we will therefore apply a 
sequence of studies to investigate the relation between 
epigenetic mechanisms, ageing, and CHD. 
Chapter 2 investigates properties of epigenetic variation 
at 16 candidate loci, that were selected from the domain of 
cardiovascular and metabolic diseases (Table 1.1), pertaining 
to the suitability of DNA samples from existing biobanks for 
epigenetic studies on these loci. First we describe the inter-
individual variation and patterns of DNA methylation at 104 
individual CpG sites of the loci on recent blood samples from 
unrelated, healthy participants (14 – 72 years old) of the 
Netherlands Twin Register (NTR) [113,114]. We also assess 
the influence of leukocyte population heterogeneity on this 
variation and present a method to account for its potential 
effect on epigenetic variation. Then, we determine the 
temporal stability of methylation variation on longitudinal DNA 
samples from blood (mesoderm) and buccal cells (ectoderm) 
over a time span of up to two decades and we survey its 
correlation between the recent samples of both tissues.
Chapter 3 investigates the effect of prenatal exposure to 
the Dutch Famine of 1945 on epigenetic marks in individuals 
from the Hunger Winter Families Study [Box 1] [11]. We compare 
DNA methylation at 15 of the candidate loci (Table 1.1) between 
individuals (57 – 59 years old) who were prenatally exposed to 
the Dutch Famine and their same sex younger or older siblings 
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(43 – 70 years old), who were not exposed in utero. By measuring 
middle aged individuals we dismiss transient epigenetic changes 
that would reverse with improving conditions, thus focusing on 
lasting effects. The uncovered associations between prenatal 
famine and persistent DNA methylation are further explored for 
the role of the timing of the exposure (around conception vs. last 
trimester) and sex of the exposed.
Chapter 4 investigates the extent to which genomic DNA 
methylation, approximated with the LINE1 assay [115], and 
DNA methylation at 7 of the candidate loci (Table 1.1) changes 
stochastically or due to environmental influences during the adult 
life span. We assess inter-individual and within-pair variation in 
DNA methylation with increasing calendar age in a combined 
cross-sectional and longitudinal study on a large population of 
Dutch and Danish monozygotic twin pairs (18 – 88 years old) 
[116,117]. We also evaluate the influence of familial versus 
individual factors on age-related epigenetic variability. The twins 
pairs are solely selected on their age in order to randomize 
potential differences in adult living environments, thus focusing 
the study on the amount of epigenetic changeability across the 
full adult lifespan due to the combined effects of stochastic and 
environmentally driven epigenetic changes.
Chapter 5 investigates whether DNA methylation at the 6 loci 
at which it marks prenatal environmental conditions (Table 1.1) 
is associated with the risk for developing a myocardial infarction 
(MI) in a population of individuals (70 – 82 years old) from the 
PROSPER study [118]. The individuals selected from this study 
had not experienced a previous CHD event in order to exclude 
potential epigenetic differences as a consequence of the disease. 
Chapter 6 explores the extent to which the variation of DNA 
methylation in blood may inform on the methylation variation 
in internal tissues using a genome wide survey of post mortem 
samples of blood, subcutaneous fat (SC fat), muscle, visceral fat 
(VS fat), liver, spleen, and pancreas obtained from six individuals 
(58 – 79 years old) during autopsy. DNA methylation is assessed 
at 378,239 CpG sites distributed throughout the autosomal 
chromosomes. Besides comparing the tissues on genome wide 
patterns, we assess differences in the methylation level and 
the amount of variation at individual CpG sites and we inspect 
correlation coefficients between the tissues. Pooled blood from 
healthy middle aged regular blood donors is included in the study, 
to ascertain that no overhauling of DNA methylation patterns 
occurs within the first 24 hours after death.
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Abstract
The prospect of finding epigenetic risk factors for 
complex diseases would be greatly enhanced if DNA from 
existing biobanks, which is generally extracted from whole 
blood, could be used to perform epigenetic association 
studies. We characterized features of DNA methylation 
at 16 candidate loci, 8 of which were imprinted, in DNA 
samples from the Netherlands Twin Register biobank. 
Except for unmethylated or fully methylated sites, CpG 
methylation varied considerably in a sample of 30 unrelated 
individuals. This variation remained after accounting for the 
cellular heterogeneity of blood. Methylation of CpG-sites 
was correlated within loci and across chromosomes for 4 
imprinted loci. In 34 additional individuals, we investigated 
the DNA methylation of 8 representative loci in 2 longitudinal 
blood and 2 longitudinal buccal cell samples (follow-up 11-
20 and 2-8 years, respectively). 5 of 8 loci were stable over 
time (ρ>0.75) in both tissues indicating that prospective 
epigenetic studies may be possible. For 4 loci, the DNA 
methylation in blood (mesoderm) correlated with that in 
the buccal cells (ectoderm) (ρ>0.75). Our data suggest that 
epigenetic studies on complex diseases may be feasible for 
a proportion of genomic loci provided that they are carefully 
designed.
Key words
Epigenome; Biobank; Human studies; Complex disease
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Introduction
Epigenetics refers to heritable differences in gene 
expression potential that are not caused by variation in the 
DNA sequence [29,119]. Its molecular basis is the chemical 
modification of either the DNA itself (cytosine methylation 
in CpG dinculeotides) or the histones that package the 
chromatin (e.g. methylation, acetylation, phosphorylation.) 
[22,24,121]. It has frequently been proposed that changes 
in these epigenetic marks significantly contribute to the 
risk of complex diseases including cancer, cardiovascular 
and metabolic disease [17,98,119,122–124]. However, with 
the exception of studies on cancer, empirical data from 
epidemiological studies supporting these hypotheses are 
largely absent mainly due to technical and methodological 
limitations. 
Many of the technical limitations have been resolved, in 
particular with respect to the high throughput measurement 
of DNA methylation [125,126]. DNA methylation is correlated 
with other layers of epigenetic marks, particularly histone 
modifications [23]. DNA methylation may be the most suitable 
epigenetic mark for large-scale epidemiological studies, since 
methyl groups are covalently bound to CpG dinucleotides 
and are not lost during routine DNA extraction, unlike histone 
modifications. This opens the possibility of exploiting existing 
DNA biobanks for research purposes, to discover epigenetic 
risk factors for complex disease.
Epigenetic studies will require the development of 
data resources analogous to those that facilitated genetic 
association studies. The resources should include epigenome 
maps charting DNA methylation marks [41], the description 
of inter-individual variation in DNA methylation (cf. single 
nucleotide polymorphisms and copy number variants)
[127] and data on the patterns within this variation (cf. 
linkage disequilibrium)[60]. To guide the development of 
such epigenome-wide resources, candidate loci may be 
studied. In this respect differentially methylated regions 
influencing imprinting [128], transposon-derived sequences 
[128], CpG island shores [129] and recognition sequences 
for methylation-dependent transcription factors [93] are of 
particular interest. 
In addition, several issues potentially limiting the use 
of existing biobanks for epigenetic epidemiology need to 
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be addressed. Firstly, DNA in biobanks is mostly extracted 
from whole blood, which, like any tissue, consists of different 
cell types that may carry different epigenetic marks and 
whose relative numbers may vary between individuals [103]. 
Secondly, the stability of DNA methylation over time should 
be known before the association of DNA methylation with 
future disease risk can be assessed. Global (or average) 
DNA methylation has been reported to change over time 
[130,131], but DNA methylation of specific loci may be 
more stable [60,132]. Lastly, it will be crucial to address 
to what extent DNA methylation measured in blood marks 
in less accessible tissues that are directly involved in 
disease. Despite scattered reports that this may be the case 
[100,133,134], the issue remains largely unresolved.
We assessed whether genomic DNA stored in existing 
biobanks would be suitable for epigenetic epidemiological 
studies. To this end we  addressed the inter-individual 
variation in DNA methylation of 16 candidate loci for 
cardiovascular and metabolic disease, the influence of blood 
cell heterogeneity on this variation, the stability of DNA 
methylation over time and its correlation between whole 
blood (mesoderm) and buccal cells (ectoderm) in individuals 
from the Netherlands Twin Register (NTR) [113,114].
Methods and Materials
Study populations
The individuals investigated in this study were selected 
from the Netherlands Twin Register (NTR) biobank [113,114], 
which includes DNA samples from Dutch twins and their 
family members (parents, siblings, offspring and spouses). 
Firstly, unrelated individuals (Table S2.3) were selected 
(n=30) to study inter-individual variation in DNA methylation, 
the influence of cell heterogeneity and patterns of DNA 
methylation. These 30 individuals were selected from the 
ongoing NTR biobank project for which 9560 individuals 
were included. Random selection would result in a sample 
of individuals with characteristics very close to the average 
in the complete cohort. For this we applied the D-optimality 
criterion to the Fisher information matrix, which enabled 
us to select 30 individuals, representive of the whole range 
of phenotypic variation in age and metabolic parameters 
Binnenwerk_opmaak.indd   22 5-12-2014   13:18:45
23
present in the complete cohort. The age of the individuals 
selected ranged from 21 to 73 years; metabolic parameters 
of interest included: waist circumference, fasting blood 
glucose level, serum LDL and HDL cholesterol. Plasma 
and serum measurements and cell counts of whole blood 
were obtained using the standardized methods previously 
described (missing cell count information for 2/30 
individuals). Furthermore, we selected the proportion of 
males to females and of those who had never been smokers, 
to former and to current smokers so that it was equal to the 
proportion in the complete cohort.
Secondly, 34 individuals were selected for assessing the 
correlation of DNA methylation across time and tissue, and 
for validating the findings on the group of 30 individuals 
described above. This group consisted of participants in the 
NTR biobank project, who also took part in previous NTR 
projects. This allowed for recent DNA samples from whole 
blood (with information of cell counts) and buccal cells, as 
well as previous DNA samples from whole blood drawn 11 to 
20 years earlier, and from buccal swabs taken 2 to 8 years 
earlier (Table S2.4). The age at first sampling ranged from 14 
to 62 years. Among the 34 individuals, 17 were male, 26 were 
unrelated individuals and 8 were monozygotic twin pairs. DNA 
from all samples was extracted from whole blood and buccal 
swabs using standard methods.
Thirdly, the results on within-individual correlation 
between CpG-units were validated using 60 controls (28 
males, mean age 57 years) from the Dutch Hunger Winter 
Families Study [11]. DNA methylation was measured at the 
same loci using the same methods as the current study 
[14,135].
DNA methylation
Loci were selected on the basis of their potential 
involvement in cardiovascular and metabolic disease through 
the role of the adjacent candidate gene in growth, lipid 
metabolism, energy metabolism, inflammation, or stress 
response. Assay design focused on the regions of these 
loci that contained features with a potential for epigenetic 
regulation as observed in human, animal or cell culture 
experiments [93,133,136–148]. The loci selected included 
promoter elements, CpG-islands, transposon-derived 
sequences, methyl-sensitive transcription factor binding sites 
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(mTFBS), imprinted differentially methylated regions (DMR) 
and regions reported to regulate transcription through DNA 
methylation. Methylation assays were designed using the 
methprimer tool [149] on sections of sequence downloaded 
from the UCSC genome browser [150]. 58 Assays were tested 
for the reliability of the methylation measurement. 40 Assays 
gave a reliable measurement, and based on the priority given 
to the associated candidate gene and epigenetic properties 
(Table 2.1), 16 of these were selected to cover the whole 
range of possible average methylation levels (0%-100%).
One microgram of genomic DNA was bisulfite-converted 
using the EZ 96-DNA methylation (Zymo Research). DNA of 
the 30 individuals, in whom variation in DNA methylation 
was investigated, was converted on a single 96-well plate. 
DNA methylation of all 16 loci was measured using the 
same bisulfite-converted sample. The 4 samples (blood, 
buccal, recent and old) from individuals selected for testing 
the correlation over time and across tissues were bisulfite-
treated on the same 96-well plate. For this sub-study, two 
96-well plates were used to process the 136 samples, each 
plate with an equal number of individuals. Methylation of the 
8 loci was measured using a single bisulfite-converted DNA 
sample. Primers used to amplify the region of each assay are 
given in table S2.5A. DNA methylation was measured using a 
mass spectrometry-based method (Epityper, Sequenom)[87] 
whose quantitative accuracy (R2 duplicate measurements ≥ 
0.98) and concordance with clonal PCR bisulfite sequencing 
was reported previously [151,152]. All measurements were 
done in triplicate. Quality control consisted of several steps. 
CpG site containing fragments that had equal or overlapping 
mass, making them irresolvable by mass spectrometry, 
and CpG-sites containing fragments whose measurement 
was confounded by single nucleotide polymorphisms [60], 
according to dbSNP build 128 were discarded (Table S2.6). 
Next, at least two of the three replicate measurements had 
to be successful and the SD of the replicate measurements 
had to be 0.10 or less. Only CpG sites with a success rate 
greater than 75 % for the latter two criteria were considered 
fit for further analysis and the average was calculated for the 
replicate measurements. With these criteria applied, DNA 
methylation of 164 CpG-sites, distributed over 104 CpG site 
containing fragments (CpG units [87]), could be measured in 
the first sample of 30 individuals (Table S2.5B), 62 CpG units 
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contained 1 CpG site, 28 CpG units contained 2 CpG sites, 10 
CpG units contained 3 CpG sites and 4 CpG units contained 4 
CpG sites. The methylation of CpG sites occurring on a single 
fragment (CpG unit) cannot be resolved individually. Average 
CpG methylation for these CpG units was calculated using 
the RSeqMEth module [151]. The average success rate for 
the 104 CpG units assessed was 97%. In the second group 
of individuals, 41 CpG units containing 55 CpG sites could be 
measured applying the same criteria only to the recent blood 
samples and 38 CpG units containing 52 CpG sites to all 4 
samples (Table S2.5C).
To exclude the influence of DNA sequence variation 
not present in dbSNP on higher correlations observed 
between DNA methylation measured in a recent and in an 
old sample and blood and buccal swab, the evaluateSNPs() 
function of the R-module MassArray was used [153]. The 
Epityper method for DNA methylation measurements is 
based on a protocol to resequence genomic DNA using 
mass spectrometry (MassCleave, Sequenom [154]). By 
comparing the mass spectrum observed with the one 
expected according to a reference sequence, data points 
can be identified that are suspected of being confounded 
by sequence variation. This interference can be directly 
because the sequence variant affects a fragment containing 
a CpG site or indirectly because a sequence variant changes 
the mass of a non-CpG fragment so that it overlaps with a 
CpG-containing fragment. It is noteworthy, that sequencing 
genomic DNA would deal with direct interference only. 
Data-points suspected to be affected by unknown sequence 
variation were excluded and correlations recalculated to 
examine their influence. CpG measurements were removed 
for APOC1, CpG 1 (4 individuals excluded for all DNA 
samples (recent, old, blood, buccal)), CpG 10 (8) and CpG 
11 (11); LEP, CpG 8 (1); IGF2, CpG 6&7 (21); IGF2R, CpG 
4&5 (1) and CpG 11-13 (4); for CRH no measurements were 
excluded.
Statistical analyses
Male and female data were analysed separately in every 
test. However, in view of the study size the outcomes of 
these analyses should be considered as purely explorative. 
All P-values are two-sided and statistical analyses were 
performed using SPSS 16.0.
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Variation in DNA methylation. 
CpG sites with average methylation levels close to 0% 
or 100% by definition have a truncated variance. In order to 
circumvent this problem, the following variance-stabilizing 
transformation was applied [155]. Transformed value = 
Arc tan ( ( Methylation / (1-Methylation) )2 ). Using the 
transformed values, the equality of the variance of CpG sites 
was tested with Levene’s test.
Accounting for cellular heterogeneity. 
To test whether variation in DNA methylation was 
confounded by cellular heterogeneity, nested linear mixed 
models [156] were applied to the transformed data. The basic 
model was created as a baseline, to be subtracted from the 
nested models. It included the CpG site as a fixed effect. The 
three nested models each had one percentage of a major 
white blood cell subclass, namely neutrophils, lymphocytes or 
monocytes, added to the basic model as an extra fixed effect 
to test whether variation in this percentage could explain 
part of the variation in DNA methylation. The actual amount 
of variation in DNA methylation that could be explained by 
the percentage of the white blood cell type was calculated 
as 100% minus the percentage of the residual variance of 
the nested model with respect to the residual variance of the 
basic model. The linear mixed model accounts for correlated 
methylation within individuals and deals with methylation 
data missing at random without imputation [14]. It may be 
seen as an extension of the paired T-test: the model will 
reduce to a paired T-test with identical results if between-
group methylation differences are assessed for a single 
CpG site and if data are complete and all other factors are 
omitted.
Correlation and patterns of CpG methylation. 
Bivariate Pearson correlation coefficients between CpG 
sites were calculated after transforming the transformed 
methylation levels for neutrophil percentage. Non-significant 
correlations were treated as if there were no correlation 
(value of correlation set to 0). Patterns in the correlation 
matrix were visualized with a heat map after unsupervised 
complete linkage clustering, which utilizes the Euclidean 
distance (the difference between two points in the matrix 
squared).
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 Stability over time. 
The difference between DNA methylation at two time 
points was calculated per individual for each CpG unit as 
methylation of the old sample minus methylation of the new 
sample. Missing values were excluded pair-wise. Spearman’s 
rank correlation coefficient was used to calculate the 
correlation between the two time points.
Correlation between tissues 
The difference between DNA methylation in blood and 
buccal cells was calculated per individual for each CpG unit 
as methylation of the recent blood sample minus methylation 
of the recent buccal cell sample. Missing values were 
excluded pair-wise. Spearman’s rank correlation coefficient 
was used to calculate the correlation between the two 
tissues.
Results
Inter-individual variation in DNA methylation
We quantitatively measured the DNA methylation of 16 
candidate loci using DNA samples from the NTR biobank, 
to estimate its variation in the general population. The 
DNA was extracted from whole blood. The DNA samples 
were from 30 unrelated individuals, who were selected 
to represent the broad range in age and metabolic 
parameters of the whole biobank. After removing CpGs 
for which local genetic polymorphisms could interfere 
with DNA methylation measurements, and CpGs that did 
not meet the quality criteria, we recorded methylation of 
164 CpG sites, distributed over 104 CpG units, of which 
62 contained a single CpG site (Table 2.1). The average 
methylation of the loci studied ranged from 0 % to 98 
% (Figure 2.1). Within the majority of loci, the average 
methylation of CpG sites was similar. Exceptions were 
LEP with a 34% methylation difference between CpG sites 
located 18 bases apart and ABCA1 with a 31% difference 
between sites 26 bases apart. Previous studies reported 
methylation differences between men and women 
[135,157]. We could not detect such differences in an 
explorative analysis. This may be related to the study size 
and the number of tests performed.
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IL10a 01q32.1 205.01 Anti-inflam-mation 4 2 + 3 6 + +[136]
NR3C1 05q31.3 142.67 Stress response
20 4 + + 3 2 +[93]
TNF 06p21.33 31.65 Pro-inflam-matory 8 5 + 2 +[138]
IGF2Ra 06q25.3 160.35 Growth/Apoptosis
10 0 ? + + + 1 +[139]
GRB10 07p12.2 50.82 IIS inhibitor 16 5 + + + 4 2 +[140]
LEPa 07q32.1 127.67 Metabolism 10 5 + + 3 +[141]
CRHa 08q13.1 67.25 Stress response 5 5 + 1 1 +[142]
ABCA1 09q31.1 106.73 Cholesterol  transport 16 3 + + 4 4 ?[143]
IGF2a 11p15.5 2.13 Early growth 5 3 + + + +[133]
INSIGFa 11p15.5 2.14 (Embryonic)  Growth 4 4 ? + 2 +[144]
KCNQ1OT1a 11p15.5 2.68 Imprintingcontrol region
14 7 + + + +[145]
MEG3 14q32.2 100.36 Growth suppressor
7 3 + + + 1 1 +[146]
FTO 16q12.2 52.38 Development 10 4 + +
APOC1a 19q13.32 50.11 Metabolism 6 6 + 3 ?[147]
GNASAS 20q13.32 56.86 Growth/Lypo-lytic signal 17 3 + 1 +[148]
GNAS A/B 20q13.32 56.90 Growth/Lypo-lytic signal 12 3 + + + +[137]
 
a:  With these assays the stability across time and the correlation between  tissues 
was also investigated
b: CpG sites that met the quality criteria described in the methods section 
c: CpG sites of which the methylation proportion was measured individually 
d: Methylation sensitive transcription factor-binding sites 
e: CpG methylation previously reported to associate with gene expression
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A considerable inter-individual variation in CpG 
methylation was observed. The variation approximated a 
normal distribution except for CpG units that showed no 
or very little variation (average DNA methylation close to 
0 % or 100 %). The extent of this variation varied per CpG 
unit (0% <SD<15%). To exclude the possibility that this 
difference in variation might merely be due to the fact that 
DNA methylation is truncated at 0 % and 100 %, a variance 
stabilizing transformation was applied [155]. The variation 
remained significantly different between CpG units (p=10-16). 
To validate these findings, we measured the DNA methylation 
of 8 out of 16 loci (55 CpG sites, 31 CpG units with 1 CpG 
Figure 2.1: Inter-individual variation in DNA methylation  
Methylation percentage, y-axis, at every CpG unit, x-axis, for each of the 30 
individuals, coloured dots. The order of the loci is based on their chromosomal 
location, starting at the lowest designation. CpG unit numbers are counted from 
the Forward primer onwards. The name of each locus is given below the x-axis. 
The bold horizontal bar gives the median, the thin horizontal bars show the in-
ter-quartile range for each CpG unit. The vertical lines across the plot separate 
the loci. The corresponding CpG sites of each CpG unit are given in table S2.5B. 
Individually measured CpG sites are marked with an “S” below the unit number.
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site) in 34 additional individuals from the NTR biobank, and 
this yielded similar results (Figure S2.1).
Cellular heterogeneity
DNA methylation was measured on genomic DNA 
extracted from whole blood. As whole blood consists of 
different cell types, which may display differences in DNA 
methylation, we tested to what extent the inter-individual 
variation observed was influenced by cellular heterogeneity 
as assessed by counting the major cell subclasses. The 
largest cellular fraction consisted of neutrophils (average 
proportion 53.7 %; SD=8.8 %) thus contributing the majority 
of DNA molecules on which CpG methylation was analysed. 
For 10 out of 16 loci, the variation in DNA methylation was 
not associated with this measure of cellular heterogeneity 
(Table 2.2). For the remaining loci, the variation in DNA 
methylation that could be explained by variation in cellular 
heterogeneity was generally small and associations were 
of borderline significance. IL10, which is highly expressed 
in leukocytes, was a notable exception: 50% of its variation 
Table 2.2: Association of neutrophil proportion with 
DNA methylation
Locus Variance explained p-value of effect
IL10 50.1 % 3.9*10-06
NR3C1 0.2 % 0.555
TNF 8.0 % 0.037
IGF2R 5.0 % 0.208
GRB10 0.7 % 0.625
LEP 7.4 % 0.019
CRH 4.0 % 0.022
ABCA1 7.3 % 0.021
IGF2 3.5 % 0.185
INSIGF 0.3 % 0.674
KCNQ1OT1 0.4 % 0.733
MEG3 4.1 % 0.165
FTO 0.1 % 0.714
APOC1 6.2 % 0.026
GNASAS 0.8 % 0.590
GNAS A/B 0.0 % 0.889
Binnenwerk_opmaak.indd   30 5-12-2014   13:18:56
31
in DNA methylation could be attributed to the neutrophil 
cell count. The analysis was repeated using the lymphocyte 
percentage (average proportion 34.4 %; SD=8.4 %), which 
was highly correlated with the neutrophil percentage (r = 
-0.95) and similar results were observed (data not shown). 
No influence of monocyte percentage was observed on DNA 
methylation (average 8.0 %; SD=1.8 %; correlation with the 
neutrophil proportion: r = -0.48). The influence of cellular 
heterogeneity was not affected by gender (data not shown).
To validate these findings, we performed the same test 
on the 8 loci in an additional 34 individuals (Table S2.1). 
The loci previously not showing an association were again 
not associated with the neutrophil percentage (IGF2R, 
IGF2, INSGF and KCNQ1OT1). Two of the associations of 
borderline significance were not found (APOC1 and CRH), 
but the modest association of LEP with the neutrophil 
percentage was replicated (p=1.0x10-4). Again, a 
substantial proportion of the variation in IL10 methylation 
could be attributed to the neutrophil percentage (27.9%, 
p=8.0x10-8).
Correlations and patterns of CpG methylation
To investigate patterns of DNA methylation further within 
and across loci, correlations between the methylation of CpG 
sites were computed and visualized using a heat map after 
unsupervised clustering (Figure 2.2). CpG methylation was 
particularly correlated within loci (rmax = 0.95) but also across 
loci (rmax = 0.68). The cluster of loci correlating irrespectively 
of chromosomal location included paternally imprinted loci 
(MEG3 and GNASAS) and maternally imprinted loci (GRB10, 
KCNQ1OT1 and GNAS A/B). These observations were unaffected 
by variance-stabilizing transformation or adjustment for cell 
heterogeneity prior to analysis (data not shown).
The correlation was studied for the same 16 loci in 60 
controls of the Dutch Hunger Winter Families Study that 
we measured previously [14,135]. The heat map of the 
correlations revealed similar patterns (Figure S2.2). Again, 
a strong correlation was observed within loci. Across loci, 
significant correlations were observed for GNASAS, GNAS A/B, 
GRB10 and MEG3. In addition, a correlation between these 
loci and IGF2 was observed, whereas the correlation with 
KCNQ1OT1 was not reproduced. The correlations were similar 
for both sexes (data not shown).
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Stability over time
To study the stability of DNA methylation over time, 
we selected 34 additional individuals from the NTR for 
whom two blood samples were taken 11-20 years apart. 
The methylation of 8 loci that were representative of the 
set of 16 loci was measured (Table 2.1). Overall, DNA 
methylation was similar at the two time points (Figure 2.3A) 
Figure 2.2: Correlation between CpG sites within and across loci  
Heat map depicting correlations between the methylation levels of all CpG 
units of the 16 loci measured in the first group of 30 individuals. For reference 
the CpG units are annotated by a colour, based on the locus, in the left and 
upper margin. The diagonal axis running from the lower left to the upper right 
corner is the line of symmetry where each CpG unit hypothetically correlates 
with itself. Full correlation (1) is plotted as the brightest red shade, full inverse 
correlation (-1) is plotted as the brightest green shade, no correlation (0) is 
plotted as black. Non-significant correlations are depicted as no correlation. The 
complete clustering is based on the Euclidean distance. 
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and only minor differences were observed (Table 2.3A). 
Similar average methylation levels between the time-
points do not indicate stability per se since methylation 
may increase in some and decrease in other individuals 
over time. The variation around the average difference was 
greatest for IL10, which also showed the greatest average 
difference (-2.8% (SD = 9.1); Table 2.3A). It was lowest for 
KCNQ1OT1 (SD = 2.8), indicating relative stability over time. 
An alternative way to express stability, which takes into 
account the differences in inter-individual variation of the 
loci, is to compute correlation coefficients (Table 2.3A). For 
5 of the 8 loci, the correlation ρ > 0.75 indicated substantial 
stability between the time points. These loci included IGF2R 
(ρ = 0.88) and APOC1 (ρ = 0.96). Note that the correlation 
was low for KCNQ1OT1 (ρ = 0.31), which can be attributed 
to the very low level of inter-individual variation. Temporal 
stability was similar in both sexes (data not shown). From 
Figure 2.3: Temporal stability and comparison between blood and buc-
cal cell DNA methylation  
Scatter plots for individual comparison of CpG methylation between the DNA 
samples. CpG units of each individual are annotated by colouring based on the 
locus. The diagonal x = y line is plotted in black for reference. A) CpG meth-
ylation in the first blood sample (x-axis) is plotted against methylation in the 
second, more recent, blood sample (y-axis). Each dot represents one CpG unit 
of one individual in both DNA samples. B) CpG methylation in the recent blood 
DNA sample (x-axis) is plotted against methylation in the recent buccal swab 
DNA sample (y-axis). Each dot represents one CpG unit of one individual in both 
DNA samples.
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the same 34 individuals, DNA samples from buccal swabs 
taken 2-8 years apart were available and showed similar 
results (Table S2.2). 
To exclude the possibility that the higher correlations 
observed were due to sequence variation not present in 
dbSNP, we used the mass spectra to identify CpG methylation 
measurements that were suspected to have been influenced 
by sequence variation [153]. This was the case for 1 or 
more individuals for 7/41 CpG units. Removal of these CpG 
measurements did not affect the correlations ρ > 0.75 
(IGF2R, ρ = 0.87; LEP, ρ = 0.90; IGF2, ρ = 0.92; CRH, ρ = 
0.94; and APOC1, ρ = 0.95).
Table 2.3A: Comparison of DNA methylation in blood 
samples of the two time points
Locus
Methylation mean (SD) Difference 
mean (SD)
Spearman’s 
rho (ρ)Old blood New Blood
IL10 22.4% (9.0) 25.2% (6.6) - 2.8% (9.1) 0.422
IGF2R 65.8% (16.8) 67.6% (17.7) - 1.8% (8.1) 0.883
LEP 20.0% (11.5) 21.8% (13.0) - 1.8% (6.1) 0.895
CRH 63.4% (22.1) 63.8% (21.1) - 0.4% (6.7) 0.942
IGF2 49.4% (11.8) 49.0% (11.3)   0.4% (4.7) 0.924
INSIGF 86.4% (4.1) 85.5% (4.3)   0.9% (3.7) 0.649
KCNQ1OT1 30.8% (2.2) 31.8% (2.6) - 1.0% (2.8) 0.307
APOC1 19.7% (11.4) 19.6% (11.7)   0.1% (3.4) 0.956
Table 2.3B: Comparison of DNA methylation in recent 
blood and buccal cell samples
Locus
Methylation, mean (SD) Difference, 
mean (SD)
Spearman’s 
rho (ρ)Blood Buccal cells
IL10 24.8% (7.1) 64.9% (18.8) - 40.1% (17.1) 0.442
IGF2R 68.3% (17.4) 81.6% (12.4) - 13.3% (10.6) 0.827
LEP 21.7% (13.7) 11.8% (8.8)      9.9% (9.9) 0.798
CRH 63.8% (21.9) 58.4% (21.4)      5.4% (7.9) 0.905
IGF2 48.8% (11.5) 32.4% (11.0)    16.4% (10.8) 0.557
INSIGF 85.4% (4.3) 84.4% (4.7)      1.0% (4.6) 0.371
KCNQ1OT1 32.0% (2.6) 34.7% (3.1)   - 2.7% (3.0) 0.481
APOC1 19.9% (11.7) 10.7% (9.6)      9.2% (7.6) 0.822
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Correlation of CpG methylation between tissues 
To test whether DNA methylation in blood could mark that 
in other tissues, we studied DNA methylation of the 8 loci in 
the recent blood (mesoderm) and buccal swab (ectoderm) 
samples of the individuals in whom stability over time was 
tested. The average level of DNA methylation was generally 
different between the two tissues and the extent of the 
difference depended on the locus (Figure 2.3B, Table 2.3B). 
The variation around the average difference also varied per 
locus. Again, IL-10 showed the highest variation (SD = 17.1) 
and KCNQ1OT1 the lowest (SD = 3.0). For all loci, the SD of 
the average difference between the tissues was higher than 
that of the average difference between the time points. For 4 
of the 8 loci, the correlation of DNA methylation between the 
two tissues was greater than 0.75. These loci included IGF2R 
(ρ = 0.83) and APOC1 (ρ = 0.82). Again, the correlations 
were similar in both sexes (data not shown). After removing 
CpGs measurements suspected to be influenced by sequence 
variation not present in dbSNP, similar correlations were 
found (IGF2R, ρ = 0.82; LEP, ρ = 0.80; CRH, ρ = 0.90; and 
APOC1, ρ = 0.81).
Discussion 
Epigenetic risk factors are thought to contribute to the 
development of common diseases such as cardiovascular and 
metabolic disease [122–124]. Here we investigated whether 
genomic DNA from existing biobanks is suitable for the 
identification of these risk factors in epidemiological studies 
[98,119].
Using genomic DNA from the Netherlands Twin Register 
biobank [113,114], we first assessed the inter-individual 
variation in DNA methylation for 16 candidate loci, since 
the human epigenome map is still in development [41] and 
epigenome-wide resources on variation (i.e. the epivariome) 
are lacking. We observed considerable variation in CpG 
methylation between individuals, except for loci that are 
either not methylated or fully methylated. The extent of 
this variation varied between CpG sites. Earlier reports 
frequently characterized CpG methylation as hypo-, iso- 
or hypermethylation [133,158]. Our data support our own 
Binnenwerk_opmaak.indd   35 5-12-2014   13:19:10
36
previous work [60] and that of others [127] in which DNA 
methylation was more accurately described as a quantitative 
trait.
Secondly, we addressed the possibility that the variation 
in DNA methylation could simply be attributed to cellular 
heterogeneity in leukocytes between individuals [103]. 
Blood, like any tissue, consists of a mixture of different cell 
types that all may have a cell-specific epigenome [24]. Our 
results show that for the large majority of candidate loci, 
inter-individual differences in the cellular composition of the 
blood sample did not contribute to the variation observed 
in DNA methylation or explained only a minor proportion of 
this variation. One notable exception was the IL10 locus for 
which cellular heterogeneity explained up to half of the total 
variation in DNA methylation. If cell counts are available for 
whole blood samples stored in a biobank, the potentially 
confounding influence of cellular heterogeneity can be 
monitored using standard statistical methods. If no data on 
cellular heterogeneity are available, it may be necessary 
to exclude the association of cellular heterogeneity either 
with the outcome of interest or with methylation of the locus 
studied. The latter can be addressed for example in a (sub)
study for which data on leukocyte populations are available. 
Our study suggests that no such relationship will be observed 
for many loci, in which case biobanks without data on cellular 
heterogeneity may still be useful.
Thirdly, we investigated patterns in CpG methylation 
within and across loci. We found that within the locus CpG 
methylation is highly correlated, except for candidate 
loci that were not methylated or fully methylated, which 
corroborates recent findings [60,90]. This observation 
suggests that assessing the methylation of a subset 
of CpGs is sufficient to cover the variation in DNA 
methylation at a locus. This is analogous to genetic 
association studies in which a small number of tagging 
SNPs can cover all genetic variation at a locus due 
to linkage disequilibrium [159]. Moreover, our results 
provide the first indication that methylation of CpG sites 
can also be correlated irrespectively of their chromosomal 
location. This was observed for a subset of mainly 
imprinted loci, which may be related to the mechanisms 
responsible for establishing methylation marks at DMRs 
[160,161]. 
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Fourthly, since DNA methylation is a reversible process 
[162], it may not be stable over time. If so, this would 
preclude conclusions about causality in epidemiological 
studies, since DNA methylation may change during a follow-
up period or the differences in DNA methylation may be 
the consequence of disease [69]. The majority of loci tested 
were stable over time in DNA from blood and buccal cells 
despite possible changes in cellular composition during 
the follow-up period. The fact  that we investigated DNA 
samples that were taken 11 to 20 years apart, implies 
that these DNA methylation marks may be investigated 
in most prospective cohort studies in which participants 
are followed for the development of disease for similar or 
shorter follow-up periods. However, for a minority of loci we 
found that although, on average, there was no difference in 
DNA methylation between the time points, the correlation 
was lower, indicating relaxed maintenance of these DNA 
methylation marks. This data resembles recent results on 
global DNA methylation studying similar follow-up periods 
[131]. The age of the individuals in our study was limited to 
young and middle ages (14 to 62 years old). Therefore, we 
cannot exclude instability over very long periods of time, nor 
can we exclude the occurrence of greater changes in old age. 
Indeed, instability of the DNA methylation marks in old age 
has been reported for both locus-specific [14,132] and global 
[163] DNA methylation. Moreover, our study did not address 
the possible occurrence of changes in DNA methylation as 
a consequence of disease or processes preceding its clinical 
manifestation [69].
DNA from existing biobanks generally is extracted from 
easily accessible tissues such as blood. Future studies may 
reveal DNA methylation patterns in such tissues that mark 
the risk of disease. As a first step towards establishing 
a possible causal role, it will be necessary to determine 
that DNA methylation measured in peripheral tissues is 
associated with that in tissues directly involved in the disease 
of interest. Although DNA methylation is thought to be a 
mechanism driving cell differentiation leading to tissue-
specific differentially methylated regions [129], initial reports 
indicated that DNA methylation measured in blood may 
be informative. For example, IGF2 and ER-α methylation in 
blood marked that of colon tissue [133,134]. Also, an autopsy 
study of 6 subjects and 11 tissues, which did not include 
Binnenwerk_opmaak.indd   37 5-12-2014   13:19:11
38
blood, suggested that the hypo- and hypermethylation status 
of loci is commonly preserved across tissues. Comparing 
the methylation of candidate loci in blood and buccal cells, 
we found that for half of the loci tested, DNA methylation 
measured in blood was a marker for that in buccal cells. 
These results are promising since blood and buccal cells 
stem from different germ layers (mesoderm and ectoderm, 
respectively) and warrant the investigation of correlations 
with other tissues involved in disease. Genome-scale studies 
in particular will be informative for defining the (sequence) 
characteristics of loci showing correlations across tissues. 
Such studies will be required to interpret the results of 
epidemiological studies on DNA methylation in blood in a 
meaningful way.
Our study on the suitability of DNA from existing biobanks 
for epigenetic studies provides leads for setting up new 
biobanks specifically aimed at epigenetic epidemiology. Since 
the correlation between DNA methylation, as measured in DNA 
from blood and other tissues (directly involved in disease), 
appears to be complex and locus-dependent, such initiatives 
should ideally include efforts to sample tissues others than 
blood (mesoderm), at least for a subgroup representing the 
cohort. Tissues representing the three germ layers, for which 
collection is feasible, include: tissue from the mesoderm: 
biopsies of skeletal muscle, subcutaneous fat and the 
dermal layer of a skin punch biopsy (fibroblasts); tissue from 
the ectoderm: the epidermal layer of a skin punch biopsy 
(keratinocytes) and buccal cells; and tissue from the endoderm: 
a urine sample (bladder lining) and a stool sample (colonic 
mucosa). In addition, follow-up sampling of the various tissues 
should be included (at least for a sub-group) to assess temporal 
stability and changes in DNA methylation as a consequence of 
pathology. To account for the cellular heterogeneity of blood 
samples, blood cell populations should be counted if whole 
blood is biobanked. This can easily be done using cheap, 
routine methods. An alternative approach to reduce the cellular 
heterogeneity is to store peripheral blood mononuclear cells 
(PBMCs) instead of whole blood. PBMCs include lymphocytes 
(T and B cells), and monocytes, while the granulocytes 
(mainly neutrophils) are lost. To completely remove cellular 
heterogeneity, cells can be separated using magnetic-activated 
cell sorting (MACS)., However, this is exceedingly costly and 
will not be feasible for larger numbers in most projects.
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Taken together, our results indicate that there are good 
prospects for the use of existing biobanks for epigenetic 
studies. Loci that are suitable for testing in epigenetic studies 
demonstrate inter-individual variation in DNA methylation, 
stability of this variation in DNA methylation over time and 
a correlation between DNA methylation as measured blood 
and the tissue of interest. Our data shows that meeting these 
criteria is locus-dependent. Therefore, it may be necessary to 
address this issue for each combination of locus, tissue and 
disease in new studies.
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Table S2.1: Association of neutrophil proportion with 
DNA methylation of the recent blood samples of 34 ad-
ditional individuals from the NTR biobank 
Locus Variance explained p-value of effect
IL10 27.9 % 8.0*10-08
IGF2R 1.2 % 0.312
LEP 1.8 % 1.0*10-04
CRH 0.0 % 0.993
IGF2 0.6 % 0.378
INSIGF 0.1 % 0.677
KCNQ1OT1 0.0 % 0.808
APOC1 0.1 % 0.763
Figure S2.1: Methylation percentage, y-axis, at every CpG-unit, x-axis, for 
each individual, coloured dots. Measurement was done on DNA from the recent 
blood samples of the 34 individuals used in the experiments on temporal stabil-
ity. The order of the loci is based on their chromosomal location, starting at the 
lowest designation. CpG-unit numbers are counted from the Forward primer on-
ward. The name of each locus is given below the x-axis. The bold horizontal bar 
gives the median, the thin horizontal bars show the inter-quartile range for each 
CpG-unit. The vertical lines across the plot separate the loci. The corresponding 
CpG-sites of each CpG-unit are given in table S2.5C. Individually measured CpG-
sites are marked with an “S” below the unit number.
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Table S2.2: Comparison of DNA methylation in buccal 






rho (ρ)Old Buccal cells
New Buccal 
cells
IL10 66.9% (13.6) 65.8% (18.4)   1.1% (17.0) 0.613
IGF2R 81.0% (12.9) 82.9% (11.7) - 1.9% (9.0) 0.701
LEP 10.7% (7.4) 11.0% (7.8) - 0.3% (7.3) 0.608
CRH 62.7% (21.0) 62.3% (21.5)   0.4% (9.2) 0.888
IGF2 32.5% (8.8) 32.3% (11.0)   0.2% (9.0) 0.686
INSIGF 84.6% (4.4) 84.4% (4.7)   0.2% (3.9) 0.543
KCNQ1OT1 35.8% (3.0) 34.9% (3.0)   0.9% (4.0) 0.097
APOC1 9.4% (7.2) 10.8% (9.7) - 1.4% (6.1) 0.836
Figure S2.2: Heatmap depicting correlations between the methylation levels of all 
CpG-units of the 16 loci measured in the controls of the periconceptional group in 
the Dutch Hunger Winter Families study [14,135] (P.I: Dr. L.H. Lumey, Department 
of Epidemiology, Mailman School of Public Health, Columbia University, New York, 
NY 10032, USA). Correlations were computed on the data after variance stabiliz-
ing transformation. For reference the CpG-units are annotated by a colour, based 
on the locus, in the left and upper margin. The diagonal axis running from the 
lower left to the upper right corner is the line of symmetry where each CpG-unit 
hypothetically correlates with itself. Full correlation (1) is plotted as the brightest 
red shade, full inverse correlation (-1) is plotted as the brightest green shade, no 
correlation (0) is plotted as black. Non-significant correlations are depicted as no 
correlation. The complete clustering is based on the Euclidean distance.
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Table S2.3: Characteristics of 30 individuals, 
selected from the NTR biobank, studied 
Male, no. (%) 12 (40 %)
Female, no. (%) 18 (60 %)
Smoker, no. (%) 3 (10 %)
Ex-smoker, no. (%) 15 (50 %)
Non-smoker, no. (%) 12 (40 %)
Age at biobanking, mean (SD) 48 (16)
Waist circumference in cm, mean (SD) 98 (22)
LDL-cholesterol (in mmol/L) , mean (SD) 2.47 (1.63)
HDL-cholesterol (in mmol/L) , mean (SD) 1.51 (0.94)
Glucose (in mmol/L) , mean (SD) 9.10 (4.83)
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Table S2.4: Age and longitudinal sampling of  
34 individuals from the NTR biobank 
Age at first 
sampling 
(blood)
Years to first 
follow-up 
(buccal swab)
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Table S2.5A: Primers used in bisulfite PCR















































10-mer tag AGGAAGAGAG + primer
T7 tag CAGTAATACGACTCACTATAGGGAGA-
AGGCT + primer
Binnenwerk_opmaak.indd   44 5-12-2014   13:19:30
45
Table S2.5B: CpG-sites per fragment of the loci that 
were analyzed for variation
Locus CpG-sitesa analyzed
IL10 1, 2&3, 4
NR3C1 1&2, 4, 7&8, 9, 10&11, 12&13, 14, 15&16, 17-20, 31, 33&34
TNF 1-3, 5, 6, 9, 10, 11
IGF2R 4&5, 8-10, 11-13, 20&21
GRB10 1&2, 4-6, 7, 8, 17, 18-21, 22&23, 24, 25
LEP 1, 8, 16&17, 19-21, 22, 25, 27
CRH 1, 2, 5, 9, 10
ABCA1 1, 3&4, 6-9, 15&16, 17&18, 19-21, 24, 25
IGF2 3, 4, 6&7, 8
INSIGF 2, 4, 5, 6
KCNQ1OT1 1, 6, 8&9, 10-12, 15, 16, 17&18, 20, 21, 25
MEG3 2, 3, 4, 8&9, 10&11
FTO 2&3, 7, 8&9, 10&11, 14, 17, 19
APOC1 1, 2, 3, 4, 10, 11
GNASAS 1&2, 3&4, 6, 7, 8&9, 10-12, 13&14, 15, 17-19
GNAS A/B 1, 3&4, 7, 8, 13-15, 16-19
 
a: CpG-site number is counted from the forward primer onward
Table S2.5C: CpG-sites per fragment of the loci that 
were analyzed for stability
Locus CpG-sitesa analyzed
IL10 1, 2&3, 4
IGF2R 4&5, 8-10, 11-13, 20&21, 22b
LEP 1, 8, 16&17, 19-21, 22b, 25, 27
CRH 1b, 2, 5, 9
IGF2 4, 6&7, 8
INSIGF 2, 4, 5, 6
KCNQ1OT1 1, 6, 10-12, 15, 16, 17&18, 20, 21, 25
APOC1 1, 2, 3, 4, 10, 11
 
a: CpG-site number is counted from the forward primer onward
b: CpG-site measurement met the quality criteria only in the recent blood samples 
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 Table S2.6: All CpG-units of the 16 loci
Locus_CpG-
unita CpG-sitesa
















NR3C1_12 CpG_21 Mass overlap with unit 14
NR3C1_13 CpG_22-28 





NR3C1_19 CpG_35-41 High Mass









IGF2R_01 CpG_1 Mass overlap with unit 8
IGF2R_02 CpG_2 Mass overlap with unit 3
IGF2R_03 CpG_3 Mass overlap with unit 2
IGF2R_04 CpG_4&5 
IGF2R_05 CpG_6&7 Mass overlap with unit 11
IGF2R_06 CpG_8-10 
IGF2R_07 CpG_11-13 
IGF2R_08 CpG_14 Mass overlap with unit 1
IGF2R_09 CpG_15&16 
Mass overlap with unit 10 and rs677882 and 
rs8191722
IGF2R_10 CpG_17 Mass overlap with unit 9
IGF2R_11 CpG_18&19









GRB10_06 CpG_9&10 Mass overlap with unit 8
GRB10_07 CpG_11 Low mass
GRB10_08 CpG_12 Mass overlap with unit 6









LEP_02 CpG_2-7 High Mass and rs791620 
LEP_03 CpG_8
LEP_04 CpG_9&10 Mass overlap with unit 9
LEP_05 CpG_11 Mass overlap with units 12 and 6
LEP_06 CpG_12&13 Mass overlap with units 5 and 12
LEP_07 CpG_14&15 Mass overlap with unit 14
LEP_08 CpG_16&17 
LEP_09 CpG_18 Mass overlap with unit 4
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control
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 Table S2.6: All CpG-units of the 16 loci
Locus_CpG-
unita CpG-sitesa
















NR3C1_12 CpG_21 Mass overlap with unit 14
NR3C1_13 CpG_22-28 





NR3C1_19 CpG_35-41 High Mass









IGF2R_01 CpG_1 Mass overlap with unit 8
IGF2R_02 CpG_2 Mass overlap with unit 3
IGF2R_03 CpG_3 Mass overlap with unit 2
IGF2R_04 CpG_4&5 
IGF2R_05 CpG_6&7 Mass overlap with unit 11
IGF2R_06 CpG_8-10 
IGF2R_07 CpG_11-13 
IGF2R_08 CpG_14 Mass overlap with unit 1
IGF2R_09 CpG_15&16 
Mass overlap with unit 10 and rs677882 and 
rs8191722
IGF2R_10 CpG_17 Mass overlap with unit 9
IGF2R_11 CpG_18&19









GRB10_06 CpG_9&10 Mass overlap with unit 8
GRB10_07 CpG_11 Low mass
GRB10_08 CpG_12 Mass overlap with unit 6









LEP_02 CpG_2-7 High Mass and rs791620 
LEP_03 CpG_8
LEP_04 CpG_9&10 Mass overlap with unit 9
LEP_05 CpG_11 Mass overlap with units 12 and 6
LEP_06 CpG_12&13 Mass overlap with units 5 and 12
LEP_07 CpG_14&15 Mass overlap with unit 14
LEP_08 CpG_16&17 
LEP_09 CpG_18 Mass overlap with unit 4
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control




LEP_12 CpG_23&24 Mass overlap with units 5 and 6
LEP_13 CpG_25
LEP_14 CpG_26 Mass overlap with unit 7
LEP_15 CpG_27
LEP_16 CpG_28
LEP_17 CpG_29 rs2167270 






CRH_06 CpG_6 Mass overlap with unit 7





































KCNQ1OT1_03 CpG_3-5 Mass overlap with unit 8
KCNQ1OT1_04 CpG_6
KCNQ1OT1_05 CpG_7 Mass overlap with units 15 and 19
KCNQ1OT1_06 CpG_8&9 
KCNQ1OT1_07 CpG_10-12 







KCNQ1OT1_15 CpG_22 Mass overlap with units 5 and 19
KCNQ1OT1_16 CpG_23 rs7940500 
KCNQ1OT1_17 CpG_24 rs379976 
KCNQ1OT1_18 CpG_25





MEG3_05 CpG_5 Mass overlap with unit 6
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control




LEP_12 CpG_23&24 Mass overlap with units 5 and 6
LEP_13 CpG_25
LEP_14 CpG_26 Mass overlap with unit 7
LEP_15 CpG_27
LEP_16 CpG_28
LEP_17 CpG_29 rs2167270 






CRH_06 CpG_6 Mass overlap with unit 7





































KCNQ1OT1_03 CpG_3-5 Mass overlap with unit 8
KCNQ1OT1_04 CpG_6
KCNQ1OT1_05 CpG_7 Mass overlap with units 15 and 19
KCNQ1OT1_06 CpG_8&9 
KCNQ1OT1_07 CpG_10-12 







KCNQ1OT1_15 CpG_22 Mass overlap with units 5 and 19
KCNQ1OT1_16 CpG_23 rs7940500 
KCNQ1OT1_17 CpG_24 rs379976 
KCNQ1OT1_18 CpG_25





MEG3_05 CpG_5 Mass overlap with unit 6
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control
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MEG3_10 CpG_12-14 High Mass
FTO_01 CpG_1 Mass overlap with Unit 5
FTO_02 CpG_2&3 
FTO_03 CpG_4 Low mass
FTO_04 CpG_5





































GNAS A/B_02 CpG_2 Mass overlap with unit 4
GNAS A/B_03 CpG_3&4 
GNAS A/B_04 CpG_5&6 Mass overlap with unit 2
GNAS A/B_05 CpG_7
GNAS A/B_06 CpG_8
GNAS A/B_07 CpG_9&10 
GNAS A/B_08 CpG_11 Low mass
GNAS A/B_09 CpG_12
GNAS A/B_10 CpG_13-15 
GNAS A/B_11 CpG_16-19 
Totals
# of amplicons 16
total # units 191
# units outside detection 
range 9
# units with equal or overlap-
ping mass 36
# units with potential SNP 12
Total # CpG-units removed 57
a: CpG-unit and CpG-site numbers are counted from the forward primer onward
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control
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MEG3_10 CpG_12-14 High Mass
FTO_01 CpG_1 Mass overlap with Unit 5
FTO_02 CpG_2&3 
FTO_03 CpG_4 Low mass
FTO_04 CpG_5





































GNAS A/B_02 CpG_2 Mass overlap with unit 4
GNAS A/B_03 CpG_3&4 
GNAS A/B_04 CpG_5&6 Mass overlap with unit 2
GNAS A/B_05 CpG_7
GNAS A/B_06 CpG_8
GNAS A/B_07 CpG_9&10 
GNAS A/B_08 CpG_11 Low mass
GNAS A/B_09 CpG_12
GNAS A/B_10 CpG_13-15 
GNAS A/B_11 CpG_16-19 
Totals
# of amplicons 16
total # units 191
# units outside detection 
range 9
# units with equal or overlap-
ping mass 36
# units with potential SNP 12
Total # CpG-units removed 57
a: CpG-unit and CpG-site numbers are counted from the forward primer onward
Locus_CpG-
unita CpG-sitesa
Reason for removal prior to 
quality control
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Abstract 
Prenatal famine in humans has been associated with 
various later-life consequences depending on the gestational 
timing of the insult and the sex of the exposed individual. 
Epigenetic mechanisms have been proposed to underlie 
these associations. Indeed, animal studies and our early 
human data on the imprinted IGF2 locus indicated a link 
between prenatal nutritional and DNA methylation. However, 
it remains unclear how common changes in DNA methylation 
are and whether they are sex- and timing-specific paralleling 
the later-life consequences of prenatal famine exposure. 
To this end we investigated the methylation of 15 loci 
implicated in growth and metabolic disease in individuals 
who were prenatally exposed to a war-time famine in 1944-
45. Methylation of INSIGF was lower among individuals who 
were periconceptionally exposed to the famine (n=60) as 
compared with their unexposed same-sex siblings (P=2x10-
5), whereas methylation of IL10, LEP, ABCA1, GNASAS and 
MEG3 were higher (all P<10-3). A significant interaction 
with sex was observed for INSIGF, LEP and GNASAS. Next, 
methylation of 8 representative loci was compared between 
62 individuals exposed late in gestation and their unexposed 
siblings. Methylation was different for GNASAS (P=1.1x10-7) 
and, in men, LEP (P=0.017). Our data indicate that persistent 
changes in DNA methylation may be a common consequence 
of prenatal famine exposure and that these changes depend 
on the sex of the exposed individual and the gestational 
timing of the exposure. 
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Introduction
Adverse environmental conditions during specific windows 
of mammalian development can have lasting effects on 
metabolic pathways and physiology, thereby influencing 
the susceptibility to chronic diseases [164]. An extensive 
epidemiologic literature has reported associations between 
characteristics of early development and health outcomes 
later in life [165,166]. Historical famines provide a quasi-
experimental setting in which the long-term consequences 
of adverse conditions during development can be studied 
in humans. Studies of the Dutch Hunger Winter, a severe 
wartime famine at the end of WWII affecting the western part 
of The Netherlands, suggest that famine exposure in utero 
can lead to various adverse metabolic or mental phenotypes, 
depending on the sex of the exposed individual and the 
timing of the exposure during gestation [167–170]. 
The period around conception may be especially sensitive 
to famine exposure [171]. Exposure to famine in this period 
is associated with diverse phenotypic outcomes such as an 
increased risk of adult schizophrenia [170] and spina bifida at 
birth in men [172]. However, the effects of prenatal famine 
exposure are not limited to this developmental period. An 
example of a general, sex-specific late life effect is the 
increase in body mass index [169,173] and various lipids in 
blood [167] among famine-exposed women, irrespective of 
the precise gestational timing of the exposure. Also, increases 
in cerebro-cardiovascular related deaths have been reported 
among individuals exposed to seasonal food shortages 
independent of the gestational timing in a historical cohort 
[174], although preliminary results from the Dutch Famine 
indicated that an increased risk of coronary artery disease 
is specific for exposure to famine early in gestation [175]. 
Animal experiments confirm the importance of timing and 
sex [176,177]. Thus, prenatal exposure to famine can have 
different long-term effects that depend on the timing of the 
exposure and the sex of the exposed individual.
Persistent epigenetic changes induced by environmental 
factors are a plausible molecular mechanism underlying 
the relationship between early development and later life 
disease [119,178]. Experiments in animal models provide 
strong supporting evidence. Manipulation of the maternal 
diet during pregnancy lead to a persistent shift in average 
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DNA methylation levels of specific genes in offspring 
resulting in permanent changes in coat color or tail shape 
[128,179]. A proof-of-principle for complex diseases was 
reported by Bogdarina et al., who showed in rats that a 
low protein diet during pregnancy was associated with 
decreased DNA methylation of the Agtr1b gene promoter 
in offspring, explaining the increase in blood pressure 
among these animals [13]. We recently showed that similar 
mechanisms may be operative in humans; periconceptional 
exposure to famine was associated with a decrease in 
DNA methylation of the insulin-like growth factor 2 (IGF2) 
differentially methylated region (DMR) [14]. However, to be a 
valid candidate mechanism in humans, the effect of prenatal 
famine on DNA methylation should be widespread, mirror 
the epidemiologic findings with sex- and timing-specific 
associations and affect genes in relevant pathways.
To further explore associations between prenatal famine 
and DNA methylation, including the role of the timing of 
exposure and the sex of the prenatally exposed individual, we 
assessed the methylation state of loci in 15 candidates genes 
involved in metabolic and cardiovascular disease and growth 
with diverse epigenetic features in our ongoing Hunger 
Winter Families Study [11]. 
Results
Periconceptional exposure 
We studied methylation of loci implicated in the 
transcriptional regulation of 15 candidate genes for metabolic 
and cardiovascular disease. The loci studied included 
imprinted loci (GNASAS, GNAS A/B, MEG3, KCNQ1OT1, 
INSIGF and GRB10), a putatively imprinted locus (IGF2R) 
and non-imprinted loci (IL10, TNF, ABCA1, APOC1, FTO, 
LEP, NR3C1 and CRH). The selection of the loci measured 
was based on a combination of factors, including binding of 
methylation sensitive transcription factors, associations of 
DNA methylation with gene expression and the presence of 
differentially methylated regions for imprinted loci (a detailed 
overview can be found in table S3.1).
DNA methylation of these 15 loci was measured in 60 
individuals conceived during the Dutch Famine (i.e. exposed 
periconceptionally) and compared with their unexposed 
same-sex sibling to minimize the possible confounding effects 
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of familial environment and genetic background. For six of the 
fifteen loci, significant differences in DNA methylation were 
observed (Table 3.1). DNA methylation was increased among 
famine exposed individuals for the imprinted genes GNASAS 
(P=3.1x10-6) and MEG3 (P=8.0x10-3) and the non-imprinted 
IL10 (P=1.8x10-6), ABCA1 (P=8.2x10-4) and LEP (P=2.9x10-3) 
proximal promoters. DNA methylation was decreased for 
the imprinted INSIGF promoter (P=2.3x10-5), which is part 
of the proximal promoter of INS [180]. For the remaining 9 
loci there was no association with periconceptional exposure 
to famine. All associations remained statistically significant 
after Bonferroni correction for multiple testing (15 loci) with 
the exception of MEG3 (PBonferroni= 0.12). When analysed 
separately, individual CpG dinucleotides showed similar 
associations with famine exposure as the complete loci 
(Figure 3.1 A). The loci affected did not share obvious 




Epigenetic modulation may also occur during other 
developmental windows [93,105]. We therefore also studied 
62 individuals who were exposed to famine late in gestation 
together with their unexposed, same-sex siblings. We 
measured DNA methylation at four loci that were associated 
with periconceptional famine exposure (IL10, GNASAS, INSIGF 
and LEP) and at four that were not (IGF2R, APOC1, KCNQ1OT1 
and CRH). These loci include four imprinted ones and diverse 
epigenetic features (Table S3.1).
No associations were observed except for a significant 
reduction in methylation at the GNASAS locus (P=1.1x10-7, 
PBonferroni= 8.8 x10-7) (Table 3.2). This association was 
consistent for the individual CpG sites within the locus (data 
not shown). The direction of the association was opposite to 
what was observed for periconceptional exposure. We then 
combined all periconceptional and late pregnancy exposed 
individuals and their controls in a single analysis to test for a 
statistical interaction between the famine associations with 
DNA methylation and the precise gestational timing of the 
exposure. The DNA methylation differences found for IL10, 
GNASAS and INSIGF were timing-specific (Table 3.2), but for 
LEP the test for interaction was not significant. 
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Sex-specific associations 
Previous work found basal DNA methylation differences 
in humans [157]. We therefore first tested for sex differences 
in DNA methylation for the measured loci combining the 
two sibling control groups (men N=56, women N=66). DNA 
methylation was higher in men for IGF2R (+2.6%, P=0.019) 
and lower in men for LEP (-2.6%, P=3.0x10-3), IL10 (-2.9%, 
P=0.015), and APOC1 (-1.5, P=0.015) as compared to 















IL10 20.8 (6.5) 2.4 0.37 1.8x10-6 2.7x10-5
GNASAS 48.8 (4.7) 1.1 0.24 3.1x10-6 4.7x10-5
INSIGF 84.8 (2.6) -1.6 -0.61 2.3x10-5 3.5x10-4
LEP 28.6 (4.9) 1.2 0.24 2.9x10-3 4.4x10-2
MEG3 54.0 (2.4) 0.5 0.21 8.0x10-3 0.12
ABCA1 19.9 (4.2) 0.7 0.17 0.017 0.26
ABCA1 methf 36.9 (8.2) 1.7 0.21 8.2x10-4 0.012
KCNQ1OT1 30.1 (1.5) -0.2 -0.16 0.053 n.s.
GRB10 47.2 (4.6) 0.4 0.08 0.091 n.s.
GNASAB 40.3 (5.0) 0.6 0.11 0.092 n.s.
APOC1 16.7 (3.1) -0.5 -0.17 0.13 n.s.
IGF2R 84.1 (6.9) -0.7 -0.10 0.29 n.s.
FTO 97.3 (0.8) -0.5 -0.61 0.28 n.s.
CRH 58.9 (6.0) 0.4 0.07 0.61 n.s.
TNF 9.6 (1.7) 0.1 0.06 0.63 n.s.
NR3C1 4.8 (1.1) 0.0 -0.01 0.79 n.s.
a:  Table sorted on P-value.
b:  Average absolute difference in DNA methylation between exposed and unexposed sib-
lings.
c:  Observed within pair difference divided by the standard deviation in the sibling controls.
d:  Two-sided P-value resulting from a linear mixed model accounting for family relations, 
bisulfite batch and age at blood draw. 
e:  The Bonferroni corrected P-values. Results that were already not significant before Bon-
ferroni correction are shown as “n.s.” (non significant).
f:  Separate analysis of methylated CpGs in ABCA1. In contrast to the 3’ CpGs, 5’ CpG 
dinucleotides (n=13) were methylated. The methylation of the methylated 5’ CpGs 
was highly correlated (R >0.87) amongst themselves, but not with methylation of 
the 3’ CpG dinucleotides, which had little to no methylation (<4.5%).
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Figure 3.1. Dif-
ference in DNA 
methylation of 
CpG dinucleo-
tides in siblings 
discordant for 
periconception-
al exposure to 
famine.  
Bars in the figures 
represent the 
average abso-
lute within pair 
difference in DNA 
methylation and 
their standard 
errors for CpG 
dinucleotides. A 
positive differ-
ence indicates a 
higher methyla-
tion level among 
exposed indi-
viduals. The exact 
location of the 
CpG dinucleotides 
can be found us-
ing supplemental 




tides for which a 
significant overall 
difference of the 
locus in DNA 
methylation was 
observed. B. As 
in panel A but for 
men. Only loci 
showing a signifi-
cant interaction 
between sex and 
exposure are 
depicted. C. As in 
panel B, but for 
women only.
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women. No significant differences were found for the other 4 
loci (GNASAS, INSIGF, KCNQ1OT1 and CRH). 
Next, we tested if the observed significant associations with 
prenatal famine were sex-specific. The interaction between 
sex and periconceptional famine exposure was significant for 
LEP (P=2.3x10-4), INSIGF (P=8.5x10-3) and GNASAS (P=0.027) 
(Table 3.3). For LEP and INSIGF the association of famine 
exposure with DNA methylation was restricted to men (PLEP, 
♂=3.6x10-7, PINSIGF, ♂=6.5x10-6) (Figure 3.1 B and 3.1 C). For 
GNASAS the association was significant in both sexes but 
most pronounced in women (Pmen=0.013; Pwomen=1.1x10-5). 
The association between late gestational famine exposure and 
GNASAS methylation was independent of sex.


























IL10 20.7 (5.0) -0.2 -0.04 0.76 n.s. 1.2x10-3
GNASAS 48.8 (4.2) -1.1 -0.26 1.1x10-7 8.8x10-7 3.1x10-12
INSIGF 84.7 (2.8) 0.0 0.0 0.95 n.s. 3.2x10-4
LEP 28.7 (4.6) 0.4 0.09 0.18 n.s. 0.13
KCNQ1OT1 30.2 (1.7) 0.2 0.12 0.17 n.s. 0.058
APOC1 16.7 (3.1) -0.6 -0.19 0.22 n.s. 0.90
IGF2R 84.0 (4.4) 0.0 0.0 0.88 n.s. 0.25
CRH 58.9 (4.8) 0.5 0.10 0.51 n.s. 0.86
a:  This table has been given the same order as table 3.1. 
b:  The batch corrected average methylation for the unexposed late gestation sibling controls 
and the standard deviation. 
c: Average absolute difference in DNA methylation between exposed and unexposed siblings.
d: Observed within pair difference divided by the standard deviation in the sibling controls.
e:  Two-sided P-value resulting from a linear mixed model accounting for family relations, bisul-
fite batch and age at blood draw. This test was performed on the late gestational exposed 
sibships (N=62)
f:   The Bonferroni corrected P-values. Results that were already not significant before Bonfer-
roni correction are shown as “n.s.” (non significant).
g:  Two-sided P value resulting from the test for timing specificity. The timing specificity 
was calculated by joining the datasets for both the periconceptional and late gesta-
tional siblings and their unexposed same-sex siblings and introducing an interaction 
term for gestational timing times exposure status. This test thus includes all 122 pairs.
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Timing independent association
For LEP there was no indication for a significant interaction 
between the famine association with DNA methylation 
and the gestational timing of the exposure, even though 
the methylation difference was significant only following 
periconceptional famine exposure. Since, this association was 
later found to be male-specific, we tested for an interaction 
with sex in the late exposure group. Indeed, a significantly 
higher LEP methylation was found for men exposed late in 
gestation (P=0.017). Analysis of the whole cohort (N=244) 
including both exposure groups, revealed a significant 
association between prenatal exposure to famine irrespective 
of the precise gestational timing (P=0.003). Further analysis 
suggested that this association was male-specific (Pinteraction= 
1.3x10-6; men: +2.2% (0.83SD), P=7.5x10-8; women: P=0.47). 
Table 3.3. Sex-specific associations of DNA methylation 
with periconceptional exposure to famine.





GNASAS 0.027 ♂ 0.7 0.15 0.013
♀ 1.5 0.33 1.1x10-5
INSIGF 8.5x10-3 ♂ -2.6 -0.99 6.5x10-6
♀ -0.8 -0.29 0.11
LEP 2.3x10-4 ♂  2.8 0.57 3.6x10-7
♀ -0.2 -0.04 0.70
a:  The two sided P-value from the test for sex-specificity of the observed pericon-
ceptional effect of prenatal famine. This was tested by entering an interaction 
term of sex times the exposure status in the linear mixed model.
b:  Average absolute difference in DNA methylation between exposed and unex-
posed siblings.
c:  Observed within pair difference divided by the standard deviation in the sibling 
controls.
d:  Two-sided P-value resulting from a linear mixed model accounting for family 
relations, bisulfite batch and age at blood draw. 
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Discussion
We studied the DNA methylation levels of 15 loci for their 
association with prenatal exposure to the Dutch Famine at 
the end of WWII. For six of the loci studied, we observed 
significant differences in DNA methylation after famine 
exposure during periconception (INSIGF, GNASAS, MEG3, 
IL10, LEP and ABCA1). This association differed by sex for 
three loci (INSIGF, GNASAS and LEP). Of the eight loci tested, 
exposure to famine late in gestation was associated with 
methylation for GNASAS and for LEP, which was specific 
for men. Of interest, the differences in DNA methylation 
included both increases and decreases, in one case even at 
the same locus after exposure during different gestational 
periods. Together with our previous finding that the IGF2 DMR 
is associated with periconceptional exposure [14] our data 
indicate that an adverse prenatal environment may trigger 
widespread and persistent changes in DNA methylation. 
Our current and previous [14] observations suggest that 
the periconceptional period may be an especially sensitive 
exposure period in humans. This might be inherent to 
mammalian development [181,182] and this hypothesis 
is also supported by detailed animal studies [183,184]. 
The association of GNASAS and LEP with late gestational 
exposure, however, suggests that environmentally induced 
DNA methylation changes may not be limited to the 
periconceptional period. This is in line with findings that 
methylation of the glucocorticoid receptor promoter depends 
on postnatal circumstances (e.g., maternal care in rats [93] 
and child abuse in humans [105]). In addition to timing-
specific associations, we observed sex-specific associations 
for three of the six loci for which DNA methylation was 
significantly associated with prenatal exposure to famine. In 
men, LEP methylation was associated with prenatal famine 
irrespective of the timing of exposure. Our observation 
that the methylation changes in relation to the prenatal 
environment may be sex-specific is in agreement with 
the sex-specific methylation changes found in offspring of 
sheep that were folate and vitamin B12 restricted during 
periconception [184]. How such sex-specific associations can 
arise is currently unknown, but interactions between sex 
hormones and the expression of DNA methyltransferases may 
be a factor [185].
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The differences in DNA methylation observed here are 
comparable, although slightly smaller, than we previously 
found for IGF2 (absolute difference of 2.7% (5.2% relative to 
the mean DNA methylation level in the population) [14]. The 
smaller average differences may be related to the inherent 
stochastic nature of epigenetic processes [186] leading to 
a large variability in responses. The stochastic nature is 
strikingly illustrated by the large variation observed in the 
response of agouti gene methylation on maternal methyl 
donor supplementation even though the mice are inbred and 
the environmental conditions are highly controlled [128]. In 
human studies, genetic and environmental heterogeneity 
may further obscure the full impact of prenatal famine. In 
our study, we tried to minimize the heterogeneity caused by 
these factors by comparing exposed individuals with their 
unexposed, same-sex siblings. Another potential source of 
heterogeneity is the cellular diversity of whole blood, the 
tissue we studied. This heterogeneity is less likely to play a 
role for the affected imprinted loci IGF2 [14], GNASAS and 
MEG3, since methylation is generally cell-type independent 
for imprinted loci [31] and the observed differences for non-
imprinted loci between exposed individuals and controls were 
similar. With respect to our finding that GNASAS methylation 
was associated with exposure to famine late in gestation, it 
should be mentioned that a compromised late gestational 
development was hypothesized to lead to an immature 
immune system. The absolute numbers of lymphocytes were 
reported to be lower in children with a shorter gestation in 
a large, population-based study [187]. However, since the 
proportions of the different cell types were not affected, it is 
unlikely that this has contributed to our findings. 
The changes observed are comparable to those found 
in the liver of rats prenatally exposed to a protein-deficient 
diet, where promoter methylation of the Pparα promoter 
was decreased from 6.1% to 4.5% with individual CpG 
dinucleotides affected up to 5% and explaining up to 43% 
of the variance in gene expression of Pparα [188]. This small 
absolute decrease of Pparα DNA methylation corresponded 
to a large ~26% relative change. It may be hypothesized 
that modest absolute changes in DNA methylation may 
lead to significant changes in gene expression for loci with 
a relatively low methylation level so that relative changes 
are substantial. The larger relative changes of LEP in men 
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(2.8/27.1=10.3%) and IL10 (2.4/20.8=11.5%) may be more 
likely to have functional consequences than that for INSIGF in 
men (2.6/84.8=3.1%).
Similar to animal studies of methionine restriction 
[184], we observed both increases and decreases in DNA 
methylation, depending on the locus studied. Our results 
cannot be readily explained by damage due to a deficiency 
in dietary methyl donors due to the famine and may thus 
be part of an adaptive response. To definitely prove or 
disprove the existence of an adaptive response it will be 
necessary to characterize epigenetic responses of entire 
relevant pathways. Epigenetic mechanisms may contribute 
to the development of a thrifty phenotype [164,178] and sex 
differences in this respect are increasingly well described 
[176]. It has been hypothesized that a thrifty phenotype 
may result from the combined effects of smaller epigenetic 
changes across the genome shifting metabolic networks 
[189]. INS [190] and LEP [189], both affected by prenatal 
famine exposure, were suggested to be particular relevant in 
this respect. Our observations provide empirical evidence for 
these hypotheses in humans. 
Our finding that the association of DNA methylation 
with prenatal conditions may depend on timing and sex 
matches the specificity in phenotypic outcomes observed 
for prenatal famine exposure, including neonatal outcomes 
[172] and psychiatric [170] and metabolic traits [167,169,173]. 
It remains to be determined if the observed differences 
in DNA methylation in blood mark functional differences 
in relevant tissues for these traits. Previous work on IGF2 
DMR has shown that methylation in blood can mark the 
methylation level in a relevant tissue [133]. Also, the CpG 
sites studied in the LEP promoter were previously reported to 
show similar methylation in peripheral blood and adipocytes 
in vivo [191] and to influence LEP expression in vitro [141]. 
Changes in DNA methylation induced early in development, 
like by prenatal famine, may be propagated soma-wide 
contributing to the observed correlation in DNA methylation 
across tissues [128,183]. A preliminary analysis of our 
data did not reveal significant associations between DNA 
methylation and plasma lipids and BMI that we previously 
reported to depend on prenatal exposure to famine in women 
in this cohort [167,169]. But DNA methylation at most genes 
relevant to these particular complex phenotypes was found 
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to be affected in men only, and not women. Similar to 
genetic studies, epigenetic studies linking variation in DNA 
methylation and complex disease will most likely require 
large study samples. Such studies may be particularly 
promising for IL10, which we found to be sensitive to 
periconceptional famine exposure. Genetic variation 
influencing IL10 expression at this locus is associated with 
schizophrenia [192,193], a phenotype also particular to the 
periconceptional period [170].
In summary, our study shows that exposure to famine in 
pregnancy may cause persistent changes in DNA methylation 
levels of multiple imprinted and non-imprinted genes with 
diverse biological functions. Our data support the hypothesis 
that associations between early developmental conditions 
and health outcomes later in life may be mediated by 
changes in the epigenetic information layer. Understanding 
how disturbances early in human development are linked to 
later life disease may suggest new ways to prevent disease.  
Methods and materials
Study population
Study participants are a subset of the population from 
our ongoing Hunger Winter Families Study, whose design 
and recruitment was described previously [11]. In short, this 
study includes individuals exposed to famine during different 
periods in pregnancy and time-controls born before or after 
the famine. Study subjects were selected from births between 
1943-1947 at three institutions in famine-exposed cities (the 
midwifery training schools in Amsterdam and Rotterdam 
and the Leiden University Medical Center). The daily rations 
distributed by the authorities during the famine period from 
November 28, 1944 to May 15, 1945 period contained an 
average energy equivalent of 667 kcal (SD, 151). During 
the famine there was little variation in the percentage of 
calories from proteins (12%), fat (19%) and carbohydrates 
(69%) [194]. In addition to time controls from these three 
institutions, we recruited whenever possible a same-sex 
unexposed sibling of these individuals to serve as sibling 
control. Clinical examinations, including blood collections, 
were completed for 311 births in these institutions and 311 
sibling controls. Ethical approval for the study was obtained 
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from the participating institutions, and all participants 
provided written informed consent. 
The subset selected for the present study includes two 
exposure groups with their unexposed sibling controls. The 
first exposure group comprises births conceived during 
the height of the famine, with periconceptional and early 
pregnancy exposure. The second exposure group comprises 
births during the height of the famine, with late pregnancy 
exposure. Periconceptionally exposed individuals were 
defined as births with a mother’s last menstrual period 
between November 28, 1944 and May 15, 1945. This group 
includes 60 individuals (age 58.1y, SD 0.35), of whom 28 
were male. Individuals exposed in late pregnancy were 
defined as births between January 28 and May 30, 1945. This 
group includes 62 individuals (age 58.8y, SD 0.40), of whom 
28 were male. As controls for each exposure group we used 
a matched same-sex sibling (age 57.1y, SD 5.50). The total 
study population therefore includes 244 individuals.
DNA methylation measurements
Genomic DNA was isolated from whole blood using the 
salting out method. One microgram of genomic DNA was 
bisulfite treated using the EZ 96-DNA methylation kit (Zymo 
Research). All samples were bisulfite treated on a total of 
three 96-well plates. Sibling pairs were on the same plate 
and periconceptionally and last trimester exposed pairs were 
equally distributed over the plates. DNA methylation of CpG 
dinucleotides were measured by a mass spectrometry based 
method (Epityper, Sequenom). The method determines the 
amount of DNA methylation by interrogating thousands of 
DNA copies assuming that 1 ng of genomic DNA equals ~ 300 
copies. The quantitative nature, accuracy and reproducibility 
of this method has been shown extensively [14,87,151]. 
All biochemical steps inherent to the methodology were 
performed according to the manufacturers’ protocol. Bisulfite 
converted DNA specific PCR primers used to amplify the 15 
investigated regions are summarized in the supplementary 
table S3.1. This table includes the precise genomic location 
of the amplified regions and an overview of the CpG sites 
quantized in each amplicon. All individuals exposed early 
in gestation and their sibling controls were measured in 
triplicate on a single 384 well plate for each locus and the 
same was true for the late gestational exposed individuals 
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and their sibling controls. Data quality control and filtering 
were done as previously described [60]. Data filtering 
consisted of the removal of CpG dinucleotides of which the 
measurement could be confounded by single nucleotide 
polymorphisms and of CpG dinucleotides of which the 
measurement success rate was below 80%. Common 
causes of a lower success rate include fragments bordering 
on the upper and lower limits of the mass range that can 
be detected and cases of fragments of which the base of 
the peak signal in the mass spectrum overlapped another 
fragment. The success rate for the CpG containing fragments 
that could be measured within the limits of the methodology 
was 93.3%.    
Statistical analysis
The analyses were performed within sibships to minimize 
the possible confounding effects of differences in familial 
environment and genetic. We applied linear mixed models 
on the raw data without imputation of missing values to 
calculate exposure specific differences between sibling 
pairs. All the analyses account for family relations, age at 
examination, bisulfite plate and the correlation between 
CpG dinucleotides. Sibship was entered as a random effect. 
Age at examination, bisulfite plate, exposure status and 
CpG dinucleotide, and where appropriate sex, were entered 
as fixed effects. The test for the timing specificity of the 
association between exposure and DNA methylation levels 
was done by adding a variable indicating the timing of 
the exposure and merging the periconceptional and last 
trimester datasets: timing specificity was tested by adding 
an interaction term of exposure status times the timing of 
the exposure to the linear mixed model. Testing the sex 
specificity of the associations between famine exposure and 
DNA methylation levels was done by adding a term for sex 
times the exposure status of the individuals in the linear 
mixed model. 
The linear mixed model was chosen over a standard 
paired t-test because it allows for the analysis of multiple 
individual CpG dinucleotides in one test, accounts for the 
correlation between adjacent CpG dinucleotides, includes 
relevant adjustments within the model on the raw data, and 
uses all available data. The linear mixed model reduces to 
a test with identical outcome to a paired t-test if the within 
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family difference is assessed for a single CpG dinucleotide, if 
no adjustments are performed and if there are no incomplete 
data for the sib pairs. 
The basal difference in DNA methylation between men 
and women in the controls was calculated using ANOVA. All 
P-values reported are two-sided. All analyses were performed 
using SPSS 16.0. 
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CpG 1, 2&3, 4 Promoter, MIR ret-
rotransposon, CpG 
4 is an ATF6, XBP1, 








region GNAS locus 
GTAATTTGTGGTAT-
GAGGAAGAGTGA
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(INS) CpG 2, 4, 5, 6 Promoter, im-
printed / SGA, IGF2 
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is an C/EBP bind-
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ling basal gene 
expression / birth 
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CpG 1, 3&4, 6-9, 10-13, 
15&16, 17&18, 19-21, 
22&23, 24, 25
Promoter, CpG 
10-13 Arnt & 
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(GR) CpG 4, 7&8, 9, 10&11, 
14, 15&16, 17-20, 31, 
33&34, 42
Exon I7, CpG 7 is 
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CpG 7, 8, 17, 22&23, 
24, 25
Promoter, CpG 
island / diabetes 











CpG 1, 2, 9, 10 Promoter, CpG 2 













CpG 1, 3&4, 7, 8, 9&10, 
12, 13-15, 16-19





a:  CpG sites measured in each amplicon. Counting starts from the part of the ampli-
con that has the identical sequence of the forward primer. Multiple CpG sites that 
are named together between brackets were not individually resolved by fragmen-
tation in the mass spectrometer and thus measured simultaneously. 
b:  Forward primer that will amplify the bisulfite converted genomic DNA. For the 
Epityper methodology a 10mer spacer tag is added at the 5’ primer end with the 
following sequence: 5’-AGGAAGAGAG+primer 
c:  Reverse primer that will amplify the bisulfite converted genomic DNA. For the 
Epityper methodology a T7 promoter is added to the 5’ primer end with the fol-
lowing sequence: 5’-CAGTAATACGACTCACTATAGGGAGAAGGCT+primer
Abbreviations: 
MIR: type of retrotransposon
QTL: quantative trait locus
SGA: small for gestational age
BMI: body mass index
TFBS: transcription factor binding sites
HPA: hypothalamus-Pituitary axis
IIS: insulin signaling
NGF1-A:  a transcription factor reported to influence NR3C1 ex-
pression [93] 
GWAS: genome wide association study
CpG 1, 3&4, 6-9, 10-13, 
15&16, 17&18, 19-21, 
22&23, 24, 25
Promoter, CpG 
10-13 Arnt & 
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Abstract
The accumulation of epigenetic changes was proposed 
to contribute to the age-related increase in the risk for most 
common diseases. In this study on 230 monozygotic twin 
pairs (MZ pairs), aged 18 to 89 years old, we investigated 
the occurrence of epigenetic changes over the adult lifespan. 
Using mass spectrometry, we investigated variation in global 
(LINE1) DNA methylation and in DNA methylation at INS, 
KCNQ1OT1, IGF2, GNASAS, ABCA1, LEP, and CRH, candidate 
loci for common diseases. Except for KCNQ1OT1, inter-
individual variation in locus specific DNA methylation was 
larger in old individuals than in young individuals, ranging 
from 1.2 fold larger at ABCA1 (p = 0.010) to 1.6 fold larger 
at INS (p = 3.7 * 10-07). Similarly, there was more within-
MZ-pair discordance in old as compared with young MZ 
pairs, except for GNASAS, ranging from an 8 % increase in 
discordance each decade at CRH (p = 8.9 * 10-06) to a 16 
% increase each decade at LEP (p = 2.0 * 10-08). Still, old 
MZ pairs with strikingly similar DNA methylation were also 
observed at these loci. After 10 year follow-up in elderly 
twins, the variation in DNA methylation showed a similar 
pattern of change as observed cross-sectionally. The age-
related increase in methylation variation was generally due 
to unique environmental factors, except for CRH, for which 
familial factors may play a more important role. In conclusion, 
sustained epigenetic differences arise from early adulthood 
to old age and contribute to an increasing discordance of MZ 
twins during ageing. 
Key words
Epigenetics; Aging; MZ twin design; Full adult lifespan; DNA 
methylation; Stochastic variation
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Introduction
The risk for most common diseases increases with age. 
A lifetime of accumulated epigenetic changes was proposed 
to contribute to the development of such diseases [186]. 
Epigenetic mechanisms determine the expression potential 
of genes without changing the DNA sequence [29]. The 
molecular basis includes the methylation of cytosines in CpG 
dinucleotides, which together with histone modifications, 
non-coding RNAs, and localization influence the accessibility 
of a genomic locus to the transcriptional machinery [23,25]. 
DNA methylation can be measured on DNA samples that are 
commonly available in biobanks [195].
Various studies have investigated whether DNA 
methylation can change with increasing calendar age. A 
cross-sectional study of limited sample size reported the 
genome-wide absence of changes in mean DNA methylation 
between young (26 years) and old (68 year) individuals [196]. 
However, cross-sectional studies that focus on changes in 
mean DNA methylation can only detect age-related changes 
that are in the same direction for most individuals. A cross-
sectional study that focussed on DNA methylation at the 
COX7A1 locus reported greater inter-individual variation in 
20 elderly individuals (> 60 years old) compared with 20 
young individuals (< 30 years old) [110], indicating that DNA 
methylation can indeed change with age in a direction that 
differs per individual. 
Longitudinal studies are even better suited to investigate 
this type of age-related methylation changes, even though 
most of them rarely span more than a period of 2 decades. A 
study on global DNA methylation, a measure of the average 
methylation level of (a representative portion of) CpG sites 
across the genome, observed changes with a direction 
that was individual-specific in whole blood samples of 111 
individuals (59-86 years) followed over 11 year and 127 
individuals (5-72 years) followed over 16 years [131]. Yet, two 
smaller studies with 10-20 years follow up demonstrated that 
at specific genomic loci DNA methylation in blood and buccal 
swab samples can remain remarkably stable [195,197]. 
A particularly powerful design to investigate the 
accumulation of epigenetic changes with age are studies of 
monozygotic twins [198]. MZ co-twins have the same age and 
a virtually identical genotype, thus controlling for their effect 
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on DNA methylation [60,92], while they may differ in their 
lifetime exposure to environmental factors and can develop 
small phenotypic differences with age [199]. To our knowledge 
only one study has as yet adopted this design to study age-
related changes into adulthood. This study on 40 MZ pairs 
aged 3 to 74 year reported that older MZ pairs (> 28 years old) 
showed larger within-pair epigenetic differences than younger 
MZ pairs (< 28 years old) in total DNA methylation and total 
histone acetylation levels. Although the functional relevance of 
such measures is uncertain, analysis on smaller subsets of MZ 
twins indicated similar trends at sites throughout the genome, 
most of which were repetitive sequences, but also included 
singly copy genes [130]. Also, it remains unclear at what age 
such changes start to arise in the population and at what rate 
they subsequently progress with increasing age.
The studies performed thus far were generally relatively 
small, focused on measures of average methylation of the 
genome and/or could investigate limited periods of the adult 
lifespan only. Here, we report on age-related changes in locus-
specific DNA methylation in a combined cross-sectional and 
longitudinal study on 460 individuals comprising 230 MZ pairs 
aged 18 to 89 years. The long age-range investigated allowed 
us to study whether epigenetic changes accumulate linearly, 
exponentially or in bursts during the full adult life span. 
Furthermore, we evaluated the influence of familial versus 
individual factors on the age-related increase in discordance. 
We assessed both global DNA methylation with the LINE1 
assay [115], and locus-specific DNA methylation close to genes 
implicated in various age-related diseases, namely the non-
imprinted loci LEP, ABCA1, CRH, and the imprinted loci IGF2, 
INS (alternate symbol INSIGF), KCNQ1OT1 (alternate symbol 
KVDMR), and GNASAS (alternate symbol NESPAS). These loci 
were selected on the basis of their previously shown features 
of epigenetic regulation as observed in human, animal, or cell 
culture experiments [133,141–143,145,200,201] (Table 4.1). 
Results
DNA methylation in young and old MZ twins
Means and inter-individual variation
Global DNA methylation and methylation status at 9 specific 
loci was compared between young twins (n = 132 individuals) 
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Table 4.1: Characteristics of the methylation assays 































+ [201] + 10 18
IGF2e Growth and 
insulin signal-
ling
DMR + [133] + 4 5





+ [133] + 5 5























+ [145] + + 11 15
LEPe Metabolism Proximal 
promoter
+ [141] + 7 10







± [115] 8 11
a: Loci are given in alphabetical order
b:  CpG-site methylation previously reported to associate with gene expression, ± 
means that this association is hinted at
c:  Amount of CpG units and CpG sites as measured in this study
d:  For ABCA1 only the methylated CpG sites at the 5’ end of the assay are used in 
analyses [135]
e:  Methylation of these assays was investigated over the full adult lifespan and 
over a 10 year follow-up period in elderly twins
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and old twins (n = 134 individuals). Old individuals had slightly 
lower mean global DNA methylation than young individuals 
(Table 4.2). Larger differences were observed at specific loci. 
Old individuals had lower mean DNA methylation at 5 of 9 loci 
(INS, KCNQ1OT1, and the 3 adjacent IGF2 loci; Table 4.2) and 
showed higher mean DNA methylation at 3 loci (LEP, ABCA1, 
and GNASAS). No difference was observed for CRH.
The inter-individual variation in global DNA methylation 
expressed as the standard deviation (SD) was small in both 
age groups (SD young = 1.2 % and SD old = 1.8 %; Table 4.2). 
At specific loci, it ranged from small in both age groups at 
KCNQ1OT1 (SD = 2.3 % in both age groups) to large in both 
age groups at ABCA1 (SD young = 7.8 % and SD old = 9.6 %; 
Table 4.2). With the exception of KCNQ1OT1, methylation 














SD Old / 
SD Young P variation
Global 61.3 (1.2) 60.9 (1.8) – 0.4 (0.19) .033 1.5 2.3 * 10
-05
KCNQ1OT1 31.2 (2.3) 29.1 (2.3) – 2.1 (0.28) 2.4 * 10
-12 1.0 .999
GNASAS 47.3 (3.2) 52.7 (4.4) + 5.4 (0.46) 4.1 * 10
-25 1.3 .002
ABCA1 34.9 (7.8) 38.5 (9.6) + 3.6 (1.04) 6.2 * 10
-04 1.2 .010
INS 81.2 (2.3) 77.6 (3.9) – 3.6 (0.38) 9.8 * 10
-18 1.6 3.7 * 10-07
IGF2DMR 54.7 (3.8) 51.2 (4.9) – 3.5 (0.52) 2.8 * 10
-10 1.3 .002
IGF2_qter 70.9 (2.8) 68.5 (5.4) – 2.4 (0.52) 1.3 * 10
-05 1.9 4.6 * 10-07
IGF2_pter 45.7 (3.0) 42.1 (4.4) – 3.6 (0.45) 6.5 * 10
-14 1.5 3.5 * 10-05
LEP 27.6 (4.2) 32.2 (6.4) + 4.5 (0.65) 3.6 * 10
-11 1.5 1.3 * 10-05
CRH 63.4 (4.3) 63.7 (6.6) + 0.3 (0.67) .671 1.5 2.2 * 10
-06
Binnenwerk_opmaak.indd   78 5-12-2014   13:19:56
79
Figure 4.1: Increase in within-pair methylation discordance with age.  
Absolute within pair difference in % DNA methylation for global DNA methyla-
tion and for specific loci plotted for A. Young MZ twins (under 30 years old; n 
= 66 pairs) vs. old MZ twins (over 74 years old; n = 67 pairs). B. The full age 
range divided by the 4 stages of adult life; from left to right: up to 25 years old 
(early adulthood, n = 30 pairs), 26 up to 50 years old (early middle-age, n = 78 
pairs), 51 up to 75 years old (late middle age, n = 56 pairs), and over 76 years 
old (old age, n = 54 pairs). C. In 19 elderly MZ pairs ( 73 – 82 years old) after 
10 years follow-up (83 – 92 years old). The bars show the inter quartile range, 
the thick line in the center of the bar shows the median and the whiskers show 
the 5th (bottom whisker) and 95th (top whisker) percentiles.
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variation was always larger in old individuals than in young 
individuals, irrespective of age-related differences in mean DNA 
methylation. The SD of global DNA methylation was 1.5 fold 
larger in old individuals (P = 2.3 * 10-05). At specific loci the age-
related difference ranged from 1.2 fold larger SD at AB CA1 (p = 
0.010) to 1.6 fold larger SD at INS (p = 3.7 * 10-07; Table 4.2).
Within-pair discordance
The extent of within-pair methylation discordance was 
also compared between the young and old twins. Similar to 
the inter-individual variation, a small within-pair discordance 
in global methylation was observed in both age groups. 
At specific loci it ranged from small in both age groups at 
KCNQ1OT1 to large for both age groups at CRH. Furthermore, 
the absolute within-pair discordance in old MZ pairs was 
always greater than in young MZ pairs (Figure 4.1A). 
Notwithstanding this overall increase, the old age group still 
contained pairs who had strikingly similar DNA methylation. 
With the exception of GNASAS, the SD of the within-pair 
differences, quantifying group discordance, was significantly 
higher in old as compared with young MZ pairs (Table 4.3). 
For global DNA methylation, methylation discordance in the 
old MZ pairs was almost double that of the young MZ pairs 
(p = 9.8 * 10-05). At specific loci the increase in discordance 
ranged from 1.4 fold greater in old MZ pairs at KCNQ1OT1 (p 
= .005) to 2.7 fold greater at ABCA1 (p = 3.8 * 10-07).
DNA methylation across the complete adult lifespan
Changes in within-pair methylation discordance between 
different age categories
The timing of the occurrence of age-related changes in 
methylation discordance during adult life was investigated in 
219 MZ pairs aged 18 to 89 years old, including an additional 
61 middle aged MZ pairs (30 – 65 years old) and 25 old MZ 
pairs (> 65 years old; Table 4.5). In this extended set of MZ 
twins, global DNA methylation and methylation at 5 specific 
loci, representative of the 9 loci studied in the young and old 
MZ pairs as described before, were measured (Table 4.1). 
The observed absolute discordance was plotted for the four 
stages of adult life: early adulthood (up to 25 years old, n 
= 30 pairs); young to middle-age (26 years up to 50 years 
old, n = 78 pairs); middle-age to seniority (51 years up to 75 
years old, n = 56 pairs); and old age (over 76 years old, n = 
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54 pairs). Discordance in global DNA methylation was small 
in all age groups (Figure 4.1B). At the loci IGF2, LEP, and CRH 
an increase in methylation discordance across the age-groups 
was observed, starting from young adulthood onward at IGF2 
and CRH, and from middle age onward at LEP. Age related 
changes in discordance were less apparent at GNASAS, and 
KCNQ1OT1 (Figure 4.1B). Plotting the absolute within-pair 
methylation differences at individual CpG units against age 
yielded similar results (Supplementary figures S4.1 to S4.6).
To quantify these observed changes the proportional 
increase in discordance was also estimated per decade. For 
global DNA methylation within-pair discordance was 9 % 
greater each decade (p = 3.4 * 10-06, Table 4.4). The greatest 
increase in within-pair discordance was found at LEP with 16 
% greater discordance each decade (p = 2.0 * 10-08), at IGF2 
and CRH within-pair discordance increased each decade with 
11 % (p = 3.8 * 10-09), and 8 % (p = 8.9 * 10-06) respectively. 
At GNASAS discordance did not change significantly with 
age. At KCNQ1OT1, although the discordance was small at 
all ages, it did increase by 11 % each decade (p = .002; 
Table 4.4). These observed relative increases in discordance 
were confirmed with absolute differences in the amount of 
Table 4.3: Variation of within-MZ-pair methylation 
difference in young and old MZ pairs
Locus
Estimate of variation 




pairs Old / young P variation 
Global 1.1 2.1 1.9 9.8 * 10-05
KCNQ1OT1 1.9 2.6 1.4 .005
GNASAS 3.1 3.4 1.1 .193
ABCA1 2.8 7.7 2.7 3.8 * 10-07
INS 2.1 4.6 2.2 2.3 * 10-06
IGF2DMR 2.6 4.9 1.9 2.1 * 10-05
IGF2_qter 2.4 5.9 2.4 9.7 * 10-07
IGF2_pter 3.3 5.9 1.8 .002
LEP 3.5 7.3 2.1 1.0 * 10-05
CRH 4.6 7.7 1.7 2.3 * 10-04 
a:  Mean within-MZ-pair difference at any locus did not significantly deviate from 
0 at in both age groups
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discordance when testing the homogeneity of variance in 
discordance  across the age groups at individual CpG units 
(Supplementary table S4.7).
Dutch and Danish MZ pairs were investigated in this 
study. The observation that the increase in within-pair 
twin discordance was not exclusive to the old age group 
(predominantly Danish twins) but was already apparent 
at younger age (Dutch twins) indicated that geographical 
origin of the MZ pairs did not contribute to our findings. To 
further exclude the influence of origin, we tested whether 
age-related changes in methylation variation or discordance 
were different between old Dutch (n = 25 pairs) and Danish 
(n = 67 pairs) twins. No significant influence of country on 
age-related changes was observed for either variation or 
discordance (Supplementary table S4.2).
The influence of cellular heterogeneity on methylation 
variation, discordance and their age related increases
Methylation was measured on genomic DNA extracted 
from whole blood and variation in cellular heterogeneity 
could induce differences in DNA methylation. In the young 
twins, neither variation in global DNA methylation (n = 132 
individuals) nor within-pair differences in global methylation 
(n = 66 pairs) were associated with cellular heterogeneity, 
Table 4.4: Variation of within-pair methylation 
discordance over the full adult lifespan
Locusa
Baseline estimate 
of variation as SD 
(% methylation)b
Increase in variation per decade
Proportional increasec Pd
Global 2.2 9.1 % 3.4 * 10-06
KCNQ1OT1 1.9 11.4 % .002
GNASAS 3.5 2.7 % .415
IGF2DMR 4.4 11.1 % 3.8 * 10-09
LEP 4.8 16.0 % 2.0 * 10-08
CRH 8.4 8.0 % 8.9 * 10-06
a: Loci are ordered from top to bottom as in Figure 1B from left to right
b:  The SD of discordance at baseline, estimated from the residual variance and the 
random effect intercept of the linear mixed model 
c:  The proportional (in percentage) increase in variation of discordance each de-
cade, estimated from the random effect of age
d:  One-sided p-value from a Z-test on the random effect estimate of age from 
the same linear mixed model
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approximated by percentage neutrophils, as recently 
described [195]. The same was true for the majority of loci 
(at 6 out of 9 loci for DNA methylation and at 5 out of 9 loci 
for within-pair differences; Supplementary table S4.3). The 
strongest influence of cellular heterogeneity was observed 
for LEP (p = 1.2 *10-10 and p = 1.0 *10-06, for both tests 
respectively). Even in this case, 85 % of inter-individual 
variation in LEP methylation and 80 % of within-pair 
differences were independent of cellular heterogeneity. 
The composition of the leukocyte population changes 
with age, of which the contribution to our findings was 
investigated in all Dutch twins. Age-related changes in 
inter-individual variation (n = 304 individuals) at 3 out of 
5 loci, and in within-pair discordance (n = 152 pairs) at 4 
out of 5 loci were not associated with changes in cellular 
heterogeneity (Supplementary table S4.4). Although an 
association with cellular heterogeneity was observed (p = 
.006 and p = 8.2 * 10-04, for both tests respectively), 90 % of 
the age-related changes in either global methylation variation 
or global methylation discordance was not attributable to 
it. The strongest influence was observed at LEP (p = 4.1 * 
10-18 and p = 4.2 * 10-12, for both tests respectively), yet 
90 % of change in inter-individual variation, and 85 % of 
change in within-pair discordance were not attributable to 
cellular heterogeneity. Thus, the age-related changes in DNA 
methylation observed cannot be explained by changes in 
leukocyte population composition.
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Longitudinal changes in DNA methylation in old age
Inter-individual and within-pair epigenetic variation, 
global and at the same 5 loci, were also investigated in 19 
elderly twin pairs during 10 years follow-up (DNA samples 
obtained in 1997 and 2007). Global and locus specific inter-
individual methylation variation was modestly larger after 10 
year follow-up, except at CRH (Supplementary table S4.5). 
Changes in within-pair methylation discordance showed 
a similar pattern as observed in comparing changes from 
young to old adults (Figure 4.1: compare C with A and B). 
Global discordance and that at 3 loci (IGF2DMR, LEP, and 
CRH) had increased during the follow-up period, whereas no 
Figure 4.2: Contribution of familial and unique (individual) environ-
mental factors to increasing methylation variation with age.  
Estimated changes in the variation in DNA methylation (y-axis, given as 
standard deviation in percentage DNA methylation) plotted against the adult 
lifespan (x-axis, age in years). The changes in total variation of DNA methyla-
tion (area under the thick line), and the contributions of familial factors (shared 
environment and genotype; filled in area between thick and dashed line) and 
unique factors (individual environment; blank area under the dashed line), were 
estimated in 219 MZ pairs ranging from 18 to 89 years old. From top left to bot-
tom right, global DNA methylation and the loci KCNQ1OT1, GNASAS, IGF2DMR, 
LEP, and CRH are investigated. Significance of the estimates of total, familial, 
and individual related increases in variation are given in Supplementary table 
S4.6.
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change was observed at the remaining 2 loci (KCNQ1OT1 and 
GNASAS). 
Familial and unique environmental factors
The study of MZ twin pairs enables separation of the 
effects of familial (i.e. genetic and common environment) and 
unique environmental environment on the accumulation of 
DNA methylation differences with age. For global methylation, 
the total variation was relatively small and mainly due to 
unique environment. The increase in variation with age was 
limited but significant (p = .004) and mostly attributable to 
unique environment (p = .003; Figure 4.2, top left graph; 
Supplementary table S4.6). The total variation increased 
significantly with age at all loci in line with the previous 
analyses (Supplementary table S4.6). This increase could be 
mainly attributed to unique environmental factors except 
for the age-related increase in variation at CRH methylation 
which had a familial component (p= 0.007).  
Discussion
In this study we report sustained age-related increases 
in variation of DNA methylation, in an analysis of 460 
individuals, comprising 230 MZ pairs, aged from 18 to 
89 years. Previously this question was investigated using 
crosssectional and longitudinal study designs on smaller 
sample sizes with narrower age ranges [108,130,195,197]. 
Our study extends their findings over the full adult lifespan, 
supporting the notion that a gradual accumulation of 
epigenetic changes, globally and at imprinted and non-
imprinted loci, occurs up to very old ages. How such changes 
affect gene expression remains unclear, although some 
evidence suggests that small differences in DNA methylation 
may cause an amplified effect on gene expression [188]. The 
increase in epigenetic variation was mainly due to unique 
individual factors that cover both stochastic processes and 
environmental exposures, between which the design of 
our study cannot distinguish. This may lead to age-related 
epigenetic dysregulation and may contribute to the age 
dependency of common diseases [29,186]. However, studies 
that can appropriately address the latter hypothesis will be 
complex in their design and execution due to the relatively 
small effect sizes involved and the tissue and cell specific 
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nature of age-related changes [202]. 
We measured LINE1 methylation to assess global DNA 
methylation [115] and found that the variation in global 
DNA methylation, both inter-individual and within-pair, was 
small at all ages, but increased proportionally with age, in 
accordance with a longitudinal study over ten years [131]. 
The small amount of global variation observed may relate 
to the fact that global DNA methylation assays measure 
methylation at a multitude of similar loci distributed 
throughout the genome [115,163], while the introduction of 
stochastic changes occurs at individual loci. We observed the 
most prominent age-related changes in variation at specific 
candidate loci for common age related diseases, such as 
IGF2, LEP, and CRH, of which the expression was shown to 
be influenced by its DNA methylation [133,141,142]. We 
observed a substantial difference between the loci in their 
vulnerability to epigenetic drift, which was consistently found 
in our various analyses (inter-individual variation, within-pair 
discordance, young versus old individuals, the adult lifespan, 
or a longitudinal analysis in old subjects). Of interest, the 
greatest age-related changes were observed for non-
imprinted loci, whereas imprinted loci appeared more stable.
MZ twin pairs share characteristics such as age, 
sex, genotype and their developmental and childhood 
environment (e.g. upbringing / education). They may acquire 
more unique characteristics as they grow older, since 
different choices on for instance lifestyle and occupation 
can increasingly change their living environments. The 
shared characteristics, namely their genotype and shared 
environment, and their individual characteristics, commonly 
named the unique environment, may both contribute to 
epigenetic variation [103,198]. We used the MZ twin study 
design to investigate how much of the age-related increase 
in variation is contributed by the familial factors and by the 
unique individual environment [198,203]. We observed that 
most of the variation in young adults could be attributed to 
the individual environment, indicating that DNA methylation 
is at least partly independent of familial (e.a. genetic) 
factors. Interestingly, studies on neonate and infant MZ 
pairs indicated that such differences are already present 
and indeed increase at a very young age [62,204]. At most 
loci we found that the age-related changes in variation 
were also mostly attributable to the unique individual 
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environment, supporting the idea that age-related changes 
in DNA methylation may be mostly independent from familial 
factors [29,59,186]. However, at CRH the increase in variation 
was mostly attributed to familial factors. Residual batch 
effects seem an unlikely explanation for this observation 
considering that the design of this study involved a batch 
allocation scheme that took age and sex into account and 
the statistical models contained a factorial variable to adjust 
for its potential influence. A previous study reported familial 
clustering of variation over time in global DNA methylation 
using the LUMA assay [131]. Since we studied MZ twins only, 
we cannot further distinguish whether this familial component 
is related to genetic or shared environmental factors, both 
of which may influence the susceptibility to stochastic or 
environmentally driven changes in DNA methylation [139].
In this study we observed that differences in mean 
methylation between the young and the old age groups were 
relatively small or even absent, while increases in variation 
were generally more substantial. This finding indicates that 
epigenetic changes accumulating with age are generally 
non-directional or are the outcome of many smaller directed 
changes with, in part, opposite direction. Changes in DNA 
methylation can be stochastic or environmentally driven; 
the relative contribution of each source of variation cannot 
be investigated in our study. Stochastic epigenetic changes 
can occur without any environmental influence and may 
be related to imperfect DNA methylation maintenance 
mechanisms [70]. We observed that the age-related increase 
in variation of DNA methylation was gradual from early 
adulthood to old age, which is compatible with stochastic 
effects [186]. Environmentally driven epigenetic changes 
may occur as a consequence of environmental exposures 
related to for instance lifestyle and occupation [71,73,108]. It 
is even conceivable that stochastic epigenetic changes occur 
more often under certain environmental conditions, parallel 
to stochastic genetic mutations that occur after exposure to 
high UV irradiation.
The power of cross-sectional studies in MZ twins is 
that large age-ranges can be studied in contrast to what 
is practically possible in longitudinal studies on unrelated 
individuals. We investigated changes in epigenetic variation, 
both in terms of inter-individual variation and within-
pair difference, over a large age-range. We observed 
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similar increases in either measure of epigenetic variation 
throughout the adult life-span. These results are in line with 
longitudinal analyses over relatively short time spans in old 
age, as we report here, middle age [195,197], and childhood 
[204]. In view of the consistency of these findings, it is 
unlikely that generation effects significantly contributed to 
our findings. Importantly, we were also able to exclude age-
related changes in cellular heterogeneity of whole blood as 
an explanation for our observations, which was previously 
proposed as a major concern for the interpretation of such 
studies [103]. Whether increased methylation variation 
in blood has any biological (phenotypic) relevance is an 
important and as yet unresolved question, although it is 
likely that other tissues than blood are similarly affected by 
epigenetic drift [108,110,204]. In general, tissues with a high 
rate of cell division may display more age-related epigenetic 
variation through stochastic errors in maintaining and 
transmitting epigenetic information than tissues with lower 
rates cell division [205]. 
In this study we investigated DNA methylation of MZ twin 
pairs with ages distributed across the full adult lifespan. In the 
first phase of the study, we explored differences by comparing 
young adult twins (18-30 years) with old twins (> 74 years) 
to generate sufficient contrast between groups. Such age-
groups at either extreme of the adult lifespan could not be 
selected from a single twin register. This required a careful 
consideration of potential biases created by selecting young 
twins from the Netherlands and old twins from Denmark 
and additional measurements to confirm the validity of our 
findings. Genetic differences between the populations were 
unlikely to play a role, since a genome-wide analysis of SNPs 
of Northern European countries reported a similar structure 
of genetic variation in the two countries [206]. Further, 
similar procedures were used for drawing blood [116,207], 
DNA was extracted using standard protocols, and there was 
no indication for differences in DNA quality (including OD 
260/280 measurements, bisulfite conversion rate and success 
rate of DNA methylation assays). Moreover, if DNA quality 
was different between the populations, one would expect a 
similar systematic effect on all assays, which could be taken 
into account in our statistical analysis. In contrast, the loci we 
studied showed a substantial variation in the degree to which 
the DNA methylation was higher in old twins and was absent 
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for KCNQ1OT1. More importantly, we experimentally validated 
the finding from the first phase for 6 loci. In this second phase, 
we compared the old Danish twins with a subset of Dutch 
twins specifically selected for a maximum age overlap (within 
the limitations of the availability of old twins in the Netherlands 
twin register). We found no indication for DNA methylation 
differences between Dutch and Danish twins with a similar 
old age. Furthermore, the locus-specific associations of DNA 
methylation variation with age originally observed in the 
young-old comparison were confirmed in both an investigation 
of intermediate age ranges selected from the Netherlands twin 
register and in a longitudinal investigation of old Danish twins. 
Taken together, differences in geographical origin or technical 
variability between populations are unlikely explanations for 
our observations in phase one of our study and the second 
phase yielded further evidence for the occurrence of sustained 
epigenetic changes during the adult lifespan.
In this study we demonstrate that epigenetic variation 
in the population, used as a proxy for stochastic and 
environmentally driven epigenetic changes in individuals, 
increases gradually with age up to old age. The rate at which 
changes are introduced differs between loci and can be 
considerable at loci regulating transcription of nearby genes. 
The observed increase was mostly driven by the unique 
environment. Our results have practical implications for study 
design in epigenetic studies investigating populations with a 
large age distribution or a long follow-up time [98,195]. Future 
research should aim to investigate the relative contribution 
of stochastic and environmental factors to age-related 
epigenetic changes and the consequences of these changes 
for development of common age-related diseases.
Methods and materials
Study population
The samples in this study are taken from Longitudinal 
Study of Aging Danish Twins (LSADT) of the Danish Twin 
Registry (DTR) [117] and from the Biobank project of the 
Netherlands Twin Register (NTR) [116]. In the LSADT study, 
DNA was extracted using the salting out method, and in 
the BIOBANK project QIAamp DNA Blood Maxi (QIAGEN, 
Düsseldorf, Germany) was used. DNA from both sources was 
of high quality (260/280 BIOBANK = 1.80; 260/280 LSADT = 1.90)
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Selection from the Danish Twin Registry (DTR)
The LSADT study, based on the DTR, is a cohort sequential 
study of elderly Danish twins. LSADT began in 1995 with an 
assessment of all members of like-sex twin pairs born in Denmark 
before 1920. The surviving members were followed up every 
2 years and additional cohorts were added at the 1997, 1999, 
and 2001 assessments and subsequently followed at 2-year 
intervals. During a home visit in 1997, blood was drawn from 
689 individuals, from which DNA was isolated [208]. The LSADT 
project has been approved by The Danish National Committee 
on Biomedical Research Ethics (journal VF 20040241). Details on 
design and data collection were described previously [207].  
This study focuses on the monozygotic twin pairs (MZ 
pairs) of whom DNA was available from the 1997 assessment, 
(73 years or older; n = 108 pairs). To investigate differences 
in epigenetic variation between young and old MZ pairs, 
all 36 male MZ pairs and 37 randomly selected female MZ 
pairs formed a study population named “old Danish twins” 
Table 4.5: Basic characteristics of the different MZ twin pair 












Young Dutch 66 34 25.2 (18.0 – 29.8) 10 +
Middle-aged  
Dutch 61 15 46.3 (30.0 – 64.0) 6 +
Old Dutch 25 8 70.5 (65.0 – 78.0) 6 +
Old Danish 67 34 79.3 (74.1 – 89.0) 10 na
Baseline Dan-
ish 19 8 76.6 (73.2 – 81.8) 6 na
10 year follow-
up 19 8 86.5 (83.4 – 91.8) 6 na
Full adult life 
spanc 219 91 52.7 (18.0 – 89.0) 6
a:  The designation for the population sample in this study, Dutch twins are participants in the 
Netherlands Twin Register (NTR), Danish twins are participants in the Danish Twin Registry 
(DTR)
b:  Availability of data on the amount of the major leukocyte fractions (neutrophils, lympho-
cytes, monocytes, basophils and eosinophils)
c:  The population sample covering the full adult lifespan combines the young, middle-
aged and old NTR and the old DTR twins
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(Table 4.5). For 2 male MZ pairs and 4 female MZ pairs there 
was insufficient DNA of both co-twins. These MZ pairs were 
excluded, the remaining 67 MZ pairs were investigated. 
For 19 of the LSADT MZ pairs (8 male pairs) a second DNA 
sample was available from a 10 year follow up in 2007 for 
both co-twins. Longitudinal epigenetic changes in the elderly 
were investigated in these MZ pairs, who were named 
“follow-up Danish twins” (Table 4.5). 
Selection from the Netherlands Twin Register (NTR) 
In 2004 the NTR started a large scale biological sample 
collection in twin families to create a resource for genetic 
studies on health, lifestyle and personality. Between January 
2004 and July 2008, adult participants of the NTR (18 years 
and over) were invited into the project. During a home visit, 
fasting blood was drawn, from which DNA was extracted and a 
hematological profile was obtained, consisting of percentages 
and numbers of neutrophils, lymphocytes, monocytes, 
eosinophils, and basophils. The study protocol was approved 
by Central Ethics Committee on Research Involving Human 
Subjects of the VU University Medical Center, Amsterdam, an 
Institutional Review Board certified by the US Office of Human 
Research Protections (IRB number IRB-2991 under Federal-wide 
Assurance-3703; IRB/institute codes, NTR 03-180). Details on 
design, biological sampling and data collection were described 
previously [116].
To investigate differences in epigenetic variation between 
young and old MZ pairs, 37 MZ pairs of each sex were randomly 
selected from all NTR MZ pairs who were under 30 years old at 
sampling (n = 98 pairs, 44 male pairs). For 3 male and 5 female 
MZ pairs there was insufficient DNA of both co-twins. These MZ 
pairs were excluded, the remaining 66 MZ pairs were named 
“young Dutch twins” (Table 4.5). To investigate differences in 
epigenetic discordance over the full adult life span 37 MZ pairs 
were selected from all NTR MZ pairs between 30 to 50 years 
old (135 pairs, 34 male pairs) using a block random selection 
procedure to guarantee an even distribution over the age range. 
They were combined with all NTR MZ pairs who were over 50 
years old (49 pairs, 16 male pairs). The MZ pairs between 30 
and 65 years old were named “middle-aged Dutch twins” (n 
= 61; 15 male pairs) and the MZ pairs over 65 years old were 
named “old Dutch twins” (n = 25; 8 male pairs; Table 4.5).




DNA methylation was measured using a quantitatively 
accurate mass spectrometry-based method (Epityper version 
1.05, Sequenom, San Diego, CA, USA) [151,152]. A total of 
10 DNA methylation assays were measured in this study, the 
LINE1 assay for global DNA methylation [115], and 9 assays for 
DNA methylation at 7 specific genomic loci (IGF2 (3 assays), 
LEP, CRH, ABCA1, INS, KCNQ1OT1, and GNASAS; Table 4.1). 
Two novel assays were designed to assess methylation of 
the CpG sites directly telomeric, named IGF2_pter, and 
centromeric, named IGF2_qter, of the assay at the IGF2 locus’ 
DMR [60], named IGF2DMR for clarity. The primers of each 
assay were designed to create a PCR bias for completely BS 
converted DNA [149]. More details on the design, features 
and measurement of the other 8 methylation assays were 
described in detail previously [60,115,195]. Briefly: bisulfite 
(BS) conversion of 0.5 μg of genomic DNA using the EZ 96-
DNA methylation kit (Zymo Research, Orange, CA, USA) 
was followed by PCR amplification (primers are given in 
Supplementary table S4.1A), fragmentation after reverse 
transcription and analysis on a mass spectrometer. Fragments 
that contain one or more CpG sites are called CpG units. 
Randomization and quality control
All methylation assays were measured in triplicate on 
the same bisulphite converted DNA sample. DNA samples 
of both co-twins of a MZ pair were always allocated to 
the same batch for BS conversion (on 96-wells plate) and 
PCR amplification (384-wells plate, 3 x 124 DNA samples). 
Each batch contained equal proportions of the age groups 
measured, of the sexes and each PCR batch contained equal 
proportions of the BS conversion batches. There were two 
phases of methylation measurement in this study. First, all 
ten methylation assays were measured in the young Dutch 
and the old Danish twins, who were randomly divided over 
the measurement batches. The ten assays contained a total 
of 74 measurable CpG units, over which 102 CpG sites were 
distributed (Table 4.1). After quality control [195], 65 CpG 
units, containing 93 CpG sites remained, with a mean call 
rate of 96.5 %.
In the second phase, six methylation assays representing 
observations on the ten assays were measured in the middle-
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aged and old Dutch twins, who were randomly divided over 
the measurement batches, and in the follow-up Danish twins 
whom were all allocated to a single measurement batch. 
The six loci contained a total of 47 CpG units, over which 
66 CpG sites were distributed. After quality control, 42 CpG 
units, containing 61 CpG sites remained both for the Dutch 
twins (average call rate = 96.4 %) and for the follow-up 
Danish twins (average call rate = 95.7 %). These CpG units 
were the same that passed quality control in the first phase. 
Supplementary table S4.1B gives the CpG units and CpG sites 
that passed quality control of each assay and the call rates 
per assay in both phases.
Bisulfite (BS) conversion was assessed using the 
MassArray R package [153], which identifies CpG less 
fragments containing a TpG and a cytosine on the assay’s 
original genomic sequence. It analyzes the mass spectra 
treating these fragments as hypothetical CpG sites, since 
incomplete BS conversion would result in the same mass 
shift as Cytosine methylation at a CpG site. For both Danish 
and Dutch twins, this analysis qualified BS conversion as 
complete within the technical limitation of the method.
Statistical analysis
Definitions
Methylation variation: the Standard deviation of the mean 
(SD) of the inter-individual differences within a group.
Within-pair methylation difference: the within pair DNA 
methylation difference at each CpG unit, with DNA 
methylation of co-twin 1 as the reference: difference = 
Twin1 – Twin2.
Methylation discordance: the range of the within-pair 
differences in a group. To quantify age-related changes 
in discordance, the SD of the within pair differences 
in a group is used. In figures the absolute within pair 
differences (absolute discordance) are used. 
Days: a continuous variable for the time between the drawing 
of blood from each co-twin of a twin pair computed in 
days, with co-twin1 as the reference.
Batch: a categorical variable with a distinct designation for 
each combination of PCR- and bisulphite batch.
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Linear mixed models, description of basic models
Linear mixed models were used to test for age-related 
changes in DNA methylation of the assays, its variation, 
and its discordance, as previously described [135,195]. 
More details on the linear mixed model are given in the 
supplementary material. In all the linear mixed models 
used for testing age-related changes in inter-individual 
methylation variation, DNA methylation was entered as 
dependent variable. Individual was the subject variable. 
Necessary adjustments were made by entering age, sex, twin 
designation (T1 or T2, to account for non-independence), 
batch, and CpG unit, as fixed effects. In all the linear mixed 
models used for testing age-related changes in within-pair 
methylation discordance, the within-pair difference was 
entered as dependent variable. Family was the subject 
variable. Necessary adjustments were made by entering age 
Twin1, days, sex, batch, and CpG unit as fixed effects. Both 
basic models were adapted to suit each specific tests as 
described below.
Adaptation of basic models for each specific test
DNA methylation, methylation variation, and methylation 
discordance were compared between young Dutch (n = 
66 pairs) and old Danish twins (n = 67 pairs). Age group 
(young or old) was added to the models as random effect to 
test for differences in variation or discordance and as extra 
fixed effect, replacing age, to estimate adjusted group mean 
methylation or mean within-pair difference and its standard 
deviation (SD; using the SE of the mean) and test for group 
differences. 
Changes in methylation discordance over the full adult 
lifespan were tested in all Dutch and the old Danish twins (n 
= 219 pairs), age was entered as random effect. 
Longitudinal methylation variation was investigated in the 
follow-up Danish twins (n = 19 pairs), the model was adapted 
as follows: DNA sample (e.a. individual per year of sampling) 
was the subject variable. Year of sampling (1997 or 2007) 
was entered as extra random effect and as extra fixed effect. 
Adjustment for age was done using age at first sampling, no 
adjustment for batch was required. 
Adjusted mean DNA methylation, the differences in 
means, inter-individual variation and within-pair discordance 
are all expressed as percentage DNA methylation. The fold 
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change of methylation variation and discordance between 
groups is expressed as a proportion by dividing the SD in 
the older group with the SD in the younger group (SD older / 
SD younger). The change in discordance over the adult lifespan 
is expressed as the proportional increase each decade as 
percentage of the discordance of the previous decade. 
Significance of the age-related changes of variation or 
discordance was tested with a one-sided Z-test applied on the 
random effect estimate of age-group, age or sampling time 
divided by its standard error (SE), which adds up to a Wald 
test.
 
Adaptation of basic models for subsidiary tests
To test whether age effects were similar between 
Dutch and Danish individuals, methylation variation and 
discordance were compared between old Dutch twins (n = 
25 pairs) and old Danish twins (n=67 pairs). Age was entered 
as extra random effect. An interaction term age*country 
was entered as extra fixed effect, insignificance of which 
would establish that Dutch and Danes represent the same 
population. 
Nested linear mixed models were used to investigate 
confounding by leukocyte population heterogeneity, 
approximated by percentage neutrophils, as recently 
described [195]. Confounding of methylation variation and 
discordance was tested on the young Dutch twins (n = 
66 pairs). Confounding of age-related changes was tested 
on all Dutch twins (n = 152 pairs). The basic models are 
as described above, with age also entered as a random 
effect when testing age-related changes. Nested models 
had percentage neutrophils for testing its influence on 
methylation variation and the within-pair difference in 
percentage neutrophils (Twin 1 – Twin 2) for testing its 
influence on methylation discordance, added to their 
corresponding basic model as an extra fixed effect. The 
amount of confounding is determined by the change in 
residual variance, or the change in the random effect 
estimate of age, in the nested model with respect to the 
basic, as described previously [195].
Variance component models for twin analysis
In this study inter-individual methylation variation and within-
pair methylation discordance have been investigated separately. 
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In the statistical models commonly used in twin research both 
aspects of variation can also be investigated simultaneously, 
thus correcting each component for the other. The classical twin 
model for MZ twins [203] postulates that the methylation values 
(y) at a given locus for co-twins 1 and 2 of twin-pair i are defined 
by an overall mean (µ) that may depend on age, sex, batch, CpG 
unit, by a random twin-pair effect (bi), the familial environment, 
which stands for the shared factors of the twin pair, including 
common environment and genotype, and by a residual error (eij), 
the individual environment which stands for the factors that are 
unique to each co-twin (in formula: yij = µ + bi + eij). However, this 
classical twin model is not able to capture that the methylation 
variance increases with age. We therefore used the following 
extension of the classical twin model to allow for such age 
variation: yij = µ + bi + eij + ageij * ai + ageij * cij, with µ, bi, and eij 
as before, and ai and cij quantifying shared (familial) and unique 
(individual) age effects independently from each other and from bi 
and eij. More details on these MZ-twin variance component models 
[203] are given in the supplementary material. 
In the linear mixed models used to test the individual and 
familial components of variation in DNA methylation over the 
adult age range (n = 219 pairs), DNA methylation was entered 
as dependent variable. Individual and family were both subject 
variables. Age was entered as random effect around family (with 
the intercept) and as random effect around individual, thereby 
adjusting each variance component for the other. For necessary 
adjustments age, sex, batch, and CpG unit were entered as fixed 
effects. Significance of the age-related increases in total, familial 
and individual variation were tested with a one-sided Z-test 
applied on the random effect estimates of age.
The square root of the resulting random effect estimates 
represents an estimation of the SD, which, expressed as 
percentage DNA methylation, is easier to interpret. The total of all 
variation (residual variance, intercept, familial and individual age-
related estimate) and the individual variation (residual variance 
and individual age-related estimate), were plotted against age 
to visualize the familial and individual age-related increase 
in variation, since total variance minus individual variance 
represents the familial variance.
Acknowledgement
The research leading to these results has received funding from 
the Netherlands Heart Foundation (2006B083), the European Union-
Binnenwerk_opmaak.indd   96 5-12-2014   13:20:23
97
funded Network of Excellence LifeSpan (FP6 036894), the European 
Union’s Seventh Framework Programme IDEAL (FP7/2007-2011) 
under grant agreement no: 259679, the Netherlands Consortium 
for Healthy Ageing (NCHA, Grant 05060810) in the framework of 
the Netherlands Genomics Initiative (NGI)/Netherlands Organization 
for Scientific Research (NWO), the US National Institute on Aging 
(P01-AG08761), the VELUX Foundation, NWO (MagW/ZonMW, 
grants 480-04-004; and 40-0056-98-9032), Spinozapremie (SPI 
56-464-14192), CMSB: Center for Medical Systems Biology (NWO 
Genomics), BBMRI –NL: Biobanking and Biomolecular Resources 
Research Infrastructure (184.021.007), the VU University: Institute 
for Health and Care Research (EMGO+ ) and Neuroscience Campus 
Amsterdam, the European Science Foundation (EU/QLRT-2001-
01254), the European Science Council (ERC230374), the National 
Institute of Health (NIH R01D0042157-01A).
Author contributions
R.P.T., K.C., D.B., P.E.S., and B.T.H. designed the research; 
K.C., and L.C. designed the LSADT study; G.W., and D.B. 
designed the NTR biobank project; R.P.T., D.K., and H.E.D.S. 
performed the research; R.P.T., and H.P. analyzed data; 
R.P.T., P.E.S., and B.T.H. wrote the manuscript; all authors 
contributed to interpretation of the data, and critical revision 
of the manuscript.
Supplementary information on 
statistical models
Linear mixed models
The linear mixed model uses all available methylation data 
per locus (assay), i.e. methylation of multiple CpG units per locus, 
accounts for the correlation between methylation of CpG units 
within a locus, and using this correlation handles data missing at 
random. It further enables the inclusion of relevant adjustments 
on the raw data within the same model. For categorical covari-
ates entered as fixed effect the model estimates adjusted means 
and tests for differences between groups. This reduces to a t-test, 
when a single CpG unit with complete methylation data is tested 
without adjustments. For continuous covariates entered as fixed 
effect the model estimates and tests the adjusted linear relation 
between the dependent and covariate. This reduces to regres-
sion analysis when a single CpG unit with complete data is tested. 
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For covariates entered as random effect the model estimates the 
increase in variance of the dependent variable per unit change of 
the random effect covariate. A Z-test applied on the estimate of 
variance divided by its standard error (SE), tests the significance 
of this change in variance of the dependent variable, which in es-
sence adds up to a Wald test.
Variance component analysis in twin studies
Define yi1 and yi1 to be the methylation values at a given 
locus for twins 1 and 2 of twin-pair i. The classical twin model 
for MZ twins postulates that yij = µ + bi + eij, where µ is an 
overall mean that may depend on age, sex, batch, CpG unit, bi 
is a random twin-pair effect, assumed normal with mean zero 
and variance σ2b, and eij is the residual error [unique environ-
ment], assumed normal with mean zero and variance σ2e, and 
independent of bi. The bi stands for shared familial factors, 
including common environment and genotype, and the eij for 
unique environment. This model implies that the methylation 
variance equals σ2tot = σ2b + σ2e, the correlation between the 
two methylation values within a twin-pair is the intraclass corre-
lation, given by ρ = σ2b / σ2tot. The within-pair difference yi1 - yi2 
is seen to have a normal distribution with mean zero and vari-
ance 2σ2e. However, this classical twin model is not able to cap-
ture 1) increases of the methylation variance with age, and 2) 
increases of the variance of the within-pair differences with age. 
We therefore propose the following extension of the classical 
twin model, similar to the variance components models in twin 
analysis [203], to allow for such age related variation: yij = µ + 
bi + eij + ageij * ai + ageij * cij, with µ, bi and eij as before, and 
ai and cij mean zero normal random variables with variances σ2a 
and σ2c, independent from each other and from bi and eij. The 
ai and cij quantify shared (family) and unique (individual) age 
effects, respectively. For this extended twin model, the meth-
ylation variance equals σ2tot = σ2b + σ2e + age2 * (σ2a + σ2c), 
and when the ages of the two twins in the twin-pair are approxi-
mately equal, then the correlation between the two methyla-
tion values within a twin-pair is given by ρ = (σ2b + age2 * σ2a) 
/ σ2tot. In that case, the within-pair difference yi1 - yi2 for this 
extended model has a normal distribution with mean zero and 
variance 2(σ2e + age2 * σ2c). So for the extended model, both 
total variance, and the variance of the within-pair differences 
increase quadratically with age.
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Supplementary Figures
Supplementary Figure S4.1: The Absolute within MZ twin pair difference 
in % DNA methylation (y-axis) plotted against age (x-axis) per CpG unit of the 
LEPTIN locus. Each dot represents the absolute within pair difference of one 
MZ pair at one CpG unit. The different CpG units are represented by different 
colours. The lines are a loess lines that show the average trend for the change 
in methylation discordance at a CpG site with age.
 
Supplementary Figure S4.2: The Absolute within MZ twin pair difference 
in % DNA methylation (y-axis) plotted against age (x-axis) per CpG unit of the 
CRH locus. Each dot represents the absolute within pair difference of one MZ 
pair at one CpG unit. The different CpG units are represented by different co-
lours. The lines are a loess lines that show the average trend for the change in 
methylation discordance at a CpG site with age.
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Supplementary Figure S4.3: The Absolute within MZ twin pair difference 
in % DNA methylation (y-axis) plotted against age (x-axis) per CpG unit of the 
IGF2DMR locus. Each dot represents the absolute within pair difference of one 
MZ pair at one CpG unit. The different CpG units are represented by different 
colours. The lines are a loess lines that show the average trend for the change 
in methylation discordance at a CpG site with age.
 
Supplementary Figure S4.4: The Absolute within MZ twin pair difference 
in % DNA methylation (y-axis) plotted against age (x-axis) per CpG unit of the 
KCNQ1OT1 locus. Each dot represents the absolute within pair difference of one 
MZ pair at one CpG unit. The different CpG units are represented by different 
colours. The lines are a loess lines that show the average trend for the change 
in methylation discordance at a CpG site with age.
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Supplementary Figure S4.5: The Absolute within MZ twin pair difference 
in % DNA methylation (y-axis) plotted against age (x-axis) per CpG unit of the 
GNASAS locus. Each dot represents the absolute within pair difference of one 
MZ pair at one CpG unit. The different CpG units are represented by different 
colours. The lines are a loess lines that show the average trend for the change 
in methylation discordance at a CpG site with age.
 
Supplementary Figure S4.6: The Absolute within MZ twin pair difference in 
% global DNA methylation (y-axis) plotted against age (x-axis) per CpG unit. 
Each dot represents the absolute within pair difference of one MZ pair at one 
CpG unit. The different CpG units are represented by different colours. The lines 
are a loess lines that show the average trend for the change in methylation 
discordance at a CpG site with age.
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Supplementary tables
Table S4.1A: primers used for the BS PCR
Locus 


























10-mer tag AGGAAGAGAG + primer
T7-tag CAGTAATACGACTCACTATAGGGAGA-
AGGCT + primer
Binnenwerk_opmaak.indd   102 5-12-2014   13:20:32
103
Table S4.1B: CpG sites per CpG unit of each assay and 
assay call rates (CR) after quality control for the two 








old Dutch MZ pairs
















CRH 1, 2, 3*, 
4*, 8*, 9, 
10
93.4 Same CpG 
sites
89.7 Same CpG sites 88.5
GNASAS 1-2, 3-4, 





97.4 Same CpG 
sites
98.2 Same CpG sites 98.9
IGF2_
pter





3, 4, 6-7, 8 99.7 Same CpG 
sites
99.1 Same CpG sites 99.3
IGF2_
qter
1*, 2, 7*, 
8, 9, 11*, 
12-13
76.5 NA NA











100 Same CpG 
sites
98.7 Same CpG sites 98.7




98.2 Same CpG 
sites
95.7 Same CpG sites 94.1
LINE1 1, 2, 3, 4, 
5, 6-7, 8-9, 
11-12
99.5 Same CpG 
sites
96.9 Same CpG sites 94.6
 
a: Loci are ordered alphabetically in both tables
b:  CpG site number is counted from the forward primer onward, CpGs that passed 
quality control are given in bold, CpGs that failed are marked by an asterix (*) 
c:  The average call rate of the 4 methylated CPG units at the 5’ end of the amplicon 
(underlined) is given, the call rate for all CpG units was 99.5 %  
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Table S4.2: Significance of the test for interaction 
between country of origin and the observed age  
related epigenetic effects 
Locus (assay)a
P interactionb








a: Loci are ordered from top to bottom as in Figure 4.1B from left to right
b: The test was done on a population of the old Dutch MZ pairs and old Danish MZ pairs
Table S4.3: Influence of percentage neutrophils on 












Global 0.2 .464 1.0 .101
KC-
NQ1OT1 0.1 .299 0.8 .519
GNASAS 0.2 .227 1.3 .164
ABCA1 0.1 .365 11.4 3.7 *10-04
INS 0.6 .112 0.4 .157
IGF2DMR 0.3 .546 4.8 .008
IGF2_qter 2.8 .002 3.0 .045
IGF2_pter 1.9 .029 1.8 .062
LEP 13.7 1.2 *10-10 19.4 1.0 *10-06
CRH 0.3 .546 0.6 .762
 
a: Loci are ordered from top to bottom as in Figure 4.1A from left to right
b:  Percentage of variation attributable to percentage neutrophil assessed from 
change in residual variance 
c:  Two sided p-value for the effect of neutrophil percentage in the appropriate 
nested linear mixed model
d:  Percentage of twin discordance attributable to neutrophil percentage assessed 
from change in residual variance
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Table S4.4: Influence of percentage neutrophils on age 








% Age related 
variationb p-valuec
% Age related 
discordanced p-valuec
Global 10.0 .006 8.7 8.2 * 10-04
KCNQ1OT1 0.0 .935 0.0 .794
GNASAS 1.2 .048 0.6 .578
IGF2DMR 3.8 .149 5.1 .132
LEP 9.7 4.1 * 10-18 15.1 4.2 * 10-12
CRH 0.5 .462 0.5 .631
a:  Loci are ordered from top to bottom as in Figure 4.1B from left to right
b:  Percentage of age related variation attributable to neutrophil percentage as-
sessed from change in random effect estimate of age
c:  Two sided p-value for the effect of neutrophil percentage in the appropriate 
nested linear mixed model
d:  Percentage of age related twin discordance attributable to neutrophil discordance 
assessed from change in random effect estimate of age
 Table S4.5: Mean (SD) DNA methylation and longitudi-
nal change in inter-individual variation in old MZ pairs
Locusa









Global 59.3 (2.9) 62.0 (3.0) .003 3.7 % .400
KCNQ1OT1 30.1 (4.6) 31.7 (4.9) .271 4.6 % .999
GNASAS 40.7 (3.2) 42.6 (3.2) .056 2.6 % .442
IGF2DMR 54.2 (9.8) 46.0 (10.2) .008 4.1 % .301
LEP 31.5 (13.8) 34.0 (14.8) .575 7.2 % .046
CRH 67.3 (12.4) 68.2 (12.4) .827 0.4 % .344
a: Loci are ordered from top to bottom as in Figure 4.1C from left to right
b:  DNA methylation and SD are adjusted for correlation between the CpG units, 
family relations, age, and sex 
c:  Two-sided p-value for testing of group means with a linear mixed model account-
ing for CpG units, sex, age, and family relations
d:  The  increase in SD during the follow-up period is given in proportion (percent-
age) to the SD at baseline
e:  One-sided p-value for testing group variation with a Z-test on the estimates of 
variance from the same linear mixed model 
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Table S4.6: Significance test for the increase in total,  
familial and individual variation in DNA methylation
Locusa Total variationb Familial variationb Individual variationb
Global .004 .077 .003
KCNQ1OT1 1.8 * 10-15 .999 1.8 * 10-15
GNASAS 1.2 * 10-05 .378 1.5 * 10-11
IGF2DMR .002 .077 3.2 * 10-04
LEP 3.5 * 10-05 .071 4.2 * 10-10
CRH 8.7 * 10-04 .007 .055
a:  Loci are ordered from top to bottom as in Figure 4.2 from top left to bottom  right
b:  One-sided p-value for testing age related increase in variation with a Z-test on the cor-
responding estimates of variance from the same linear mixed model, effect sizes are 
shown in Figure 4.2
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Table S4.7: Homogeneity of variance test for the within-pair 





Up to 25 
years olda
26 to 50 
years olda
50 to 75 
years olda
Over 75 years 
olda
P Levene’scSDb Minb Maxb SDb Minb Maxb SDb Minb Maxb SDb Minb Maxb
Global_1 1 2.8 -6.7 5.7 2.5 -6.2 7.3 5.0 -11.3 22.7 4.1 -9.0 11.0 .003
Global_2 2 1.8 -3.7 4.5 1.6 -4.0 4.0 2.2 -5.0 7.7 2.4 -5.7 5.3 .024
Global_3 3 1.2 -2.3 2.3 1.3 -3.3 2.7 1.6 -3.7 5.0 1.6 -4.0 3.7 .119
Global_4 4 3.9 -5.7 10.3 3.2 -6.0 7.0 4.2 -9.0 10.7 4.7 -7.0 24.2 .546
Global_5 5 1.1 -3.3 2.3 1.2 -2.7 4.3 1.6 -3.0 4.3 4.6 -3.2 32.7 .190
Global_6 6-7 1.0 -2.3 2.0 1.3 -5.3 3.0 1.8 -4.0 3.7 1.4 -3.7 4.0 .006
Global_7 8-9 0.8 -1.0 1.7 1.2 -4.0 2.3 1.5 -3.3 3.3 1.3 -3.3 3.0 .048
Global_9 11-12 1.3 -1.7 4.3 1.4 -5.7 2.7 1.4 -2.7 3.7 2.3 -14.3 3.0 .386
KCNQ1OT1_1 1 1.6 -3.3 3.3 2.1 -5.0 4.7 2.0 -6.7 4.7 2.8 -7.7 8.7 .057
KCNQ1OT1_4 6 1.9 -3.7 3.7 2.0 -5.7 5.7 2.0 -5.0 4.7 2.8 -8.3 10.7 .439
KCNQ1OT1_6 8-9 1.7 -3.0 3.7 3.0 -8.7 6.0 2.6 -6.3 5.0 2.8 -4.7 7.3 .072
KCNQ1OT1_7 10-12 1.5 -2.3 2.7 2.4 -7.0 5.3 2.4 -8.5 4.7 2.9 -5.7 11.0 .099
KCNQ1OT1_9 15 1.5 -2.3 3.7 1.9 -4.7 5.3 2.0 -5.0 4.3 3.0 -7.7 9.7 .048
KCNQ1OT1_10 16 2.2 -3.3 5.3 2.2 -4.7 5.0 2.2 -5.0 4.7 3.1 -8.0 11.0 .717
KCNQ1OT1_11 17-18 1.6 -3.3 3.3 2.2 -6.0 5.3 1.8 -5.0 3.7 2.6 -8.7 7.3 .240
KCNQ1OT1_13 20 1.8 -4.3 4.3 2.0 -5.0 4.7 1.8 -6.0 3.3 2.5 -9.3 6.0 .549
KCNQ1OT1_14 21 1.3 -2.3 2.7 1.7 -4.0 5.0 1.9 -5.0 4.3 2.8 -8.0 9.3 .023
KCNQ1OT1_18 25 1.8 -3.0 4.7 2.2 -6.3 4.7 2.1 -6.7 4.3 3.1 -8.3 11.0 .089
GNASAS_1 1-2 3.0 -6.0 4.7 4.0 -13.0 7.3 3.3 -10.0 9.7 4.1 -12.3 9.7 .399
GNASAS_2 3-4 2.6 -5.3 5.0 3.3 -14.7 6.0 3.1 -8.3 6.7 3.8 -9.7 10.7 .280
GNASAS_3 5 4.3 -7.0 12.3 4.8 -15.7 7.0 4.5 -14.7 7.7 5.7 -16.0 7.7 .357
GNASAS_4 6 3.8 -8.3 9.0 3.5 -11.3 7.0 3.1 -10.0 6.7 3.6 -6.3 7.3 .357
GNASAS_5 7 3.2 -7.0 6.0 3.5 -13.0 6.3 3.4 -10.3 7.7 3.4 -6.7 6.0 .927
GNASAS_6 8-9 2.6 -6.0 6.0 3.2 -13.0 5.3 3.0 -10.0 6.0 3.2 -6.3 7.7 .507
GNASAS_7 10-12 2.6 -6.0 6.0 3.3 -10.0 6.0 3.3 -9.7 7.0 3.8 -10.0 6.3 .146
GNASAS_8 13-14 2.5 -6.0 6.3 3.3 -12.0 6.7 3.1 -8.7 7.3 2.9 -6.0 5.7 .455
GNASAS_9 15 3.2 -6.7 7.0 3.7 -16.3 6.0 3.6 -12.3 7.3 3.4 -7.7 9.3 .910
GNASAS_11 17-19 3.0 -7.7 5.7 4.1 -11.0 8.0 4.1 -15.0 7.3 3.7 -7.0 8.0 .335
IGF2DMR_3 3 3.5 -7.5 5.0 5.0 -15.7 12.3 6.6 -18.2 10.7 9.6 -24.0 25.5 6.0*10-05
Binnenwerk_opmaak.indd   107 5-12-2014   13:20:39
108
IGF2DMR_4 4 2.9 -8.0 7.0 4.4 -11.3 9.7 7.1 -23.7 16.7 9.5 -25.0 21.7 1.6*10-07
IGF2DMR_6 6-7 2.9 -7.3 5.0 2.6 -7.0 7.5 4.1 -10.7 11.7 5.9 -18.0 10.7 3.3*10-07
IGF2DMR_7 8 2.6 -5.0 4.3 3.0 -6.7 7.3 4.3 -12.0 13.3 5.1 -14.3 12.0 9.6*10-04
LEP_1 1 4.0 -8.0 8.7 4.9 -17.3 11.7 9.1 -22.3 30.0 10.6 -23.3 42.3 6.8*10-05
LEP_3 8 2.8 -5.0 5.3 2.7 -5.0 10.7 7.0 -36.3 15.0 6.5 -17.3 16.3 7.3*10-06
LEP_8 16-17 2.5 -5.0 5.0 2.7 -7.0 7.0 4.9 -11.3 14.0 5.3 -15.3 18.0 4.9*10-04
LEP_10 19-21 3.7 -8.0 6.3 3.4 -8.0 7.7 4.3 -19.0 7.3 6.4 -26.0 11.2 .005
LEP_11 22 4.9 -8.0 10.0 5.3 -15.7 17.3 8.2 -24.3 21.3 10.1 -34.7 29.7 .002
LEP_13 25 6.8 -12.0 13.7 6.0 -12.3 14.7 10.2 -30.3 33.0 11.0 -37.7 16.3 .008
CRH_1 1 5.5 -7.7 17.7 6.8 -12.5 22.8 13.1 -46.3 32.5 10.1 -16.0 34.7 .003
CRH_2 2 3.5 -7.3 9.0 5.6 -19.7 21.3 4.5 -9.5 12.0 8.0 -29.7 14.0 .012
CRH_9 9 6.4 -12.0 15.0 8.6 -32.8 25.3 11.7 -27.0 28.3 12.2 -26.7 36.7 .015
CRH_10 10 5.7 -11.3 14.7 7.5 -22.0 20.3 15.3 -36.0 38.5 12.4 -29.7 26.0 2.4*10-04
a:  Population sizes: ≤ 25 yrs, n = 30 pairs; 26 – 50 yrs, n = 78 pairs; 51 – 75 yrs, n 
= 56 pairs; ≥ 76 yrs, n = 54 pairs
b:  Standard deviation of within pair difference (SD) minimum (Min) and maximum 
(Max) differences are given in % DNA methylation






Up to 25 
years olda
26 to 50 
years olda
50 to 75 
years olda
Over 75 years 
olda
P Levene’scSDb Minb MaxbSDb Minb Maxb SDb Minb Maxb SDb Minb Maxb
Table S4.7: (continued) Homogeneity of variance test for the with-
in-pair methylation differences across the age groups per CpG unit
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Human epidemiological studies suggest that small size at 
birth and food deprivation during gestation confer an excess 
risk of coronary heart diseases (CHD) in adulthood, frequently 
in a sex-specific manner. Prior epigenetic studies indicate 
that such prenatal conditions are marked by persistent, 
sometimes sex-specific changes in DNA methylation. Here, 
we investigated the association between DNA methylation 
and myocardial infarction (MI) at six loci sensitive to prenatal 
nutrition, anticipating potential sex-specificity. 
Method
Within the placebo group of the PROSPER trial on Pravastatin 
and the risk of CHD, we compared all individuals who were 
event free at baseline and developed MI during 3 years 
follow-up (n = 122) with a similar sized control group. 
Methylation at IL10, LEP, ABCA1, IGF2, INS, and GNASAS 
was measured in DNA extracted from leukocytes using mass 
spectrometry. 
Results
DNA methylation at GNASAS was modestly higher in MI 
cases compared with controls (p=0.030). A significant sex 
interaction was observed for INS (p = 0.014) and GNASAS 
(p = 0.031). Higher DNA methylation at these loci was 
associated with MI among women (INS: + 2.5 %, p = 0.002; 
GNASAS: + 4.2 %, p = 0.001). Hypermethylation at one 
locus and at both loci was associated with odds ratios of 2.8 
and 8.6, respectively (Ptrend = 3.0 * 10-04). No association was 
observed among men. 
Conclusions
The risk of MI in women is associated with DNA methylation 
marks at specific loci previously shown to be sensitive 
to prenatal conditions. This observation may reflect a 
developmental component of MI.
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Introduction
The developmental origins of health and disease 
hypothesis poses that conditions during early development 
influence the risk for developing coronary heart diseases 
(CHD) and other chronic diseases in later life [209,210]. In 
human studies, this hypothesis is being investigated using 
various proxies for developmental adversity. Small size at 
birth, for example, is linked to a consistent albeit modest 
increase in risk of type 2 diabetes mellitus [166] and CHD [9] 
in later life. Prenatal exposure to the Dutch Famine at the end 
of World War II is associated with an adverse CHD risk profile 
in adulthood in individuals who had a normal size at birth 
[167,211]. These proxies, however, generally lack specificity. 
Small size at birth can be caused by many factors and 
cannot distinguish between specific prenatal conditions and 
their timing. Studies of historical famines can be relatively 
precise for the type and the timing of prenatal conditions but 
provide limited information for exposures at the individual 
level. Moreover, data on these proxies is rarely available in 
epidemiological studies of CHD. The molecular modifications 
underlying epigenetic regulation are an alternative resource 
for markers of the prenatal environment that could meet 
these limitations. 
Epigenetic mechanisms maintain heritable variation in 
gene expression potential that is not caused by variation 
in the DNA sequence [29]. The molecular basis includes the 
methylation of cytosines in CpG dinucleotides, which together 
with histone modifications, and non-coding RNAs, influences 
the accessibility of DNA to the transcriptional machinery [23]. 
DNA methylation is recognized as the most stable epigenetic 
mark [25]and can be measured on DNA samples that are 
commonly available in biobanks [195]. 
Although generally stable, the prenatal environment can 
induce persistent changes in DNA methylation. Crucially, 
these changes can be specific to the type of exposure, 
its timing during gestation and the sex of the exposed 
individual. In sheep, maternal methyl-donor deficiency 
from preconception to preimplantation resulted in sex-
specific DNA methylation changes throughout the genome 
in the adult offspring [184]. In rats, prenatal dietary protein 
restriction [212] and prenatal caloric restriction [213] had 
opposite effects on DNA methylation at the same candidate 
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loci illustrating that methylation marks at specific loci can 
be meta-stable and that the direction of epigenetic changes 
may be exposure-specific [214]. Similar mechanisms apply 
to humans. We reported timing and sex-specific changes in 
DNA methylation at candidate loci sixty years after exposure 
to the Dutch Famine [14,135]. The relevance of sex-specific 
effects is highlighted by the observation that the association 
of prenatal famine exposure with an adverse cardiovascular 
risk profile is predominantly present among women [167,169]. 
In addition, periconceptional exposure to famine was 
associated with lower DNA methylation at the IGF2 locus 
whereas periconceptional folic acid supplementation was 
associated with higher DNA methylation at this locus [120]. 
Other prenatal conditions that have been associated with 
Table 5.1: Epigenetic properties of the six methylation 
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GNASAS 






a: Exposure to famine in the period around conception
b: Exposure to famine in late gestational period (last trimester)
c: Methylation-sensitive transcription factor-binding site
d: The association between DNA methylation and prenatal famine was sex specific
NT: The association between DNA methylation and famine was not tested
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changes in DNA methylation in humans include intrauterine 
growth restriction [215] and maternal tobacco smoking during 
pregnancy [216]. In line with these data, it has been proposed 
that the developmental origins of CHD may eventually be 
investigated with epigenetic signatures that are specific for 
both timing and type of adverse prenatal conditions [69,106].
In this study, we investigated the association of DNA 
methylation with myocardial infarction (MI) during a 3.2 years 
follow-up period. To this end, DNA methylation was measured 
at six loci implicated in metabolic and cardiovascular 
diseases, namely IL10, LEP, ABCA1, IGF2, INS (alternate 
symbol INSIGF), and GNASAS (alternate symbol NESPAS). 
These methylation marks cover the genomic region that 
contains features with a potential for epigenetic regulation 
as observed in human, animal, or cell culture experiments 
[133,136,141,143,200,201] (Table 5.1). DNA methylation 
at these loci was previously found to mark prenatal 
environmental conditions [14,120,135]. Analyses took into 
account potential sex-specificity since prenatal adversity was 
reported to be sex-specifically associated with both changes 
in DNA methylation [135] and with  prevalence of metabolic 
risk factors for CHD [167,169,217]. 
Methods and materials
Study population
This study was based in the ongoing PROspective 
Study of Pravastatin in the Elderly at Risk (PROSPER) trial. 
Details of the design of the PROSPER study were described 
previously [118,218]. Briefly: PROSPER is a prospective 
multicenter randomized placebo-controlled clinical trial to 
asses if treatment with pravastatin could reduce risk of major 
vascular events in the elderly. Between December 1997 and 
May 1999, subjects were screened and enrolled in Glasgow 
(Scotland), Cork (Ireland), and Leiden (the Netherlands). For 
the PROSPER study men and women aged 70 – 82 years were 
recruited if they had pre-existing vascular disease or were at 
a moderately increased risk due to smoking, hypertension, 
or diabetes. A total number of 5804 subjects were randomly 
assigned to either Pravastatin (n = 2891) or placebo (n = 
2913) treatment. Mean follow-up period was 3.2 years after 
randomized assignment to Pravastatin or placebo treatment. 
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All endpoints of the study were adjudicated by a study 
endpoint committee. In the current study, MI includes the 
definitions of definite fatal and nonfatal myocardial infarction 
as devised for the PROSPER trial [118]. Further details on 
the measurement and definition of baseline characteristics 
are described elsewhere [118,218]. DNA was extracted 
from blood drawn before the placebo run-in medication was 
issued. Samples were centrifuged after lysis of erythrocytes, 
the supernatant was removed, and DNA was extracted from 
the pellet, consisting of the leukocytes, using the salting out 
method.
Eligible individuals for this study were allocated to placebo 
treatment to exclude an influence of Pravastatin treatment 
and were free of CHD events at baseline (n = 1654). The 
remaining risk factors for which the study population was 
selected (smoking, hypertension or diabetes) are common at 
older age and the individuals can be expected to be largely 
representative of their age group. A further inclusion criterion 
for this study was availability of sufficient DNA (n = 1375). 
Controls were selected from those alive at the end of the 
follow-up period who did not develop CHD, stroke or cancer 
(n = 1248), cases suffered an MI during the follow-up period 
(n = 122). The study focused on a single end-point to reduce 
heterogeneity. A case-control study was designed to compare 
all eligible cases to a representative control group of similar 
size. Assuming that the differences in DNA methylation 
between cases and controls are similar to those we previously 
observed between individuals prenatally exposed to famine 
[14,135] or periconceptional folic acid [120] (mean difference 
expressed in standard deviations = 0.35), the estimated power 
of our study is 0.78 (122 cases, 122 controls; α = 0.05; two-
sample t-test). Because this would leave space for 4 additional 
samples on the PCR-plates, 126 individuals were included 
in the control group. To select the controls, we used block-
random selection in order to obtain a similar sex distribution 
in the controls as in the cases (females 48.4 %). From the 
group of eligible controls (females 60.9 %), 302 females were 
randomly removed. Next, from the remaining group (n = 946), 
126 individuals (females 49.2 %) were randomly selected to be 
the control group, which was similar in baseline characteristics 
as the whole group of eligible controls.
The institutional ethics review boards of all study centers 
approved the protocol, and all participants gave written 
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informed consent. The protocol was consistent with the 
Declaration of Helsinki.
DNA methylation
DNA methylation was measured using a mass 
spectrometry-based method (Epityper version 1.05, 
Sequenom, San Diego, CA, USA). Previous studies showed the 
quantitative accuracy (R2 duplicate measurements ≥ 0.98) 
and high concordance with clonal PCR bisulphite sequencing 
[14,151,152]. The design, features and measurement details 
of the assays to measure DNA methylation at IL10, LEP, 
ABCA1, IGF2, INS (INSIGF), and GNASAS (NESPAS) were 
described previously [195]. Briefly: bisulfite conversion of 
0.5 μg of genomic DNA using the EZ 96-DNA methylation 
kit (Zymo Research, Orange, CA, USA) was followed by PCR 
amplification, fragmentation after reverse transcription and 
analysis on a mass spectrometer. Fragments that contain one 
or more CpG sites are called CpG units, methylation of which 
is assessed in a single measurement for all CpG sites on the 
fragment. Cases and controls were randomly divided over 
bisulfite conversion (3 x 96-well plates) and PCR amplification 
batches (2 x 384 well plates). For each individual, the six 
assays were amplified from the same bisulfite treated DNA. 
All methylation measurements were done in triplicate from 
the same bisulfite treated DNA. 
The six assays contained a total of 59 CpG units, over which 
96 CpG sites were distributed. After applying a stringent quality 
control procedure [195], 32 CpG units, containing 49 CpG sites 
remained (Table S5.1B). In total 23 CpG units (41 CpG sites) 
were removed since their fragment’s mass overlapped or wass 
outside the detection range,  potential confounding by single 
nucleotide polymorphisms both due to known (dbSNP build 28) 
or unknown genetic variation (R-module MassArray [153]), and 
4 CpG units (6 CpG sites) were removed since they had success 
of less than two of the three replicate measurements, standard 
deviation (SD) greater than 10 % for the replicates, and success 
rate < 75 % after quality controls. The average call rate for the 
32 CpG units was 94%.
Statistical analysis
The differences in baseline characteristics between the 
case and control group were assessed with a chi-square test 
for the qualitative variables, and an independent t-test for 
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the quantitative variables. For HDL-cholesterol, triglycerides, 
glucose and CRP, significance of the difference was assessed 
after natural logarithmic transformation. 
We estimated the mean DNA methylation at the six 
loci and the standard error of the mean (SE) for cases and 
controls as previously described [135,195]. Linear mixed 
model were used to test for differences in methylation of 
the loci between cases and controls [135,195,219]. It uses 
all available methylation data per locus, i.e. methylation of 
multiple CpG units per locus, accounts for the correlation 
between methylation of CpG units within a locus, and using 
this correlation handles data missing at random. It further 
enables the inclusion of relevant adjustments on the raw 
data within the same model. The linear mixed model may be 
seen as an extension of a t-test, resulting in identical results 
when between-group methylation differences are assessed 
for a single CpG unit (in stead of all CpG units within a locus) 
and covariates are omitted. In the linear mixed model DNA 
methylation was entered as dependent variable. Individual 
was entered as a random effect. Incidence of MI, age, sex 
(when applicable), country of origin, PCR- and bisulphite 
batch, and CpG unit, were entered as fixed effects. The 
difference between case and control groups at a locus 
was expressed as percentage DNA methylation and as the 
proportion of the standard deviation (SD) of the adjusted 
mean methylation in the control group (estimated from the 
SE), i.e. the standardized difference (SD-unit). 
To test for sex specificity of the association between DNA 
methylation and MI the interaction term MI*sex was entered 
as a fixed effect to the model. This was done in view of the 
previously observed sex-specificity of the association between 
prenatal exposure to famine and both DNA methylation at 
LEP, INS, and GNASAS [135] (Table 5.1) and cardiovascular 
risk factors [167,169]. For loci showing a significant interaction 
between sex and MI, the study population was reanalyzed for 
men and women separately. Traditional CHD risk factors, that 
showed a difference (p < 0.05) between cases and controls, 
were added to the model as fixed effects, separately and 
simultaneously to obtain adjusted DNA methylation differences 
between cases and controls. 
Logistic regression was used to calculate odds ratios (OR) 
for hypo– (i.e. lower than the median) or hypermethylation 
(i.e. higher than the median) at a locus and incidence of 
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MI. The median, being independent of the distribution of 
variation in DNA methylation, was chosen as cut-off to 
compare the analyses across the loci. To categorize DNA 
methylation at a locus as hypo- or hypermethylated, the 
mean methylation at a locus was calculated by averaging the 
methylation of the CpG units measured across the locus after 
imputing missing data. Imputation was performed using the 
linear mixed model, which exploits the correlation between 
methylation of neighboring CpG sites to achieve accurate 
imputation [14]. In the regression model, incidence of MI 
status was the dependent variable, and methylation status, 
age, sex (when applicable), country of origin, PCR- and 
bisulphite batch, and traditional risk factor (when applicable) 
were entered as independent variables. Odds ratios for hypo 
- and hypermethylation were calculated with methylation of a 
locus entered as categorical covariate (hypomethylation was 
the reference category). Loci were tested individually and 
combined; interaction between loci was tested by entering 
an interaction term locus1*locus2 as covariate. Statistical 
significance for combined effects was assessed using a test 
for trend. All P-values reported are two-sided. All analyses 
were performed using SPSS 16.0 (SPSS inc., Chicago, IL, 
USA).
Results
Our study was based in the PROspective Study of 
Pravastatin in the Elderly at Risk (PROSPER) trial [118]. Eligible 
individuals for the current epigenetic study were selected from 
the placebo group and were free of CHD events at baseline 
(n = 1654). Individuals who developed MI during follow-up 
(n = 122) had a higher BMI, lower HDL-cholesterol, higher 
triglycerides, and higher CRP than a randomly selected control 
group (n=126; Table 5.2). Of note, the association of many 
CHD risk factors had a different distribution between the two 
sexes in this study population. Metabolic risk factors such 
as BMI, triglyceride levels, and fasting blood glucose were 
only associated with MI in women, whereas CRP levels and 
hypertension were only associated with MI in men (Table 5.2).
DNA methylation at IL10, LEP, ABCA1, IGF2, INS, and 
GNASAS was measured using a mass spectrometry-based 
method [152]. Linear mixed model were used to test for 






































































































































































































































































































































































































































































































































































































































































































































































































































Binnenwerk_opmaak.indd   118 5-12-2014   13:20:48
119
differences in methylation of the loci between cases and 
controls [135,195,219]. DNA methylation was modestly higher 
in MI-cases at GNASAS (+ 1.8 % (= 0.26 SD-units), p = 0.030; 
Table 5.3) compared with the control group. No differences 
in DNA methylation were observed at the other loci. Sex-
specificity of the associations was tested. An interaction 
between sex and MI was observed for INS (Pinteraction = 0.014) 
and GNASAS (Pinteraction = 0.031) (Table 5.3). Women and men 
were subsequently analyzed separately for these loci. 
In women, DNA methylation at INS was higher in MI cases 
compared with controls (+ 2.5 % (= 0.59 SD-units), p = 0.002) 
(Table 5.4), which was independent of traditional risk factors (+ 
2.6 % (=0.62 SD-units); p = 0.002). This difference was similar for 
all four CpG units at the locus, when expressed in SD-units (Figure 
5.1B). DNA methylation at GNASAS was also higher in female 
cases compared with controls (+ 4.2 % (= 0.61 SD-units), p = 
0.001), and was also independent of traditional risk factors (+3.5 
% (=0.51 SD-units); p = 0.009). This difference was similar for all 




































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.1: DNA hypermethylation is associated with risk for MI 
DNA methylation difference between the female case - and control groups 
(y-axis) at each CpG unit (x-axis) of the loci INS (grey bars) and GNASAS (open 
bars). Differences were nominally significant for all CpG units when tested 
individually (P<0.05), except for CpG 6 of INS (A) Difference in percentage DNA 
methylation. (B) Difference in SD-units, a proportion of the standard deviation 
from the adjusted mean methylation in the control group. Bars represent the 
average difference, the whiskers represent the SE of the difference. Numbers 
under each bar are the CpG units, numbered from the forward primer onward. 
A positive difference indicates that the case group had a higher average DNA 
methylation, values are adjusted for bisulphite - and PCR batches, country and 
age at baseline.  
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DNA methylation were observed between cases and controls.
We assessed the association between hypermethylation at 
INS and at GNASAS with the risk of MI (Table 5.5). No interaction 
between the two loci was observed. Therefore, three categories 
were analyzed: hypomethylation at both loci (reference), 
hypermethylation at either INS or GNASAS and hypermethylation 
at both loci. In the whole study population, hypermethylation at 
one locus and at both loci was associated with odds ratios of 1.7 
(95 % Confidence interval (95 % CI): 0.9 – 3.3) and 2.8 (95 % 
CI: 1.4 – 5.9), respectively (ptrend = 0.006). This association could 
be solely attributed to women among whom single and double 
hypermethylation were associated with odds ratios of 2.8 (95 % CI: 
1.0 – 7.8) and 8.6 (95 % CI: 2.7 – 27.9), respectively ( ptrend = 3.1 * 
10-4). Adjustment for traditional risk factors did not appreciably alter 
these associations (ORsingle = 3.1 (95 % CI: 1.0 - 9.7); ORdouble = 11.1 
(95 % CI: 2,9 - 43.4), Ptrend = 5.2 * 10-4). In men, no association was 
observed. 
Discussion
We report the association of a higher DNA methylation 
at the imprinted loci INS and GNASAS with the incidence 














IL10 27.6 (0.79) 29.2 (0.88) + 1.6 (1.11) + 0.18 (0.12) 0.148 0.232
LEP 29.2 (0.54) 29.7 (0.60) + 0.4 (0.75) + 0.07 (0.12) 0.558 0.435
ABCA1 14.8 (0.35) 15.0 (0.38) + 0.2 (0.47) + 0.04 (0.12) 0.752 0.093
IGF2 52.0 (0.52) 53.2 (0.58) + 1.2 (0.73) + 0.21 (0.13) 0.089 0.087
INS 75.7 (0.42) 76.8 (0.46) + 1.1 (0.58) + 0.23 (0.12) 0.063 0.014
GNASAS 49.0 (0.60) 50.9 (0.67) + 1.8 (0.84) + 0.27 (0.12) 0.030 0.031
a:  Average DNA methylation at the locus, adjusted for batch effects, country, age at 
baseline, and sex
b:  The difference is expressed in percentage DNA methylation
c:  The standardized difference is expressed as a proportion of the standard devia-
tion in the control group
d:  Two sided p-value for the difference, adjusted for batch effects, country, age 
at baseline, and sex
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of MI in women. Until now, only the association between 
various measures of genomic methylation and CHD have 
been investigated with varied outcomes [220,221]. Our 
results suggest that methylation at specific loci may be an 
epigenetic marker for the risk of CHD.  
It remains to be determined which factors or mechanisms 
underlie the observed association. Our results may be linked 
Table 5.4: DNA methylation differences and incidence 













♂ 76.0 (0.64) 75.7 (0.68) − 0.4 (0.87) − 0.07 (0.17) 0.659
♀ 75.5 (0.53) 77.9 (0.60) + 2.5 (0.76) + 0.59 (0.18) 0.002
GNASAS
♂ 49.3 (0.83) 49.6 (0.89) + 0.2 (1.12) + 0.03 (0.17) 0.850
♀ 48.4 (0.89) 52.6 (1.01) + 4.2 (1.28) + 0.60 (0.18) 0.001
a:  Average DNA methylation at the locus, adjusted for batch effects, country, and 
age at baseline
b:  The difference is expressed in percentage DNA methylation
c:  The standardized difference is expressed as a proportion of the standard devia-
tion in the control group
d:  Two sided p-value for the difference, adjusted for batch effects, country, and 
age at baseline
Table 5.5: Hyper-methylation at INSIGF and GNASAS 





Whole group ♂ ♀
n OR (95% CI) n OR (95% CI) n OR (95% CI)
Hypo / Hypo 69 1 34 1 35 1
Hypo / Hyper or 
Hyper / Hypo 103 1.7 (0.9 – 3.3) 59 1.1 (0.4 – 2.7) 44 2.8 (1.0 – 7.8)
Hyper / Hyper 70 2.8 (1.4 – 5.9) 33 1.1 (0.4 – 3.1) 37 8.6 (2.7 – 27.9)
Test for trend (ptrend) b 0.006 0.868 3.1 * 10-4
a:  Hypo-methylation is defined as below median, hyper-methylation as above me-
dian.
b:  Two sided p-value, adjusted for batch effects, country, age at baseline, and sex 
where appropriate
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to the developmental origins hypothesis which predicts 
that individuals who go on to develop CHD were subjected 
to less favorable conditions in early life than those who 
do not [209,210,222]. INS and GNASAS are regulators of 
fetal growth. Methylation at GNASAS is crucial for normal 
imprinting throughout the GNAS locus, in which expression of 
the antagonists G protein α-subunit (Gαs) and its extra large 
isoform (XLαs) regulate fetal nutrient demand [201,223]. 
Methylation at the INS promoter establishes imprinting in 
extra-embryonic tissues, in which expression of the INSIGF 
transcript regulates placental development [180,224]. Further 
highlighting the putative link to the developmental origins 
hypothesis are the differences in DNA methylation at INS and 
GNASAS observed after prenatal exposure to famine that 
persist throughout life, are of the same magnitude and are 
sex-specific [135]. 
Our findings are compatible with a developmental 
component of MI, however the current study population lacks 
data on the potential prenatal factors involved, although it 
is certain that participants of the study population did not 
experience famine during gestation. Previous work indicated 
that epigenetically meta-stable loci like INS and GNASAS 
may be sensitive to various perturbations during early 
development [14,120,212,213]. Prenatal conditions that are 
associated with an adverse CHD risk profile in adulthood and 
that have been suggested to produce persistent epigenetic 
changes include maternal micronutrient deficiency [225], 
maternal smoking [226], and placental morphology [217]. 
Social-economic status may be another relevant but as 
yet less investigated factor related to prenatal conditions 
[8]. If persistent epigenetic signatures of specific prenatal 
conditions can be established in studies in which these 
prenatal conditions have been recorded [195,197], they can 
subsequently be used as surrogate markers to indirectly 
assess the association of such prenatal conditions to CHD 
risk in studies that, like our study, lack information on the 
prenatal environment [69,106]. 
The loci studied here were selected for their sensitivity to 
prenatal conditions and the influence of prenatal conditions 
on DNA methylation is well-established. However, the 
difference between female MI cases and controls may also 
have accumulated during aging as a result of a differential 
exposure to environmental factors over the life course [227]. 
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If life course exposures indeed contributed to our findings, 
they appear to be unrelated to traditional CHD risk factors, 
since the associations between DNA methylation and MI 
remained after adjustment for these CHD risk factors. 
Similar to the studies on prenatal exposures, we measured 
DNA methylation on DNA extracted from leukocytes. We 
previously demonstrated that heterogeneity of the leukocyte 
population does not influence INS and GNASAS methylation 
in whole blood [195] and, furthermore, individuals with signs 
of inflammation were excluded from the current study [118]. 
Thus, it is unlikely that cellular heterogeneity contributed to 
our results.
Epigenetic changes were proposed to be mechanistically 
involved in CHD development [65], and it may be explored 
whether the current data can be viewed as supportive 
of this hypothesis. Higher DNA methylation at INS is 
associated with lower expression of the insulin gene in 
pancreatic β-cells [200]. Higher DNA methylation at GNASAS 
is associated with higher expression of Gαs in adipose 
tissue, the pituitary and the thyroid gland [201,223]. Gαs is 
a key component of the cAMP mediated intracellular signal 
transduction cascade [223]. Both cAMP and insulin signaling 
are implicated in obesity, insulin resistance and other signs 
of metabolic dysregulation [228], all of which are risk factors 
for developing CHD. The differences in DNA methylation that 
we report here, however, were observed in leukocytes, in 
which insulin is not expressed [200] and expression of Gαs is 
not controlled by DNA methylation at GNASAS [223]. Still, the 
methylation status of imprinted loci in leukocytes is generally 
thought to mark that of (internal) tissues that are directly 
involved in disease [30,195]. Also, it should be noted that 
the observed differences in percentage DNA methylation are 
small, although their magnitude is in line with other human 
studies [14,73,120,135,215,216]. In a rat study small changes 
in percentage DNA methylation were demonstrated to explain 
almost half the variance in gene expression [188]. Studies 
in non-peripheral tissues, incorporating a study design that 
addresses confounding and reverse causation [99], should be 
used to establish whether or not small but long-term changes 
in expression of these loci can influence pathways that are 
involved in CHD development.
In the current study we only found an association between 
DNA methylation and risk of MI in women, but not in men. 
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This may indicate sex-specificity of the association, similar 
to sex-specific epigenetic changes associated with prenatal 
exposure to the Dutch Famine [135]. In view of the study size 
and the characteristics of the PROSPER study, the absence of 
an association in men should be interpreted with caution. We 
observed sex-specific associations with MI for traditional risk 
factors that are known to be sex-independent in middle age. 
This may be related to the age range of the study subjects 
(70-82 years) and the exclusion of individuals with a history 
of CHD at baseline. The age is well above the average age of 
a first MI for men (63 years), but below the average age of a 
first MI for women (74 years) [229,230]. To definitely establish 
whether the associations of INS and GNASAS methylation are 
sex-specific, larger series of patients and controls that include 
younger age-ranges should be investigated.
It has been proposed that epigenetic marks that are 
sensitive to the prenatal environment can be used as 
biomarkers to investigate the developmental origins of health 
and disease hypothesis [69,106]. Our data, in combination 
with previous results on prenatal exposures [14,120,135] 
indicate the feasibility of this approach. The success of 
the approach will rely on the identification of epigenetic 
signatures that mark a specific prenatal condition, e.g. 
maternal micronutrient deficiency [225], maternal smoking 
[226], and placental morphology [217]. This will entail 
epigenome-wide screening in studies designed to investigate 
exposures during early development. These epigenetic 
signatures can subsequently be utilized as biomarkers for 
disease risk in epidemiological studies of CHD or other 
chronic diseases. 
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Table S5.1A: Primers used in bisulfite PCR







10-mer taga AGGAAGAGAG + 
T7 taga CAGTAATACGACTCAC-TATAGGGAGAAGGCT +  
a: The primer is attached to the tag at the + site
Table S5.1B: CpG-sites per fragment of the loci that 
were analyzed for variation
Locus
UCSC coordinatesb CpG-sites ana-
lyzedc Call rated
IL10 chr1:206,946,011-206,946,339 1, 2-3 91%
LEP chr7:127,881,054-127,881,410 1, 8, 16-17, 19-21, 22, 25, 28 95%
ABCA1 chr9:107,690,502-107,690,821 3-4, 5, 15-16, 17-18, 19-21, 25 92%
IGF2 chr11:2,169,459-2,169,796 3, 4, 8 94%
INS chr11:2,182,336-2,182,640 2, 3, 5, 6 99%
GNASAS
chr20:57,425,815-57,426,108 1-2, 3-4, 5, 6, 7, 8-9, 
10-12, 13-14, 15, 
17-19
92%
b: UCSC genome browser coordinates from Feb. 2009 (GRCh37/hg19) Assembly
c:  CpG-site number is counted from the forward primer onward, and given per CpG 
unit
d: Percentage of CpG unit methylation measurements that remained after qual-
ity control
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Human studies on epigenetic variation and disease are 
usually restricted to measuring peripheral tissues, while many 
diseases manifest in internal tissues. Due to the extensive 
epigenetic remodeling involved in tissue development, it is 
unclear to what extent inter-individual epigenetic variation 
measured in peripheral tissues marks that of the internal 
tissues related to the disease.
Methodology & Principal Findings
To investigate epigenetic differences and similarities 
between blood and internal tissues we obtained samples 
from 6 individuals during post-mortem examination 
within 24 hours after death. Using the Illumina Infinium 
HumanMethylation450 BeadChip microarray We compared 
DNA methylation of blood with subcutaneous fat, skeletal 
muscle, visceral fat, liver, pancreas and spleen at 378,239 
CpG sites distributed over the autosomal chromosomes. 
Principal component analysis on this data revealed that most 
differences in genome wide DNA methylation patterns were 
between tissues rather than individuals. This analysis also 
revealed that the methylation patterns in post-mortem blood 
samples were similar to the patterns in blood samples form 
40 middle aged regular blood donors. The tissues showed a 
similar overall distribution of mean methylation levels and 
methylation variation at individual CpG sites. A quarter of 
the CpG sites measured showed no detectable methylation 
difference between blood and any of the internal tissues. 
Further, the methylation variation at more than 30% of CpG 
sites showed a strong correlation (r ≥ 0.75) between blood 
and an internal tissue. 
Most strong correlations were between blood and one internal 
tissue exclusively, although strong correlations between 
blood and several tissues were observed at 6092 CpG sites. 
searching for characteristics marking CpG sites with a strong 
tissue correlation, we found that these were unrelated to 
DNA methylation levels, variation, or differences between 
the tissues, nor did we observe an association with genetic 
sequence motifs, genome structure, or localization relative to 
genomic, epigenomic, or repetitive elements.
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Conclusions
Variation in DNA methylation is correlated between blood and 
internal tissues at a subset of CpG sites, depending on both 
the genomic locus and the tissue. These results indicate the 
existence of loci at which epigenetic information in peripheral 
tissues marks that of internal tissues.
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Introduction
A popular theme in research on the development of 
common age related diseases is its epigenetic component 
[17,65,68,231]. Epigenetic mechanisms regulate the local 
condensation of DNA thereby influencing the capacity 
of the transcription machinery to access a locus upon 
reception of the correct cues [21,23,29]. There are several 
correlated layers of epigenetic information, including 
post-transcriptional control by microRNAs, nucleosomal 
packaging, histone modifications and DNA methylation [22–
25]. Epigenetic remodeling of cellular expression potential 
during embryogenesis is commonly thought to create the 
different cellular phenotypes from the single genotype of 
a zygote [182]. Epidemiological studies investigating the 
epigenetic component of common diseases mainly focus on 
DNA methylation since it can be reliably measured on DNA 
samples that are stored in a biobank, even after several 
decades [195]. 
Associations between locus specific DNA methylation 
and risk for rheumatoid arthritis [232], obesity [48] and 
myocardial infarction [233] have recently been reported. 
However, as bone [232], visceral fat [48] and myocardium 
[233] are unavailable for such studies, these associations 
were found in blood, which is readily available but not directly 
involved in the disease. Thus, the epigenetic contribution to 
these diseases remains unclear, since the relation between 
DNA methylation in blood and that of other tissues is not 
yet established. This is a pressing issue in epigenetic 
epidemiological research for most diseases. Clinical biobanks 
store DNA that was extracted from peripheral tissues, 
usually blood, occasionally buccal cells, and sporadically 
skin, subcutaneous fat, and skeletal muscle. This requires 
epigenetic studies to carefully consider the availability of 
tissues and the relevance of the information that can be 
obtained [98,99,202]. 
Documenting the loci at which DNA methylation measured 
in blood is a useful marker for inaccessible disease related 
tissues, will benefit interpreting the results of epigenetic 
studies, and may help even designing these studies if many 
such loci exist. DNA methylation differences between tissues 
have been reported at many loci [100–102,234]. Importantly 
though, despite the focus of these studies on tissue 
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differences, they also observed genomic areas with similar 
DNA methylation between the tissues within an individual 
[100,234]. Moreover, a study on candidate loci found a strong 
correlation between DNA methylation in blood and buccal 
swabs at 4 of the 8 loci investigated [195] and a genome wide 
study found loci with correlations between blood and brain 
cortex or cerebellum [234]. Together these results suggest 
that for a potentially subset of loci, DNA methylation in blood 
may mark the methylation status of another (disease related) 
tissue.
In this study we investigate epigenetic similarities 
between blood and several internal tissues. We obtained 
post mortem samples of blood, subcutaneous fat (SC 
fat), muscle, visceral fat (VS fat), liver, spleen, and 
pancreas from six individuals. We use the Illumina Infinium 
HumanMethylation450 BeadChip microarray (Illumina, San 
Diego, USA) to measure DNA methylation at 485,462 CpG 
sites distributed throughout the genome [85]. We focused on 
the 378,239 CpG sites for which the measurement was not 
influenced by known genetic variation. Principal component 
analysis (PCA) was used to investigate genome wide patterns 
of DNA methylation. At each of these 378,239 CpG sites 
we compared average DNA methylation and computed 
correlation coefficients between tissues. Our exploration 
of tissue correlations focused on 219,558 CpG sites which 
had multiple nearby CpG sites measured, using smoothed 
correlations over these CpG sites to indicate a more robust 
local effect [195]. 
Methods and materials
Subjects 
The samples in this study were collected during post-
mortem examination (within 24 hours after death) of 6 
individuals (3 men) between 58 and 79 years old. From 
each individual we collected samples of 6 different tissues. 
Samples of blood, skeletal muscle, subcutaneous fat (SC fat) 
and visceral fat (VS fat) were collected from each individual, 
liver samples were collected from 5 individuals, pancreas 
from 4 individuals and spleen from 3 individuals. Autopsy 
case with tissue sample information is listed in Table 6.1. 
Blood was drawn from the carotid arteries, collected in BD 
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vacutainer EDTA blood collection tubes (Becton, Dickinson 
and Company, Franklin Lakes, NJ, USA), and treated according 
to standard protocol. The other tissues collected were 
dissected at the time of autopsy, glued to a piece of cork 
using Tissue-Tek OCT Compound (Sakura Finetek, Alphen 
aan de Rijn, Netherlands), snap-frozen in liquid nitrogen and 
stored at -80° C until further use. With a CM3000 Cryostat 
(Leica, Wetzlar, Germany) cryosections were made of the 
tissues. Two slices of 5 μm thick at either end of a tissue 
sample were stained with hematoxylin and eosin (H&E) to 
check tissue integrity and cell type heterogeneity, since 
each sample represent a mixture of the cell types normally 
found in that organ. All tissue from which DNA was isolated 
were histologically normal (Supplementary figure S6.1) and 
of similar consistency between the two HE-stained section of 
an individual, indicating an even heterogeneity throughout 
the tissue sample. Tissue heterogeneity was also similar 
between individuals, except for visceral fat where substantial 
differences in heterogeneity were observed between 
individuals (Supplementary figure S6.1). 
DNA from blood was extracted from the buffy coat layer 
after centrifugation. Tissue in between the histological slides 
was cut into 20 μm thick slices, 30 to 40 of which were lysed 
overnight at 56° C in QIAGEN ATL buffer + proteinase K 
(Qiagen, Düsseldorf, Germany). DNA was extracted using a 
double Phenol : Chloroform : Isoamyl alcohol (25:24:1) (PCI) 
separation. The supernatant of the first separation, was 
treated with PCI once again to remove all residual traces of 
fatty acids, which was especially necessary for tissues with a 
Table 6.1: Characteristics of selected individuals
Subject# Gender Age PMI (h) Cause of death Tissues 
1 Female 61 7 Sepsis B F V M L S
2 Male 58 12.5 Heart failure B F V M L S
3 Male 64 9 Myocardial infarction B F V M L P
4 Female 65 15 Aortic aneurysm B F V M L P
5 Female 66 10 Liver cirrhosis B F V M S P
6 Male 79 10 Sepsis B F V M L P
PMI: Post Mortem Interval in hours
Tissues: B = Blood, F = Subcutaneous fat, V = Visceral fat, M = Muscle,  
L = Liver, S = Spleen, P = Pancreas
Binnenwerk_opmaak.indd   132 5-12-2014   13:21:07
133
high lipid content. The remainder of the procedure followed 
the standard protocol. 
All samples were obtained with approval of the pathology 
department of the LUMC and according to the ‘Proper 
Secondary Use of Human Tissue’ code of conduct by the 
‘Federatie van Medisch Wetenschappelijke Verenigingen’.
Genome wide DNA methylation 
DNA methylation was measured at 485,462 CpG sites 
using the Illumina Infinium HumanMethylation450 BeadChip 
array (Illumina, San Diego, USA) according to manufacturer’s 
protocol [85]. In short: about 700 ng of genomic DNA was 
bisulphite converted using the EZ-96 DNA Methylation Kit 
(Zymo Research, Orange County, USA). Each DNA sample 
was whole-genome amplified, and enzymatically fragmented. 
The DNA fragments were hybridized to locus-specific DNA 
oligomers linked to individual bead types. After single base 
pair extension, the array was fluorescently stained, scanned 
and the intensities of the non-methylated and methylated 
bead types were measured.
All samples of an individual were measured on the same 
chip. To check whether DNA methylation is affected by death, 
we compared DNA methylation of the post mortem blood 
samples with DNA from blood samples of living blood donors 
(35 – 40 years old), who represent DNA methylation in the 
healthy adult population [235]. This DNA was measured 
in two mixtures, one containing DNA of twenty men, the 
other of twenty women. Methylation of pooled DNA samples 
was recently demonstrated to accurately reflect the group 
average [236].
Quality control
Technical variability between chips was tested by 
measuring a duplo series of methylation titers from 
standardized non-methylated and methylated DNA samples 
(0%, 25%, 50%, 75%, 100% methylated; Zymo Research, 
Orange County, USA). Between chip variability was found 
negligible (Supplementary figure S6.2). All samples met 
the criteria tested with a fixed set of technical probes for 
bisulphite conversion, background signal, and hybridization 
efficiency, according to the Controls Dashboard from 
Illumina’s GenomeStudio software [85]. Probe performance 
within each sample was investigated with the detection 
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P-value. It compares the signal generated at each CpG site to 
negative controls and can be interpreted as the probability 
of seeing a certain signal level without specific probe-
target hybridization. Probes with detection P-value ≥ 0.05 
in one of the samples were discarded for all samples before 
normalization with the Simple Scaling Normalization (SSN) 
method of the R-package lumi [237], which relies on signal 
intensity and methylation patterns (Supplementary figure 
S6.3). 
In this study we focused on probes assessing CpG 
methylation on autosomal chromosomes, discarding the 
11,650 probes on X- and Y- chromosomes. As annotated by 
the manufacturer, 86,769 contain a SNP (dbSNP 30) in their 
50 bp target sequence or the CpG dinucleotide. Since it was 
shown on a earlier version of the platform that this could 
interfere with methylation measurements [238], we discarded 
measurements at these CpG site for further analyses. In all, 
we analyzed methylation measurements at 378,239 CpG 
sites in all six tissues for all six individuals.
Analyses
Comparing DNA methylation between the tissues
DNA methylation results from the Beadchip array platform 
can be described by two inter-exchangeable values, the 
ß-value and the M-value [239]. The ß-value represents DNA 
methylation on an interpretative scale of 0 to 1. The M-value 
represents it on a quantitatively more accurate logarithmic 
(log2) scale that resolves the skewed distribution in the upper 
(ß > 0.8; M > 2) and lower (ß < 0.2; M < -2) methylation 
levels [239]. For analyses and calculations the M-value was 
used for methylation levels of CpG sites, for presentation 
purposes the relevant results were transformed into the 
ß-value. 
For genome wide DNA methylation patterns, principal 
component analysis (PCA) was used to investigate inter-
individual variation vs. between-tissue (intra-individual) 
variation. At individual CpG sites, methylation differences 
between blood and the other tissues were tested with a 
two-sided t-test, and mean methylation, transformed into 
ß-value, and methylation variation, represented with the size 
of the standard deviation (SD) interval (mean ± 1*SD) in 
ß-value, were compared. Further, relative similarities between 
blood and the tissues were investigated using the Pearson 
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correlation coefficient (r). From here on in this study, tissue 
correlation, unless specified, refers to the correlation of DNA 
methylation in blood with that of another tissue, and tissue 
difference, unless specified, refers to differences in mean 
DNA methylation between blood and another tissue. 
Smoothing tissue correlations and tissue differences
Previous research has demonstrated that methylation of 
nearby CpG sites is often correlated [195] and that this intra-
class correlation can be used as a powerful tool to reveal 
subtle differences in DNA methylation that are consistently 
similar across several nearby CpG sites [135,233]. Exploiting 
this principle, we applied a smoothing algorithm with a 
sliding bandwidth of 2,000 bases centered around the 
cytosine residue of the CpG site under investigation. This 
created a more robust measure for tissue correlations and 
differences at individual CpG sites, partly compensating for 
the small amount of individuals in this study. After smoothing 
the absolute difference was used in combination with results 
from the two-sided t-test to describe tissue differences. 
For tissue correlations we discriminated between CpG sites 
with fewer than 3 and those with 3 or more additional CpG 
sites within the bandwidth (Supplementary figure S6.4). The 
smoothed correlation at the latter CpG sites was considered 
indicative of a more robust local effect, representing the 
mean over 4 or more CpG sites. We focussed our exploration 
of tissue correlations on these CpG sites, which creates a 
bias for more CpG rich genomic areas, as CpG poor areas are 
less likely to meet these criteria. A smoothed correlation was 
considered strong when r > 0.75. Note that in this study all 
negative tissue correlations, even when strong (r < -0.75), 
were given the same weight as weak positive correlations, 
since, although mathematically equal to positive correlations, 
there is to our knowledge no experimental data in support of 
a biological interpretation of negative tissue correlation. 
To scan for genomic regions enriched in tissue correlations 
we divided the genome in blocks with a length of 100,00 bp. 
For each block, we counted the number of probes with at 
least 3 additional CpG sites within the smoothing bandwidth 
(CpG rich area probes), the number of such probes with a 
strong tissue correlation, the proportion of correlated probes 
(for blocks ≥ 15 probes counted), the number of probes with 
strong tissue correlation between blood and 1 or 2 tissues, 
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between blood and 3 to 5 tissues, and between blood and 
all 6 tissues. We plotted this information against the human 
genome (assembly hg18/NCBI36) using the genome graph 
function of the UCSC genome browser [150] (website: http://
genome.ucsc.edu/).
Identifying characteristics of tissue correlations
To investigate whether CpG sites with a strong correlation 
can be identified by characteristics of DNA methylation, we 
first explored the relation of tissue correlation with mean 
methylation, methylation variation, and tissue differences. For 
this means and SD interval sizes were categorized based on 
their observed distributions across all CpG sites, and tissue 
differences based on previously published observations on 
inter individual and between tissue differences [100,195,233]. 
Mean methylation categories: low (ß < 0.2), below medium 
(0.2 ≤ ß < 0.4), medium (0.4 ≤ ß < 0.6), above medium 
(0.6 ≤ ß < 0.8), and high (ß ≥ 0.8). Methylation variation 
categories: low (SD interval < 0.05), intermediate (0.05 ≤ 
SD interval < 0.15), and high (SD interval ≥ 0.15). Tissue 
difference categories: high (absolute difference ≥ 0.2 & p t-test 
≤ 0.05), intermediate (0.05 ≤ absolute difference ≥ 0.2 & p 
t-test ≤ 0.05), low (absolute difference ≤ 0.05 & p t-test ≤ 0.05), 
and insignificant (p t-test > 0.05). The distributions across 
these categories were inspected for CpG sites from CpG poor 
areas, CpG sites from CpG rich areas with no strong tissue 
correlation and CpG sites from CpG rich areas with a strong 
correlation with at least one tissue. Note that a previous 
version of the platform already observed that CpG rich 
areas have different distributions of mean methylation and 
methylation variation compared with CpG poor areas [90].
To investigate whether CpG sites with a strong correlation 
can be identified by the function of their genomic area 
as annotated by the manufacturer [85] (Supplementary 
table S6.2, for full list of genomic locations) we inspected 
frequency distributions of these locations between strong 
correlations with 3 or more tissues, strong correlations with 1 
or 2 tissues and weak correlations with all tissues in CpG rich 
areas, and also between strong and weak correlations in CpG 
poor areas. 
To test for structural differences, CpG sites with the 
strongest correlations (r > 0.75 for at least 1 tissue 
correlation, and r > 0.25 for all tissue correlations; 6,539 
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CpG sites) were compared to CpG sites with the weakest 
correlations (r < 0.25 for all tissue correlations; 5,837 CpG 
sites), all located in CpG rich areas. A Chi2 test was used 
to discern differences in the distributions of their genomic 
location (as annotated by the manufacturer). The Wilcoxon 
test of the epigraph web tool [240] (website: http://epigraph.
mpi-inf.mpg.de/WebGRAPH/) was used to investigate 
differences in immediately adjacent DNA sequence (base 
composition and 2-mers, +/- 10 bp from C residue), location 
in transcription factor binding sites (TFBS) and repeats, 
and all available data on DNA structure, chromosome 
organization, and epigenome and chromatin structure 
(histone code in blood) [240]. 
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Figure 6.1: Scatter plots of principal components 1 to 7, 
derived from the Principal Component Analysis comparing 
the genome wide DNA methylation patterns of the tissue 
samples. In the top left corner the two lowest components 
(1st and 2nd) are plotted against each other, in the bottom 
right the two highest (6th and 7th). The lowest of two compo-
nents is on the x-axis, the percentage giving on the axes is 
a measure of the amount variation represented by the com-
ponent in this analyses. The symbols plotted are specific 
for samples of each individual, with open symbols for men, 
and a color specific to samples of each tissue. The distance 
between the samples is a measure of their similarity.
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Results
PCA analysis on genome wide methylation patterns
A genome wide survey resulted in DNA methylation data 
across seven tissues of six individuals at 378,239 CpG sites 
distributed throughout the genome. Variation of genome wide 
patterns in DNA methylation was investigated by visualizing 
results from principal component analysis (PCA; Figure 6.1). 
Plotting the 1st vs. the 2nd principal components, covering 
almost all variation between the genome wide methylation 
patterns, showed tight clusters of the samples from the 
same tissue of each individuals (Figure 6.1, top left), even 
plotting the 6th vs. 7th principal component, covering roughly 
10 % of variation, still showed no clusters of the samples 
from the various tissues of the same individual (Figure 6.1, 
bottom right). In this analysis the male and female blood 
mixes, representing healthy individuals, were observed to 
cluster together with the post mortem blood samples up to 
the 5th principal component, in the 6th and 7th components the 
blood mixes separated somewhat from the rest of the blood 
samples, but from the fourth component onward the analysis 
revealed no specific clusters of DNA samples (Figure 6.1). 
Mean methylation and variation per tissue
The distribution of mean methylation across all 378,239 
CpG sites investigated showed a similar bimodal shape in 
all tissues with peaks at low and high methylation and a 
valley at medium methylation (Figure 6.2). The distribution of 
methylation variation across all CpG sites also had a skewed 
shape similar for each tissue, with the SD interval peaking 
around 0.05 in ß-value and a long tail of higher variation, 
starting at SD interval around 0.2 in ß-value, and continuing 
to a maximum SD interval around 0.9 in ß-value (Figure 6.3). 
Inspecting tissue differences at individual CpG sites 
revealed that almost 74 % of CpG sites showed a nominally 
significant (p T-test < 0.05) difference in DNA methylation 
between blood and at least one of the other tissues (Table 
6.2). Looking at the comparison of blood with each tissue, at 
the most 48 % of CpG sites, in the case of the spleen, and at 
the least 9 % of CpG sites, in the case of the pancreas, were 
differently methylated (p T-test < 0.05). Most CpG sites with 
tissue differences had a different DNA methylation between 
blood and multiple tissues. For the spleen the biggest set of 
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Figure 6.2: Frequency distributions 
of mean DNA methylation at each 
CpG site in every tissue expressed 
in ß-value.
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Figure 6.3: Frequency distributions of 
variation in DNA methylation at each 
CpG site in every tissue expressed as 
the standard deviation (SD) interval in 
ß-value.
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differently methylated CpG sites were uniquely so between 
blood and spleen, whereas for the pancreas the biggest set 
was differently methylated between blood and all six tissues 
(Table 6.2).
 
Correlations of CpG methylation between tissues
An alternative way to express tissue similarity, which 
takes into account differences in inter- and intra-individual 
(between-tissue) variation in DNA methylation across the 
tissues, is to compute correlation coefficients between 
blood and the other tissues. To inspect tissue correlations 
at a local genomic scale the correlation coefficients of 
each CpG site were smoothed over all measured CpG sites 
within the bandwidth of 2000 bp. For 92,916 CpG sites 
there were no additional CpG sites within the 2000 bp 
bandwidth (Supplementary figure S6.4). The other 285,323 
CpG sites had from 1 up to 59 additional CpG sites within 
the bandwidth. The smoothed correlation was considered 
indicative of a local genomic effect when the bandwidth 
contained at least 4 CpG sites. The resulting smoothed 
correlation of such CpG sites thus represents a mean of 
measurements at 4 to 60 CpG sites. To illustrate this, the 
methylation values of blood against the other tissues were 
plotted for each of the 5 CpG sites within the bandwidth 
around probe cg2201694 (Figure 6.4). 
Inspecting the smoothed correlations revealed that over 
30 % of CpG sites had a strong correlation (r > 0.75) between 
blood and at least one other tissue. This was true for CpG rich 
(219,558 CpG sites) and CpG poor (158,681 CpG sites) areas 
(Table 6.3A). Looking at the distributions of tissue correlations 
for each tissue at the most 15.5 %, in the case of the spleen, 
and at the least 3.2 %, in the case of muscle, showed a 
strong correlation with blood. Remarkably, the endodermal 
tissues had more CpG sites strongly correlated with blood 
than the mesodermal tissues. Liver, the endodermal tissue 
with the lowest amount of CpG sites (15,444 sites) with a 
strong tissue correlation, still had almost 2,000 such CpG 
sites than SC fat, which was the mesodermal tissue with the 
highest amount CpG sites (13,501 sites) with a strong tissue 
correlation (Table 6.3A). 
Looking in CpG rich areas at CpG sites with a strong 
correlation between blood and more than one tissue, there 
were 3 times more CpGs exclusively correlated between 
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Figure 6.4: An example of smoothing tissue correlations over all CpG sites 
within a region of 2000 bp. The scatter plots show DNA methylation (in β-value) 
of blood (x-axes) against each other tissue (y-axes) per individual (plotted sym-
bol) per CpG site (color) in the smoothing bandwidth around probe cg2201694. 
The smoothed tissue correlation of cg2201694 is given above each plot. The x 
= y line is given in black for reference.
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blood and the endodermal tissues compared with the 
mesodermal tissues (Table 6.3B). Although, a strong tissue 
correlation was observed between blood and one tissue 
exclusively for most CpG sites, more than 6,000 CpG sites 
showed a strong tissue correlation with three or more 
tissues, and 372 CpG sites with all tissues (Table 6.3B and, 
for each combination of tissues, Supplementary table S6.1). 
We then counted the amount of these tissue correlations 
per genomic fragment of 100,000 bp long (100K block) and 
scanned for genomic areas enriched for tissue correlation 
in a genome wide plot (Figure 6.5). We found that genomic 
areas with a higher amount of correlated probes (67,148 
probes distributed over 11,080 100K blocks, plotted in blue) 
corresponded to areas with more measurements in general 
(219,558 probes distributed over 12,060 100K blocks, plotted 
in black). The proportion of correlated probes per 100K block 
(≥ 15 measurements; 162,014 probes distributed over 4,907 
100K blocks, plotted in green) revealed no extended area 
with specific enrichment of tissue correlation, although there 
were 100K blocks with low ( < 0.10) and with a high (> 0.50) 
proportion of correlated probes. In general one third of probes 
displayed a tissue correlation irrespective of measurement 
density, with a similar genome wide distribution of the 
amount of probes at which methylation of blood was 
correlated with one or two internal tissues (61,052 probes 
distributed over 11,077 100K blocks, plotted in purple), or 
with multiple tissues (5,674 probes distributed over 3,850 
100K blocks, plotted in orange). At last, the distribution of the 
372 probes correlated between blood and all internal tissues 
(distributed over 288 100K blocks, plotted in red) seems less 
related to measurement density.  
Characteristics of correlated CpG sites
We inspected the distributions of CpG sites across the 
categories of mean methylation, methylation variation, 
and tissue differences to investigate whether strong tissue 
correlations could be marked by such characteristics of DNA 
methylation. We focused this inspection on CpG sites from 
CpG rich areas (219,558 sites), as their correlations represent 
a weighted average over multiple CpG sites. We observed 
no difference in these distributions between CpG sites with 
a strong tissue correlation compared with all CpG sites from 
CpG rich areas in any of the tissues (Tables 6.4 and 6.5). 
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Figure 6.5: Plot of correlation of DNA methylation between blood and internal 
tissues (subcutaneous fat, visceral fat, skeletal muscle, liver, pancreas, and 
spleen) across the human genome (assembly: hg 18 / NCBI 36). Lines above 
each chromosome represent frequency information per unit of 100,000 bp long 
(100K block) of the number of probes with 3+ additional CpGs in the 2,000 
bp smoothing bandwidth (black line), the number of probes with strong tissue 
correlation (blue line), the proportion of tissue correlated probes for blocks 
containing ≥ 15 probes (green line), the number of probes with tissue correla-
tion between blood and 1 or 2 tissues (purple line), between blood and 3 to 5 
tissues (orange line) and between blood and all 6 tissues (red line). The plot 
was made using the genome graph function of the UCSC genome browser [150] 
(website: http://genome.ucsc.edu/).
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Table 6.4: Frequency distributions of mean DNA 
methylation and methylation variation for CpGs with 
strong and weak correlations
Tissue
CpG sites
























Strong CpG richc 67148 53.9 8.9 5.6 10.9 20.6 44.5 46.4 9.2
All CpG richd 219558 56.0 8.9 5.5 10.2 19.4 46.0 44.9 9.1
All CpG poore 158681 6.9 5.0 7.7 25.8 54.6 19.6 66.9 13.5
SC Fat
Strong CpG richc 13501 55.6 8.5 8.9 11.8 15.2 49.8 46.7 3.5
All CpG richd 219558 56.2 8.8 8.2 10.8 15.9 50.8 46.0 3.2
All CpG poore 158681 5.9 5.7 12.5 28.2 47.8 33.9 62.4 3.7
VS Fat
Strong CpG richc 11102 52.6 9.2 7.9 12.7 17.7 46.4 39.4 14.2
All CpG richd 219558 54.3 9.4 7.6 11.0 17.6 50.1 36.9 13.1
All CpG poore 158681 5.1 4.6 10.2 28.6 51.5 28.0 50.7 21.4
Muscle
Strong CpG richc 6986 56.3 9.2 8.6 10.0 15.8 68.0 30.1 1.9
All CpG richd 219558 56.2 9.0 8.0 10.3 16.5 68.3 29.9 1.8
All CpG poore 158681 6.4 7.7 12.7 24.7 48.6 46.7 50.4 2.9
Liver
Strong CpG richc 15444 51.1 10.9 8.6 10.9 18.5 63.3 33.9 2.9
All CpG richd 219558 52.1 10.7 8.1 10.5 18.6 64.6 32.8 2.6
All CpG poore 158681 4.8 5.1 10.5 26.1 53.5 48.2 47.6 4.2
Spleen
Strong CpG richc 34005 54.2 8.7 6.8 11.7 18.6 65.5 29.6 4.9
All CpG richd 219558 55.4 8.7 6.7 10.7 18.5 66.3 29.1 4.7
All CpG poore 158681 5.6 4.6 9.0 27.6 53.1 51.2 42.0 6.8
Pan-
creas
Strong CpG richc 16415 55.8 9.0 8.0 10.3 16.9 61.3 32.5 6.1
All CpG richd 219558 55.8 8.7 7.5 10.3 17.7 62.2 31.8 5.9
All CpG poore 158681 5.8 6.1 11.4 29.6 47.0 33.4 56.2 10.4
 
a: Lower to upper boundary of mean methylation for categories expressed in β-value
b: Lower to upper boundary of size of SD interval for categories expressed in β-value
c:  CpG sites in CpG rich areas with a strong correlation (r > 0.75) between blood and at 
least one tissue, for blood this means all such CpG sites
d:  All CpG sites in CpG rich areas, which had 3 or more additional CpG sites available for 
smoothing within the 2000 bp bandwidth
e:  All CpG sites in CpG poor areas, which had 2 or less additional CpG sites available 
for smoothing within the 2000 bp bandwidth 
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Different distributions were observed between CpG sites from 
CpG rich areas and CpG poor areas. Mean methylation in CpG 
rich areas displayed a similar bimodal distribution as for all 
378,239 CpG sites (Supplementary figure S6.5), although the 
peak at low methylation (ß < 0.2) was substantially higher 
(> 50 % of CpG sites) than the peak at high methylation (ß ≥ 
0.8; 15 % – 20 % of CpG sites). In contrast, mean methylation 
Table 6.5: Frequency distributions of tissue differences 





Distribution (%) over methylation dif-
ference categoriesa
Category n Insignificant
0 –  
0.05





Strong CpG richb 13501 72.5 16.2 9.1 2.2
All CpG richc 219558 73.0 18.0 7.5 1.5
All CpG poord 158681 59.9 26.9 10.9 2.2
VS Fat
Strong CpG richb 11102 83.5 13.5 2.8 0.1
All CpG richc 219558 81.2 14.6 3.8 0.4
All CpG poord 158681 73.9 20.2 5.2 0.6
Muscle
Strong CpG richb 6986 58.5 25.2 11.6 4.7
All CpG richc 219558 59.3 23.4 12.6 4.6
All CpG poord 158681 46.5 30.9 16.7 5.8
Liver
Strong CpG richb 15444 70.5 14.6 10.9 4.0
All CpG richc 219558 70.0 19.6 8.3 2.2
All CpG poord 158681 59.2 26.5 11.4 2.8
Spleen
Strong CpG richb 34005 51.9 36.6 10.7 0.9
All CpG richc 219558 53.1 37.8 8.5 0.6
All CpG poord 158681 51.0 39.8 8.6 0.6
Pancreas
Strong CpG richb 16415 92.3 3.4 3.2 1.0
All CpG richc 219558 91.6 4.6 3.0 0.8
All CpG poord 158681 90.1 5.6 3.4 0.9
a:  Lower to upper boundary of methylation difference for categories expressed in 
β-value, when p T-test < 0.05
b:  CpG sites in CpG rich areas with a strong correlation (r > 0.75) between blood 
and at least one tissue, for blood this means all such CpG sites
c:  All CpG sites in CpG rich areas, which had 3 or more additional CpG sites avail-
able for smoothing within the 2000 bp bandwidth
d:  All CpG sites in CpG poor areas, which had 2 or less additional CpG sites 
available for smoothing within the 2000 bp bandwidth
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in CpG poor areas displayed a skewed shape, with the tail at 
low methylation (< 7 % of CpG sites) and the peak at high 
methylation (> 50 % of CpG sites). These distributions were 
of similar shape in al tissues (Table 6.4). Methylation variation 
in all tissues was substantially higher in CpG poor areas 
compared with CpG rich areas (Table 6.4). Tissue differences 
also appeared more pronounced in CpG poor areas compared 
with CpG rich areas, except for spleen and pancreas (Table 
6.5). 
Finally, we investigated the possibility of identifying CpG 
sites with strong tissue correlations by the genomic function, 
structure, or genetic sequence of their surrounding area. We 
first inspected frequency distributions of functional areas and 
observed differences in the function of the location of CpG 
rich and CpG poor areas, but not of CpG sites with strong or 
weak tissue correlations, either in CpG rich or in CpG poor 
areas (Supplementary table S6.2). Comparing CpG sites with 
the strongest and the weakest tissue correlations (6539 and 
5837 sites, respectively), we tested and found that neither 
repetitive DNA, nor RefSeq defined genetic components, nor 
CpG islands, nor most regulatory features were associated 
with strong tissue correlations (Table 6.6). We further tested 
and found that CpG sites with strong tissue correlations do 
not have different DNA structure or sequence compared with 
CpG sites with weak tissue correlations. Most differences 
between strongly and weakly correlated CpG sites were 
observed for epigenomic features (Table 6.6). Details of 
features with nominally significant (p < 0.05) differences 
between CpG sites with strong and weak tissue correlations 
are given in Supplementary table S6.3. 
Discussion
In this study we surveyed DNA methylation at 380,000 
CpG sites distributed throughout the genome across 
seven tissues of six individuals, with the aim to uncover 
loci at which DNA methylation in blood may mark that of 
inaccessible tissues [202]. Resembling results of previous 
studies [100–102], variation in genome wide DNA methylation 
patterns was largely determined by tissue differences. 
However, in line with results from recent studies [195,234], 
a substantial subset of individual CpG sites, showed similar 
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average DNA methylation or a high correlation coefficient 
between blood and an internal tissue. High correlation 
coefficients were neither associated with levels of average 
DNA methylation in both tissues nor with methylation 
variation, nor with methylation differences between the 
tissues. Genetic sequence, structure and genomic location 
also appeared unassociated with tissue correlations. Hence, 
although we found loci for which blood can represent 
epigenetic marks of inaccessible tissue, we did not find a 
distinguishing feature by which such loci can be recognized. 
Still, cataloging the loci with methylation similarities between 
tissues, both those with comparable methylation levels and 
those with a high correlation of methylation variation, will 
indicate the loci at which an accessible tissue like blood 
Table 6.6: Exploration of associations between tissue
correlation and structural genomic and epigenomic fea-




Genomic or epigenomic features investigated for as-
sociation with tissue correlationb
Feature name Investigated Associated
epiGRAPH 
(wilcoxon)
Chromosome Organisation 27 3
DNA Structure 63 0
Epigenome and Chromatin 
Structure
107 23
Conserved TFBS 260 8
Repetitive DNA 162 0
Illumina 
(chi square)
Regulatory feature 8 2
Relation to CpG island 5 0
RefSeq group 6 0
a:  Features and relative genomic locations using the epigraph web tool, or the an-
notations of the platform manufacturer
b:  The number of features investigated vs the number of features with a nomi-
nally significant ( p < 0.05) difference between CpG sites with strong and 
weak tissue correlations
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can be used as a marker tissue for disease related tissues 
that are inaccessible. Using a marker tissue for inaccessible 
tissues may help the design of epigenetic epidemiological 
studies and relate results to common diseases beyond the 
context of the tissue measured [98,99,202]. 
Despite the striking differences in genome-wide methylation 
patterns between the tissues, we also observed that average 
DNA methylation at individual CpG sites was more often similar 
than different between blood and each tissue, which was 
also reported on in a previous study [100]. Further, roughly a 
quarter of the CpG sites investigated showed a similar average 
DNA methylation level across multiple tissues (frequently 
hypo- or hyper-methylated). In line with previous studies 
[100–102], these results indicate the existence of many loci 
at which methylation levels will be similar between blood 
and an inaccessible tissue of interest. As tissue differences 
in methylation levels at CpG sites are often interpreted as 
indicative of a difference in epigenetic regulation of gene 
expression [101] and / or cell type differentiation [88,102]. 
Conversely, CpG sites with a similar methylation level between 
tissues might indicate a similar regulatory role of the epigenetic 
mechanism at the locus for both tissues. However, the aim 
of this study was to uncover loci at which the methylation 
status of blood marks that of inaccessible tissues for which the 
correlation of methylation variation between the tissues will be 
more relevant than the actual methylation level in either tissue.
We observed that a substantial subset of CpG sites showed 
a strong correlation between blood and another tissue. Previous 
studies have reported on inter tissue correlations at specific 
candidate loci [133,134,195], and here we present more of 
such data on a genome wide scale [234]. The majority of 
strong correlations were found between blood and one tissue 
exclusively, but a still sizeable minority showed a strong 
correlation across multiple tissues. A few CpG sites were 
strongly correlated across all tissues, however the most logical 
explanation for such seemingly soma-wide correlation of DNA 
methylation will be unknown genetic background variation, 
unless there is a biological reason to assume otherwise, such as 
genomic imprinting. Thus, for epigenetic case-control studies, 
not the similarity of average methylation, but a high correlation 
of methylation variation between the tissues will define loci at 
which blood can be a marker tissue for inaccessible tissues that 
are more relevant for the disease [119,195,234].
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We focused our survey on correlated CpG sites that 
were smoothed over a minimum of four CpG sites, which 
were inevitably located in CpG rich areas. such CpG sites 
with a strong tissue correlation after smoothing are more 
likely to produce reliable assays in epigenetic epidemiology 
potentially marking the epigenetics of an internal tissue. 
However, the percentage of CpG sites with a strong 
correlation was similar between CpG rich and CpG poor 
areas. Thus, there is no reason to assume that by definition 
CpG poor areas will provide less suitable targets. This could 
be ascertained by validating the strong tissue correlations 
of CpG poor areas in a study with bigger sample sizes. 
Since DNA methylation changes progressively during cell 
differentiation [30] the differences between cell lineages 
that separated early during development are likely 
more pronounced. We therefore anticipated more tissue 
correlations between blood and the other mesodermal tissues 
compared with blood and the endodermal tissues [195]. 
However, we observed the contrary, which suggests that 
fewer DNA methylation changes occur before the separation 
of the germ layers than occur between the different cell 
lineages within a germ layer. On the other hand, there 
were fewer individuals sampled for each of the endodermal 
tissues, the influence of which cannot be estimated. Tissue 
correlations, either between blood and one tissue or across 
multiple tissues, were unrelated to mean methylation levels, 
methylation variation, or tissue differences at the CpG site, 
indicating that such characteristics of DNA methylation itself 
cannot be used to identify likely candidate CpG sites with 
strong correlation between marker tissue and disease related 
tissue. Correlation between DNA methylation in blood with 
that in other tissues appears to be complex and dependent 
on both locus and tissue, as previously suggested [195]. 
Design of epigenetic studies and interpretation of their 
results, would be greatly enhanced if genetic or genomic 
characteristics could be revealed by which the potential for 
tissue correlation of a locus can be recognized [119,195]. 
A good source for such characteristics may be related to 
the function of DNA methylation [24]. Repetitive DNA tends 
to be hyper-methylated in all tissues [39], which implies 
that DNA methylation at repetitive elements may be more 
discriminative between individuals [241]. In contrast, DNA 
methylation at CpG island shores was recently demonstrated 
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as especially discriminative between tissues [129]. It may 
be reasonable to expect CpG sites with a strong correlation 
between tissues to be located more frequently in repetitive 
elements and less frequently in CpG island shores. However, 
in neither of these features did we observe a different 
frequency of appearance for the most correlated CpG sites 
compared with the least correlated CpG sites. Similarly, we 
also did not observe any difference between CpG sites with 
strongest and weakest correlations with respect to their 
genetic sequence motifs, their genome structure or their 
location relative to genomic functional elements, for all of 
which the epigenetic state has been repeatedly related to 
cellular gene expression potential [21,89]. These results 
would suggest that correlation of DNA methylation between 
tissues may not be related to its functional aspects. On the 
other hand, our exploratory results indicate that a subset of 
epigenomic features in blood, such as histon modifications, 
particularly methylation at various lysine residues of Histon 
H3, and associations with RNA polymerase II, may be related 
to tissue correlations. This apparent contradiction cannot 
be resolved in our current study. To elucidate what causes 
a strong correlation of DNA methylation between tissues at 
certain loci, and by which features such loci can be identified 
will require substantial research efforts. 
 We compared CpG methylation of DNA from tissue 
samples collected during autopsy. DNA methylation is a 
covalent chemical bond that is stable over many years 
in stored DNA [195,197], and was shown to change little 
within the first few days after death [238], hence we set the 
maximum post mortem interval to 24 hours after death. In 
blood we found no indication that DNA methylation patterns 
were dramatically altered within these 24 hours after death, 
and there is no reason to assume this would be different for 
the other tissues. Thus the extrapolation of our observations 
to living individuals seems reasonable. Between chip variation 
of measurements was shown to be small and individuals 
whose DNA was analyzed on the same chip did not form 
clusters in the PCA. Data from probes with a known SNP in 
their 50 bp target sequence [238] was excluded from our 
analyses. Therefore technical artifacts seem an unlikely 
explanation for most of the observed tissue correlations, 
although the influence of (unknown) genetic variation in 
cis cannot be excluded [242,243]. To accommodate the 
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limitations of the small sample size of our study we employed 
a smoothing algorithm to create a median of the observed 
effects across the CpG sites within an area the size of 2000 
bases. This will make the observation indicative of more 
robust locally carried effects, a method with demonstrated 
validity [135,233,244]. This will only work well at CpG sites 
if the recorded value can be internally validated by effects 
at sufficient nearby CpG sites. Thus, our observations at 
CpG sites in CpG poor areas lack the confidence granted 
by a sufficient sample size, and unfortunately have no 
other method available for increasing the robustness of the 
observed effect. This compelled us to adjust the comparison 
of strong and weak correlations to the CpG richer areas, which 
have different methylation characteristics (mean, variation 
and tissue differences), as observed in this study and in 
previous literature [90]. 
In this study we report that DNA methylation in blood 
may mark that of an internal tissues at a substantial subset 
of loci, which can be exploited for choosing assays and for 
interpreting results of epigenetic research. This capacity was 
established by strong correlation coefficients, which were 
complex in nature, depending on both locus and tissues. 
Strong correlations were unrelated to characteristics of 
DNA methylation, nor to the genetic sequence and genomic 
features surrounding the CpG site. Blood is the only tissue 
collected in most current human biobanks, due to its simple 
and cheap sampling techniques with low invasiveness. Other 
tissues that can also be collected in sufficient quantities for 
large populations with simple, inexpensive, and low invasive 
techniques are buccal swabs [245], epidermis [108], bladder 
lining from urine, and colonic mucosa from stool [195]. Such 
tissues may be used as marker tissues for the internal disease 
related tissues at different loci than are marked with blood. 
Although the effort to assess the usability maker tissues is 
substantial, epigenetic research on the common diseases will 
benefit greatly from the capacity to interrogate as many loci as 
possible, providing meaningful results through use of the right 
marker tissue (or more than one tissue for extra robustness) 
for that locus in combination with the disease related tissue. 
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Supplementary Figures 
Supplementary Figure S6.1: Microscopy images of tissue coupes. Coupes 
are stained with HE, staining proteins and cytoplasm red and nuclei blue. SC 
Fat: subcutaneous fat; VS Fat: visceral fat.  Except for visceral fat, the heteroge-
neity of the tissues appears similar between the individual
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Supplementary Figure S6.2: Density plots of the raw M-values. Different 
methylation patterns are observed across all CpG sites between the tissue 
samples (black lines) and the methylation titer series (red lines). B:Blood, F:Fat, 
O:Visceral fat, M:Skeletal muscle, L:Liver, S:Spleen, P:Pancreas. 1-6: invididual 
1 to 6, BMixM/F: Blood mixture Male/Female, S1/2.x%: Series1 or 2, x% methyl-
ated.
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Supplemental Figure S6.3: Boxplots showing the intensity distribution (y-
axis) of the two colour channels of the samples (x-axis) before (A) and after (B) 
normalization. 
B:Blood, F:Fat, O:Visceral fat, M:Skeletal muscle, L:Liver, S:Spleen, P:Pancreas. 
1-6: invididual 1 to 6, BMixM/F: Blood mixture Male/Female, S1/2.x%: Series1 or 
2, x% methylated.
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Supplementary figure S6.4: Distribution plot of the amount of CpG sites over 
which the correlation at a CpG site was averaged during smoothing. The verti-
cal line represents the boundary between what are called in this study the CpG 
sites in CpG rich areas (3 or more additional CpG sites, thus correlation being a 
median over 4 CpGs) and the CpG sites in CpG poor areas.
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Supplementary tables
Table S6.1: Frequency distribution of CpG sites in CpG 
rich areas with strong correlation (r ≥ 0.75) between 








SCFat VSFat Muscle Liver Spleen
Pan-
creas







2 794 x x
2 420 x x
2 327 x x
2 853 x x
2 378 x x
2 303 x x
2 1505 x x
2 1648 x x
2 894 x x
2 2516 x x
2 652 x x
2 634 x x
2 313 x x
2 1067 x x
2 2478 x x
3 141 x x x
3 178 x x x
3 112 x x x
3 52 x x x
3 461 x x x
3 206 x x x
3 182 x x x
3 430 x X X
3 343 x X X









SCFat VSFat Muscle Liver Spleen
Pan-
creas
3 177 X X X
3 93 X X x
3 69 x x x
3 83 X X x
3 161 x x x
3 100 x x x
3 46 X X x
3 241 x X X
3 374 x X X
3 160 x X X
3 411 X X X
4 74 X X X X
4 139 X X X x
4 195 X X X X
4 110 x X X X
4 73 X X X X
4 41 X X X x
4 40 X X x x
4 51 x x X x
4 26 X X X x
4 103 X X X X
4 38 x x X X
4 80 X X X X
4 84 x x x X
4 76 x X X X
4 47 X X X X
5 203 x x X X X
5 127 X X X X x
5 68 X X X X X
5 59 X X X X X
5 34 x X X X X
5 32 x X X X X
6 372 X X X X X X
 
The green background designates the mesodermal tissues and the blue 
background designates the endodermal tissues a: Information as supplied by manufacturer (Illumina, San Diego, USA)
b: 6T: in all six tissues; 1T – 6T: in one or more tissues; 1T – 2T: in one or two tissues; 
3T – 6T: in 3 or more tissues
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Supplementary table S6.2: Distributions of genomic 
locations for CpG sites in CpG  poor and rich areas with 
weak and strong tissue correlations
Genomic 













3T – 6Tb 
(n = 6092)
 In relation to RefSeq gene
none 41173 (37.4 %) 18257 (37.5 %) 21703 (14.2 %) 8834 (14.5 %) 900 (14.8 %)
1stExon 1154 (1.0 %) 490 (1.0 %) 11332 (7.4 %) 4665 (7.6 %) 423 (6.9 %)
3 UTR 6393 (5.8 %) 2944 (6.0 %) 2716 (1.8 %) 1057 (1.7 %) 93 (1.5 %)
5 UTR 7694 (7.0 %) 3331 (6.8 %) 15767 (10.3 %) 6367 (10.4 %) 604 (9.9 %)
Body 46985 (42.7 %) 20886 (42.9 %) 40377 (26.5 %) 16096 (26.4 %) 1639 (26.9 %)
TSS 1500 5453 (5.0 %) 2368 (4.9 %) 32681 (21.4 %) 13112 (21.5 %) 1360 (22.3 %)
TSS 200 1131 (1.0 %) 422 (0.9 %) 27834 (18.3 %) 10925 (17.9 %) 1073 (17.6 %)
 In relation to regulatory feature and cell type specificity (CTS)
none 93036 (84.6 %) 41855 (85.9 %) 72808 (47.8 %) 30403 (49.8 %) 3089 (50.7 %)
Gene 
Associated




720 (0.7 %) 276 (0.6 %) 376 (0.2 %) 166 (0.3 %) 15 (0.2 %)
Non Gene 




37 (0.0 %) 16 (0.0 %) 75 (0.0 %) 36 (0.1 %) 3 (0.0 %)
Promoter 




816 (0.7 %) 276 (0.6 %) 2458 (1.6 %) 903 (1.5 %) 85 (1.4 %)
Unclassified 4539 (4.1 %) 1892 (3.9 %) 12712 (8.3 %) 5033 (8.2 %) 512 (8.4 %)
Unclassified 
(CTS) 7768 (7.1 %) 3207 (6.6 %) 12567 (8.2 %) 5254 (8.6 %) 543 (8.9 %)
 In relation to CpG island
Open sea 68053 (61.9 %) 30002 (61.6 %) 23978 (15.7 %) 9655 (15.8 %) 936 (15.4 %)
N Shelf 10553 (9.6 %) 4560 (9.4 %) 2638 (1.7 %) 1125 (1.8 %) 104 (1.7 %)
N Shore 8783 (8.0 %) 3937 (8.1 %) 25944 (17.0 %) 10286 (16.8 %) 1101 (18.1 %)
Island 6388 (5.8 %) 2967 (6.1 %) 77380 (50.8 %) 30901 (50.6 %) 3016 (49.5 %)
S Shelf 9724 (8.8 %) 4330 (8.9 %) 1979 (1.3 %) 846 (1.4 %) 83 (1.4 %)
S Shore 6482 (5.9 %) 2902 (6.0 %) 20491 (13.4 %) 8243 (13.5 %) 852 (14.0 %)
a: Information as supplied by manufacturer (Illumina, San Diego, USA)
b: 6T: in all six tissues; 1T – 6T: in one or more tissues; 1T – 2T: in one or two tissues; 











3T – 6Tb 
(n = 6092)
Supplementary table S6.2: Distributions f genomic 
locations for CpG sites in CpG  poor and rich areas with 
weak and strong tissue correlations
: I formation as supplied by manufacturer (Illumina, San Diego, USA)
b: 6T: in all six tissues; 1T – 6T: in ne or more tissues; 1T – 2T: in one or two tissues; 
3T – 6T: in 3 or more tissues
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Supplementary table S6.3: Differences in structural 






























.003 54.19 77.77 58.57 80.98
Overlap Total 
Length
.004 32.78 44.43 35.20 45.93
tissue H1 overlap 
Regions Count
.003 27.15 41.54 29.55 43.39
tissue H1 overlap 
Total Length








.018 27.03 41.81 29.03 43.50
cTissueHes hues8 
oMeth ratio




.007 22.71 104.89 20.88 112.90





.006 107.92 276.97 94.20 259.81
chromMod H2A Z 
overlap Regions 
Count
.002 72.97 171.05 65.12 156.06
chromMod H2A 
Z overlap Total 
Length




































8.1*10-07 252.51 394.28 219.14 375.02
 
a:  Unadjusted p-value from Wilcoxon (epigraph webtool) or Chi Square test, 









Mean SD Mean SD
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.006 0.48 0.01 0.48 0.01
Overlap Re-
gions Count
9.5*10-06 823.96 1041.14 761.10 981.93
Overlap Total 
Length






.017 1.98 0.28 2.33 0.49
cNameV creb 
02 oZscore
.004 1.76 0.13 2.36 0.42
cNameV elk1 
01 oZscore
.030 2.58 0.59 2.13 0.43
cNameV hen1 
02 oZscore




.032 2.09 0.35 1.89 0.26
cNameV ncx 
01 oZscore
.032 2.62 0.54 1.99 0.31
cNameV stat1 
01 oZscore
























.026 462 498.1 594 557.9
a:  Unadjusted p-value from Wilcoxon (epigraph webtool) or Chi Square test, only 
attributes with nominally significant (p < 0.05) differences are given
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Chapter 7
Thesis Summary and discussion 
of results
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Table 7.1: Summary of thesis results at candidate loci
Locusa




related changes Risk for CHDl





















NR3C1 < 20 < 3.0 - -
TNF < 20 < 3.0 + + -
APOC1 < 20 3.0 – 6.0 + + + + - - -
IL10 20 – 40 > 6.0 + - - - ↑ - - + - -
LEP 20 – 40 3.0 – 6.0 + + + + ↑ - M - ++ ++ + - - -
KCNQ1OT1 20 – 40 < 3.0 - - - - - - - + + -
ABCA1m 20 – 40 > 6.0 + + ↑ - + ++ - -
GNASAB 20 – 40 3.0 – 6.0 - -
GRB10 40 – 60 3.0 – 6.0 - -
GNASAS 40 – 60 3.0 – 6.0 - ↑ ↓ F + + - + - ↑ F
MEG3 40 – 60 < 3.0 - -
IGF2 40 – 60 3.0 – 6.0 - + - ↓n -n -n +n ++ ++ + - - -
CRH 60 – 80 > 6.0 + + + + - - - ++ ++ - +
IGF2R 60 – 80 > 6.0 - + + - - -
INS > 80 < 3.0 - - - ↓ - M + ++ ++ ↑ F
FTO > 80 < 3.0 - -
a:  Loci are ordered on mean level of methylation from lowest to highest
b:  Significant influence of cell population heterogeneity on methylation variation: + = p < 
0.05; - p > 0.05 (uncorrected for multiple testing)
c:  The amount of influence of cellular heterogeneity is sufficiently small to allow statistical 
adjustment for it
d:  Correlation of methylation variation between longitudinal blood samples (follow-up = 
20 years):  - = ρ < 0.75; + = ρ > 0.75
e:  Correlation of methylation variation between blood and buccal cells: - = ρ < 0.75; + = 
ρ > 0.75
f:  DNA methylation is associated with famine in the period around conception
g:  DNA methylation is associated with famine in the last trimester of gestation (and early 
post natal life)
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Table 7.1: Summary of thesis results at candidate loci
Locusa




related changes Risk for CHDl





















NR3C1 < 20 < 3.0 - -
TNF < 20 < 3.0 + + -
APOC1 < 20 3.0 – 6.0 + + + + - - -
IL10 20 – 40 > 6.0 + - - - ↑ - - + - -
LEP 20 – 40 3.0 – 6.0 + + + + ↑ - M - ++ ++ + - - -
KCNQ1OT1 20 – 40 < 3.0 - - - - - - - + + -
ABCA1m 20 – 40 > 6.0 + + ↑ - + ++ - -
GNASAB 20 – 40 3.0 – 6.0 - -
GRB10 40 – 60 3.0 – 6.0 - -
GNASAS 40 – 60 3.0 – 6.0 - ↑ ↓ F + + - + - ↑ F
MEG3 40 – 60 < 3.0 - -
IGF2 40 – 60 3.0 – 6.0 - + - ↓n -n -n +n ++ ++ + - - -
CRH 60 – 80 > 6.0 + + + + - - - ++ ++ - +
IGF2R 60 – 80 > 6.0 - + + - - -
INS > 80 < 3.0 - - - ↓ - M + ++ ++ ↑ F
FTO > 80 < 3.0 - -
h:  The association with famine around conception is restricted to men (INS and LEP) or 
more pronounced in women (GNASAS)
i:   The association with famine is restricted to only one period, or for GNASAS is in oppo-
site direction between both periods
j:   Significant (+) or substantial (++) increase of methylation variation (inter-individual 
and within pair discordance) calendar age
k:  Attributability of the increase in methylation variation to the unique (individual) or the 
familial (shared) environment
l:   Significant association of DNA methylation at the locus with risk of MI during 3 year 
follow-up is restricted to the women of the study
m: Information is on the methylated CpG sites at the 5’end of the assay (Chapter2)
n:  These observations [14] are not included as a chapter of this thesis but were the study 
directly preceding Chapter 3 
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Epigenetic mechanisms regulate cellular gene expression 
potential without changing the genetic code [29]. Like the 
genetic sequence, epigenetic marks are faithfully transmitted 
during mitosis and are generally stable in differentiated 
cells, but in contrast with the static genome, the epigenome 
retains the capacity for dynamic changes in each individual 
cell. Epigenetic variation is therefore a topic of interest for 
research on ageing and its related common diseases [47,50]. 
In this thesis we focus on DNA methylation, which is the most 
studied layer of epigenetic information [28], and is correlated 
to the other epigenetic layers [21,25]. We used a combination 
of successive studies to investigate aspects of variation in 
DNA methylation, various sources generating such variation 
and its relation with risk for myocardial infarction (MI) at 
candidate loci for cardiovascular and metabolic diseases.
Thesis results
In chapter two we investigated the possibilities of 
epigenetic epidemiological research using samples stored 
in existing bio-repositories, most of which were originally 
designed for genetic research and usually contain DNA 
from blood drawn at baseline without longitudinal sampling. 
With reference epigenome browsers still under construction 
[88,89], we first established a reference of inter-individual 
variation in the methylation status of 104 CpG sites 
distributed over 16 loci (Table 7.1). These loci were selected 
because they map to candidate genes for cardiovascular 
and metabolic diseases and their epigenetic characteristics 
represent various potential targets for epigenetic regulation 
of gene expression (Chapter 1). We established that CpG 
methylation in the cell population of a tissue sample is 
a quantitative trait at these loci. We further found that, 
although both average methylation level and the amount 
of variation could vary substantially between adjacent CpG 
sites, the methylation of nearby CpG sites was generally 
correlated, which may have some practical analogy to the 
linkage disequilibrium blocks of genetic variation [159] and 
fits the common view that the regulatory effect of DNA 
methylation usually relies on the status of multiple CpG sites 
within a genomic region [94]. A recent whole methylome 
study confirmed the existence of such correlations and 
showed that they extent roughly a hundred base pairs to 
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either side [83]. We then investigated the concern that inter-
individual variation in DNA methylation might be a reflection 
of leukocyte population heterogeneity [103]. We found that 
variation in DNA methylation at 10 loci was not influenced 
by leukocyte population heterogeneity, this influence was 
marginal at 5 loci, and it was substantial only at the IL10 
locus (Table 7.1). We described a statistical method to 
account for minor influences of cell type heterogeneity on 
DNA methylation variation. Recent studies have observed 
similar proportions of unaffected, marginally affected and 
strongly affected loci in a study on different candidate loci 
[246] and on a large set of individual CpG sites distributed 
throughout the genome [77]. 
Next we investigated the stability of variation in DNA 
methylation over time in longitudinal DNA samples of both 
blood (10-20 year time span) and buccal cells (2 – 8 year 
time span) in 34 individuals (Table 7.1). Although DNA 
methylation was not perfectly maintained at any locus, 5 
of 8 loci assessed displayed a strong correlation (ρ ≥ 0.75) 
between the time points in both tissues, indicating that 
prospective studies on DNA methylation are possible. Such 
locus specific temporal stability was also found in another 
longitudinal study [197]. DNA methylation levels of imprinted 
loci are commonly thought to be similar between tissues, 
since they originate in early development [69,106]. We finally 
investigated whether the variation in DNA methylation of 
blood may correspond to that of another tissue. We found 
that DNA methylation at 4 of 8 loci displayed a strong 
correlation (ρ ≥ 0.75) between the recent blood and buccal 
cell samples, irrespective of imprinting status. A recent 
genome wide study reported indicated that DNA methylation 
patterns in blood could be a surrogate marker for cerebellum 
at some loci [234]. In all, depending on the locus of interest 
and with careful study design, some epigenetic research 
questions can be answered using DNA from existing 
biobanks. 
In chapter three we investigated whether in utero 
exposure to the Dutch Famine of 1944-1945 is associated 
with persistent differences in epigenetic information at 
the candidate loci described in chapter 2, assessing the 
generality of our primary findings at the IGF2 locus [14]. We 
compared DNA methylation between middle-aged individuals 
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who were born or conceived during the Dutch Famine and 
their same sex older or younger siblings. We found that 
DNA methylation was persistently altered in prenatally 
exposed individuals at 6 of the 15 loci assessed (Table 
7.1). The direction of these exposure related changes was 
specific for the loci, with 5 showing higher, and 1 lower DNA 
methylation. Furthermore, the exposure related change in 
DNA methylation was sex-specific at 3 loci, and specific to the 
timing of the exposure at 5 loci. At 4 of these loci only famine 
exposure in the period around conception was associated 
with altered DNA methylation, whereas at the GNASAS locus 
famine exposure in both the period around conception and 
in the final three months of gestation resulted in altered 
DNA methylation in opposite directions. The combination of 
epigenetic changes specific to the locus, the type and timing 
of the exposure and the sex of the exposed can unlikely be 
explained solely by epigenetic damage due to a deficiency 
in methyl donors. Further research may reveal whether 
and which other mechanisms underlie these observation, 
including the proposed possibility of an adaptive response 
being recorded in the epigenome [178].
More prenatal conditions have been reported to 
produce persistent epigenetic changes, including maternal 
micronutrient deficiency [225], folate supplementation 
[120,219], maternal smoking [67,226], and placental 
morphology [217]. Such observations in humans resemble 
results from intervention studies in animal models 
[13,63,184]. In animal studies the epigenetic changes 
were also associated with phenotypic changes related to 
disease development, forwarding epigenetic alterations as 
a plausible molecular mechanism for the developmental 
origins hypothesis of adult disease, which poses that adverse 
conditions during development and early life increase the risk 
for age related common diseases like CHD [165]. However, 
since the Dutch Famine related epigenetic differences were 
observed in blood, it remains unclear whether and how they 
are involved in the phenotypic observations related to the 
Dutch Famine that indicate a predisposition to metabolic 
and cardiovascular diseases [167,168]. In any case, the 
persistence and specificity of epigenetic information found 
associated with early life exposures makes such marks 
attractive potential reporters for developmental conditions, 
for which the genetic sequence itself cannot provide any clue. 
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Further, epigenetic marks found associated with conditions 
around conception and early embryogenesis might even 
correlate across the tissues that developed from the same 
progenitor stem cells affected at the time of the exposure, 
thus potentially marking the epigenetic state of inaccessible 
tissues [69,94]. 
In chapter four we investigated the susceptibility of 
epigenetic information to changes during the whole adult life 
span, having observed in Chapter 2 that every locus assessed 
displayed some degree of epigenetic changeability over 
20 years. This chapter aims to extend findings of previous 
studies investigating this question with cross-sectional and 
longitudinal designs on smaller sample sizes with narrower 
age ranges [130,197,247]. In 230 monozygotic twin pairs (MZ 
twins) ranging from young to elderly adults (18 – 88 years 
old) we compared the amount of inter-individual variation 
and within-pair discordance in both global DNA methylation 
and DNA methylation at 7 of the loci, assessed in chapter 2. 
Increases in these measures of epigenetic variation in the 
population were used as a proxy for combined stochastic and 
environmentally driven epigenetic changes in individuals and 
were both found to be largely independent from leukocyte 
population heterogeneity. Although at all ages global DNA 
methylation showed little variation, its variation increased 
significantly with age, and results at most candidate loci 
further indicated that epigenetic changes accumulate 
gradually with increasing calendar age. Recent genome-wide 
studies also report associations of DNA methylation with 
age [58,248]. The rate of accumulation appeared specific to 
the locus with some loci (e.g. IGF2, INS, LEP) displaying a 
substantial accumulation of (random) epigenetic changes 
throughout adult life, while inter-individual variation at 
KCNQ1OT1 and within-pair discordance at GNASAS remained 
stable (Table 7.1). 
At the CRH locus mean methylation levels were similar 
at all ages while increases in variation were substantial, 
potentially indicating that changing methylation marks 
may yield another trait in epigenetic research. Epigenetic 
instability is proposed to be both a stochastic initiator 
of disease development [50] and an important biological 
mediator of environmentally driven disease risk [68]. The 
age related increase in DNA methylation variation fits both 
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slightly contrasting views. Stochastic DNA methylation 
changes without an environmental component are likely 
related to imperfect epigenetic maintenance processes 
during mitosis [51,205]. However, the directed DNA 
methylation changes that result from environmental 
exposures related to lifestyle and living conditions [72,77] 
may likely accumulate as changes in (partly) opposite 
directions, since conditions change across a lifetime. Both 
processes will manifest as random epigenetic changes with 
age, which is commonly called epigenetic drift. We observed 
that most epigenetic variation and most of its age-related 
increase was generally attributable to individual factors 
(Table 7.1), which fits both causes for epigenetic instability. 
Remarkably, although longitudinal examination showed 
that the increase in methylation variation was continued 
into old age, there were still old twin pairs with virtually 
identical DNA methylation signatures, indicating that either 
the epigenome of some individuals is less changeable, 
or that these individuals are better capable of correcting 
epigenetic changes. The eventual build-up of dysfunctional 
epigenetic changes in each cell is thought to result in an age 
related increase in the proportion of cells in a tissue that 
are epigenetically dysregulated [50,205], a state that has 
been forwarded as a possible molecular mechanism in the 
process of ageing [58,59]. Our observations at old age may 
thus forward epigenetic marks in the elderly as a potential 
indicator of biological age [249], rather than calendar age 
[250]. Future research into the causes and phenotypic 
consequences of epigenetic instability may be able to shed 
light on such questions. 
In this chapter we examined 5 of the 6 loci at which DNA 
methylation was found associated with prenatal famine 
[14]. We found that 4 of these loci showed considerable 
susceptibility to epigenetic drift, which would seem to 
contradict the observed persistence of the epigenetic 
changes induced by the Dutch Famine (Table 7.1). However, 
observations at the IGF2 locus showed that the differences 
induced by the Dutch Famine were not similar for every 
exposed and non-exposed sibling pair, with the persistence 
of the difference manifested at the group level [14]. We 
observed in this chapter that there were still old twin pairs 
with similar methylation levels, and, although the loci 
show substantial increases in variation with age, changes 
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in the population averages seem proportionately smaller 
across a lifespan. A plausible interpretation of this would 
be that epigenetic differences related to the (prenatal) 
environment might be most pronounced in the population 
just after the event, and then slowly fade as epigenetic 
variation around the average increases with age through 
accumulated (random) epigenetic changes in each individual. 
An alternative explanation may view the Dutch Famine 
associated differences in DNA methylation as a persistently 
accelerated DNA methylation age in the prenatally 
exposed group, with the age related increase in epigenetic 
variation at these loci relating to an increased variation 
in DNA methylation age [251]. Both interpretations fit the 
developmental component and the stochastic variation of 
ageing [59,178]. 
In chapter five we investigated whether, in line with the 
developmental origins hypothesis [165], DNA methylation was 
related to risk for CHD at the 6 candidate loci, at which it was 
associated with prenatal famine [14] (Chapter 3). Within the 
placebo group of the PROSPER trial on Pravastatin and the 
risk of CHD [118,218], we compared all individuals who were 
event free at baseline and developed myocardial infarction 
(MI) during 3 years follow-up (n = 122) with a similar sized 
control group. Due to our results from the Dutch Famine 
study, we tested for and found a significant sex interaction 
for INS and GNASAS. Higher DNA methylation at these loci 
was associated with an increased risk for MI among women 
(Table 7.1) with the association strongest for individuals 
displaying hypermethylation at both loci. We observed no 
epigenetic associations among men, which could be due to 
an aspect of study design such as inclusion age [230] and / 
or may have a biological reason. This study was one of the 
first to show a locus specific epigenetic association with 
CHD, but more are emerging. A case-control study [252] on 
coronary artery disease (CAD) found an association with 
methylation of a candidate gene in the 9p21 locus, implicated 
in CHD by genome wide association studies [253]. A smaller 
retrospective study on familial hypercholesterolemia patients 
[254] reported an association between CAD and methylation 
at the exact same CpG sites of ABCA1 as measured in 
this thesis. Our prospective study on MI risk found no 
association at ABCA1, the simplest explanation for which 
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would be differences in the study population (event free vs. 
hypercholesterolemic) and the study design (prospective vs. 
retrospective). The associations we found were independent 
of the well-established traditional risk factors of CHD (i.e. lipid 
profile, hypertension, Type 2 diabetes), suggesting that DNA 
methylation at specific loci may be an epigenetic marker for 
disease risk. This view has been substantiated by two recent 
longitudinal studies reporting associations in blood between 
persistent DNA methylation at candidate loci and obesity 
or type 2 diabetes [48,49]. With our investigation limited to 
blood, our results do not directly implicate an epigenetic 
mechanism in disease development. 
Do results in this chapter reflect a developmental 
component of CHD? The original developmental origins 
hypothesis (Figure 7.1 A) was formulated on epidemiological 
studies in which various proxies for poor conditions in early 
life were associated with an increased incidence and severity 
of CHD in middle age [8,165]. In line with this hypothesis, 
epidemiological studies on both Dutch Famine cohorts 
[167,168] indicate that prenatally exposed individuals have 
a higher incidence of its phenotypic pre-stages (Figure 7.1 
C). Results from a wealth of intervention studies on animal 
models [66] show that adverse early life conditions result 
in epigenetic changes specific to the insult and the locus, 
and that these associations coincide with proxies for the 
pre-stages of CHD (Figure 7.1 B). Both INS and GNASAS 
methylation is important in regulating fetal growth [180,201]. 
Chapter 3 showed that persistently different methylation at 
INS and GNASAS was associated with prenatal exposure to 
the Dutch Famine (Figure 7.1 C). In this chapter we observe 
that higher methylation at both loci is associated with risk 
for CHD independently of the traditional CHD risk factors 
(Figure 7.1 D). The associations at GNASAS are a complete 
match between prenatal (peri-conception) susceptibility 
and risk for CHD, both in terms of direction of the difference 
as in terms of sex-specificity (Table 7.1). Chapter 4 shows 
that methylation at GNASAS is mostly inert to epigenetic 
drift, making an unknown developmental component the 
most likely explanation for its association with CHD. The 
associations at INS are in opposite direction and in the other 
sex, prenatally exposed men have lower DNA methylation 
and women at risk for CHD have higher DNA methylation. 
Further, INS methylation is susceptible to changes, stochastic 
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Figure 7.1: Schematic summary of results related to DOHaD. A) The 
original developmental origins hypothesis was formulated on epidemiological 
investigations that found a relation between birth and early childhood in poor 
areas and increased risk and severity of ischemic heart attack in middle age [8]. 
B) Many intervention studies on animal models provide convincing evidence 
that prenatal conditions affect epigenetic information at CHD candidate loci 
resulting in phenotypes that lead to CHD development in humans [65,66]. C) 
In Chapter 3 of this thesis we present evidence that prenatal exposure to the 
Dutch Famine of 1944-1945 affected DNA methylation at CHD candidate loci, 
but the study was not fit due to size and age of the participants to investigate 
a further association between DNA methylation and CHD directly. However, 
epidemiological studies on both Dutch Famine cohorts do indicate the prenatal 
exposure to it is associated with increased manifestation of the pre-stages of 
CHD  [167,168], although DNA methylation is not indicated in these studies as a 
potential explanation. D) in Chapter 5 we find an association of risk for MI with 
DNA methylation at 2 of the loci that showed persistent changes in Chapter 
3. Although we have no specific information on the early life conditions of the 
study participants, we do know that they were born in the same period as the 
populations, that were the basis of the developmental origins hypothesis.  
Binnenwerk_opmaak.indd   177 5-12-2014   13:22:02
178
and / or environmentally driven, during the adult period 
(Chapter 4). Thus, although a developmental explanation 
for its association with CHD risk is still plausible, it is equally 
plausible to explain its hypermethylation in cases with 
epigenetic events in adult life. This can only be resolved 
with data on both prenatal and adult life conditions of the 
PROSPER participants. 
In chapter six we performed a genome-wide 
investigation on autopsy derived samples from 6 individuals 
(blood, subcutaneous fat, visceral fat, muscle, liver, pancreas, 
and spleen) using the recently launched Illumina 450k DNA 
methylation chip on the capacity of DNA methylation in blood 
to mark that of internal tissues. Principal component analysis 
(PCA) revealed that DNA methylation patterns remain 
stable within at least 24 hours after death, demonstrating 
that autopsy derived tissue samples can be used to 
create reference DNA methylomes of inaccessible tissues. 
PCA further showed that genome-wide variation in DNA 
methylation is primarily due to tissue differences, dismissing 
the use of surrogate tissues to mark whole methylome 
patterns of internal tissues. In contrast, we observed that 
average DNA methylation levels were similar between blood 
and each internal tissue at most CpG sites, and across all 
tissues at roughly a quarter of CpG sites. Both observations 
were in line with existing literature [100–102]. 
Chapter 2 showed that at specific loci DNA methylation in 
blood may correlate with DNA methylation in another tissue, 
which a recent genome wide study expanded upon [234]. 
We therefore inspected correlation of CpG methylation at 
individual sites across the tissues, focusing mostly on CpG 
rich areas for technical reasons, and found that over 30 % 
of CpG sites showed a strong correlation (r ≥ 0.75) between 
blood and another tissue. At the majority of CpG sites such 
correlations were between blood and one tissue exclusively, 
although at a sizeable minority they were found across 
multiple tissues. At a few CpG sites we observed correlation 
across all tissues which likely reflects the effect of unknown 
genetic variation [92,243]. Strong correlation coefficients were 
not associated with average DNA methylation, its variation, 
or its difference between the tissues. Our observations were 
repeated in a recent study on the same dataset extended 
with additional samples and analyzed using different 
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Figure 7.2: Correlation of CpG methylation between blood and spleen (green), 
pancreas (blue), liver (purple), skeletal muscle (red), visceral fat (orange), 
and subcutaneous fat (yellow) at CpG sites within and around 500 bp from 
either start (vertical dotted line at S) or end (vertical dotted line at E) of the 
SEQUENOM EPITYPER assays for the candidate loci INS (left) and GNASAS 
(right) measured in Chapters 2 to 5. The numbers on the x-axis correspond to 
the chromosomal coordinates (hg 18) of the assay +/- 500 bp, the tick-marks 
on the x-axis represent all the CpG sites, the green ticks indicate CpG sites of 
which the methylation was called using the EPITYPER platform. The colored 
dots represent correlation between blood and the tissues at CpG sites called 
using the 450K ILLUMINA BeadChip Array in Chapter 6. Horizontal dotted lines 
are for reference, representing a correlation coefficient of 0.75.
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statistical methods [255]. Further, a recent whole methylome 
study suggested that blood and buccal cells can both be 
used as surrogate tissues for internal tissues [256]. There are 
more peripheral tissues that can be obtained with minimal 
(e.g. buccal cells and epidermis) [107,108] or moderate 
(e.g. biopsies of subcutaneous fat or muscle) [109,110] 
invasiveness. As the capacity of a surrogate tissue to mark a 
target tissue appears locus and tissue specific a reference of 
DNA methylation correlation across tissues will be of value in 
choosing the relevant surrogate tissues that mark the target 
tissue in future epigenetic epidemiological studies. 
The current chapter is a pilot when it comes to finding 
locus specific surrogate tissues, but this data may already 
help interpret the associations found at INS and GNASAS 
in this thesis. We therefore plotted the correlation between 
blood and the internal tissues for the CpGs on and around 
(+/- 500 bp) both Sequenom EPITYPER assays (amplicon) 
measured in chapters 2 to 5 (Figure 7.2). For INS, 3 of the 
CpG sites called in the amplicon were assessed in this 
chapter, as were 3 CpG site within 60 bp of the Start of the 
amplicon, and 1 CpG site 470 bp away from the End. The 
CpG sites around the Start of the INS amplicon show some 
promising correlations between blood and the other tissues. 
Insulin, under the influence of DNA methylation at INS, is 
produced in pancreatic β-cells [200], which constitute only 
a tiny fraction of the whole pancreas, yet 1 CpG site shows 
a correlation with some promise between blood and whole 
pancreas (Figure 7.2). For GNASAS none of the CpG sites 
called within the amplicon were assessed in this chapter and 
only 1 CpG site 300 bp from the Start of the amplicon, but 
within 500 bp from the End of the amplicon we assessed 15 
CpG sites in this chapter, of which the CpGs 155 - 455 bp 
away show promising correlations between blood and other 
tissues. Higher DNA methylation at GNASAS is associated 
with higher expression of Gαs, a key component of the 
intracellular cAMP signaling, in adipose tissue (both brown 
and white), the pituitary and the thyroid gland [201,223]. A 
few CpG sites show promising correlations between blood 
and subcutaneous fat or visceral fat. Although there is 
evidence that small changes in percentage DNA methylation 
may explain almost half the variance in gene expression 
[188], and the cAMP and insulin signaling pathways are 
implicated in metabolic dysregulation [228], it still remains 
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unclear whether the observed differences associated with 
MI in chapter 5 indicate an epigenetic process involved 
in disease development. However, this possibility has not 
been disproven either, if anything our exploration warrants 
a bigger investigation with more individuals and samples of 
tissues involved in cardiovascular and metabolic diseases.
Sequential Study Design
In this thesis we applied a sequence of research 
questions, each with a specific study design and population 
cohort, to investigate the causes of epigenetic variation 
and its consequence for disease risk at the same loci. We 
found that epigenetic marks can be persistently altered by 
conditions of the prenatal environment (Chapter 3), that they 
may change dynamically throughout life (Chapter 4), and 
that they are associated with risk for CHD (Chapter 5). The 
summation of random and directed epigenetic variation with 
a heritable [243], or prenatally determined background fits 
both the observed randomness in onset of complex diseases, 
the influence of environmental components on disease 
development, and the association between conditions 
during prenatal and early life with risk for these diseases 
[257]. Unfortunately, there is no single study design that can 
readily isolate all components of epigenetic variation, nor 
will one population cohort likely accommodate all research 
questions involved in investigating the accumulated causes 
and consequences of epigenetic variation across a lifetime. 
However, careful formulation of specific research question 
and subsequent selection of appropriate study designs, may 
still promise meaningful epigenetic research on ageing and 
its related diseases [112], as demonstrated by sequentially 
carrying results across chapters 3, 4, and 5 in this thesis. 
The sequential study design that we applied with chapters 
3 to 5 combines a retrospective, a (mainly) cross-sectional, 
and a prospective study, developing epigenetic markers of a 
past environmental exposure, establishing their susceptibility 
to epigenetic drift, and using these markers to investigate 
disease risk in a clinical trial, respectively. This approach 
exploits the potential of epigenetic research, covering time 
periods and events from preconception till death that are 
beyond single population studies and providing insight into 
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the environmental and stochastic components of the common 
age related diseases. However, prospective and retrospective 
investigation necessitates using epigenetic marks with 
a stable variation for at least the duration of the study. 
Investigating longitudinal samples would be best for this 
[49], but, when not available, another form of evidence on 
temporal stability can be obtained. Similarly, isolating specific 
leukocyte cell types will be impractical for large studies, 
many of which even lack information on the proportions of 
the major leukocyte sub-populations (e.g. chapters 3 and 
5), although in genome wide studies another method can 
be applied [104]. As, in humans, direct analysis of internal 
tissues is practically impossible in anything but a study on 
post mortem biosamples, establishing the correlation of 
methylation in peripheral tissues with these disease relevant 
tissues will be crucial for deeper interpretation of uncovered 
associations. Thus, effective epigenetic research requires 
information on the stability of epigenetic variation over time 
and its correspondence across tissues and cell types. 
In this thesis we used a preliminary sub-study on 
longitudinal biosamples from healthy individuals (potential 
controls) to assess the amount of epigenetic variation at 
the candidate loci, the influence of leukocyte population 
heterogeneity and its temporal stability during a period 
covering the follow-up period of most clinical studies (chapter 
2). As an auxiliary we used a (small) genome wide study on 
autopsy samples (Chapter 6) to interpret the associations 
of GNASAS and INS with disease risk in relation to the 
mechanism of disease development. With the eventual 
completion of epigenetic data bases, such as those of the 
International Human Epigenome Consortium [96] (http://
www.ihec-epigenomes.org/) and the National Institutes 
of Health (NIH) Epigenomics Roadmap [97] (http://www.
roadmapepigenomics.org/), such steps in the sequential 
design can be performed by a database search. Thus, from 
this thesis it follows that the design and interpretation of 
epigenetic associations studies into ageing related diseases 
requires data bases that record data from: 1) studies 
on genome wide DNA methylation marks in longitudinal 
samples of peripheral tissues from healthy individuals to 
assess temporal stability (Chapter 2; [88,89]. 2) studies 
on postpartum samples of extra-embryonic tissues from 
neonates [62] to acquire references for developmental DNA 
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methylation dynamics in humans from gametogenesis till 
birth; 3) studies on post-mortem samples of peripheral and 
internal tissues to assess the influence of cell type population 
heterogeneity on DNA methylation marks for each tissue 
(Chapters 2 and 4), and the correlation of methylation marks 
across tissues (Chapter 6), and preferably to also provide a 
record of whole DNA methylomes from each cell type [104]; 
4) studies on mono-cultures of multiple cell types to assess 
the overlap between DNA methylation and the other layers of 
epigenetic information (i.e. DNA methylation and other base 
modifications, histone modifications, association with nuclear 
lamina, or CTCF hubs); 5) studies on multiple cell cultures 
coupling epigenomic with transcriptomic, and perhaps also 
proteomic, analyses to assess the downstream effects of 
epigenetic signatures on cellular gene expression; 6) classical 
twin studies comparing monozygotic, dizygotic twin pairs 
and unrelated individuals to assess the influence of heritable 
genetic sequence variation and environmental (prenatal 
and late) factors on the epigenetic status at a locus; and 7) 
human intervention studies to investigate the epigenetic 
consequences of medication, therapy and lifestyle changes. 
Statistical analyses
Studying the epigenetic basis of common disease not 
only requires specific study designs, but also particular 
statistical tools. We implemented linear mixed models to 
address issues for analyzing DNA methylation data. It uses 
all available methylation data, accounts for the correlated 
CpG methylation of a locus, actually using this information 
to handle data missing at random (Chapters 2, 3, 4, and 5) 
and achieve accurate imputation for further analyses such 
as logistic regression (Chapter 5). Besides powerful, the 
linear mixed model is also versatile and we used several 
adaptations of it in our various analyses throughout this 
thesis. The model simultaneously tests whether the observed 
effect is independent of included covariates (e.g. age, sex, 
blood parameters, exposures) and adjusts the effect for it. We 
used this aspect to make all relevant adjustments on the raw 
data simultaneously (Chapter 2, 3, 4, and 5). The model also 
calculates the amount of variation that remains unaccounted 
for by its covariate structure (i.e. residual variance). We 
used this residual variance in a nested model approach [156] 
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to assess the methylation variation explained by each of 
the major leukocyte sub types (Chapters 2 and 4). Random 
effect covariates allow estimation of changes in variation, 
which we used to investigate ageing related changes in 
methylation variation (Chapter 4). Further, by inclusion of 
multiple subject variables in the model, we assessed the 
separate effects of shared and unique environmental factors 
on age related variation in DNA methylation (Chapter 4). The 
crucial characteristic of a statistical model for analyzing CpG 
methylation at candidate loci is that it can accommodate 
the correlation in methylation between adjacent CpG sites 
(Chapter 2). The linear mixed model can, and is our model of 
choice for this type of data due to its statistical robustness 
and its analytical versatility. However, other models that can 
handle the correlation of adjacent CpG sites exist and can be 
used. 
Future prospects
In this thesis we explored the limits and possibilities of 
the emerging research field of epigenetic epidemiology, 
investigating the kind of research questions on the 
developmental and environmental components of CHD 
that existing biobanks can be used for. We first described 
characteristics of variation in DNA methylation at 16 
known CHD candidate loci with demonstrated or suspected 
epigenetic regulation. Then, using a sequence of studies 
with linked design, we found evidence that epigenetic 
signatures at some of these loci can persistently change due 
to environmental (prenatal) conditions, are susceptible to 
stochastic perturbations that gradually accumulate during 
life and that epigenetic signatures at two of these loci were 
associated with risk for CHD. Expanding on these results, 
epigenetic research promises the potential to reveal the 
molecular mechanisms that underlie the influence of the 
developmental period in CHD, the environmental components 
of CHD and the randomness in CHD development [112,257]. 
The epigenetic epidemiology of CHD and other complex 
diseases is still in its infancy, but a recent study reported an 
association of adult smoking with DNA methylation signatures 
persisting in blood years after the exposure [71] and in a 
second study of linked design the same marks were found 
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associated with risk for CHD [258]. Such results parallel 
results from the sequential study design in this thesis and 
present another model of a disease related exposure that is 
associated with epigenetic marks that are also associated 
with the outcome. Whether the associated epigenetic 
signatures mark the exposure or mediate between exposure 
and outcome remains to be revealed. Interestingly, another 
study reported DNA methylation associated with prenatal 
exposure to smoking [67]. In addition there is increasing 
speculation of transgenerational epigenetic inheritance, 
with some associations reported between environmental 
exposures and phenotypic changes across multiple 
generations [259,260]. However, no convincing empirical 
evidence has yet been reported on its importance for humans 
in context of CHD development [112].
Current epigenetic knowledge may help understand 
the functional relevance of major GWAS hits in non-coding 
genomic regions [252], but it only scratches at the surface 
of the epigenetic contribution to CHD development in later 
life. Assessing the phenotypic relevance of associations 
between epigenetic marks and CHD in this thesis and other 
studies [55,254] requires a much deeper understanding of the 
epigenome, the origin of epigenetic variation, and its causal 
relation with disease development. A technological hurdle to be 
cleared for epigenetic epidemiology is the creation of a platform 
that integrates the possibilities of whole genome bisulphite 
sequencing [83], with the simultaneous genome wide calling 
of other modified bases, such as hmC, and various histone 
modifications [261,262]. Such integrated whole epigenome 
scans will allow a better assessment of the function of disease 
associated epigenetic marks in relation to all other epigenetic 
marks at the locus and throughout the epigenome. A practical 
hurdle is the necessity to use peripheral tissues as surrogates for 
inaccessible tissues that are relevant for disease development. 
Current research has started to map the possibilities of 
epigenetic marks in accessible tissues for use as surrogate 
markers [255,256], but the potentially interesting epigenetic 
signatures of some tissues will likely remain out of reach. 
Methodological hurdles to be cleared are the establishment of 
an atlas of soma-wide epigenetic variation as reference [96,97] 
development of study designs that enable investigating the 
mechanisms behind the establishment and maintenance of 
epigenetic marks and the environmental factors that affect 
Binnenwerk_opmaak.indd   185 5-12-2014   13:22:14
186
these processes from preconception throughout life [15,251,263]; 
and the creation of an integrated functional –omics paradigm 
that combines genomic, epigenomic, and transcriptomic data 
[47,112]. Eventually such knowledge will aid understanding the 
downstream effects of disease associated epigenetic marks on 
gene expression of the locus in relation to cellular expression 
pathways, and the functionality of the tissue(s) involved in the 
process of disease development [94,263] 
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Epigenetische mechanismen reguleren het gebruik van de genen
De chromosomen in een menselijke cel bereiken kop-
aan-staart gelegd een lengte van ongeveer 2 meter. Om in 
een celkern met een diameter van ongeveer 1 micrometer 
(= 0,001 mm) te passen moet het DNA worden opvouwen. 
Dit wordt bewerkstelligd door het DNA eerst te wikkelen 
rondom histon eiwitten. Het koppelen van verschillende 
kleine chemische groepen aan de histon eiwitten zorgt 
ervoor dat deze eiwit - DNA complexen elkaar aantrekken 
of afstoten wat een strakker of losser opgevouwen stuk 
chromosoom tot gevolg heeft. Ook aan het DNA zelf kan op 
specifieke plaatsen een chemische groep, een methyl groep, 
gekoppeld worden wat de affiniteit beïnvloedt tussen DNA en 
DNA bindende eiwitten zoals transcriptiefactoren. Het geheel 
van chemische groepen aan en rondom het DNA wordt 
epigenetische informatie genoemd (Oud Grieks: epi = op). 
Een cel maakt geen gebruik van genen die in strak 
opgevouwen stukken DNA liggen. Simpel gezegd wordt 
door epigenetische informatie bepaald onder welke 
omstandigheden de cel bepaalde genen überhaupt kan 
‘gebruiken’ om biologische taken te verrichten. Wanneer 
we bijvoorbeeld eten wordt insuline alleen gemaakt in de 
eilandjes van Langerhals van de alvleesklier, terwijl elke 
cel in ons lichaam hetzelfde gen voor insuline bezit en vele 
cellen insuline nodig hebben. Tijdens de celdeling wordt 
zowel de genetische als epigenetische informatie van de 
oorspronkelijke cel correct doorgegeven aan beide dochter-
cellen. Echter, waar het genetisch gereguleerde gen gebruik 
vanaf de bevruchting vast staat voor elke cel in het lichaam, 
kan het epigenetisch gereguleerde gen gebruik van een cel 
veranderen. Een bekend voorbeeld van zulke epigenetische 
veranderingen is de ontwikkeling van gespecialiseerde 
cellen uit stamcellen (met een bevruchte eicel als de ultieme 
stamcel). Tijdens dit proces leiden omvangrijke epigenetische 
herstructureringen tot het strak opvouwen van verschillende 
stukken DNA in dochtercellen waardoor genetisch 
identieke cellen er toch anders uit zien, andere biologische 
functies verrichten en verschillend kunnen reageren op 
signalen uit de omgeving. In een gespecialiseerde cel is 
epigenetische informatie over het algemeen stabiel, maar 
de mogelijkheid tot veranderingen blijft. Willekeurige 
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epigenetische veranderingen kunnen spontaan voorkomen 
of ontstaan als gevolg van een schadelijke blootstelling, 
enigszins vergelijkbaar met genetische mutaties. Echter, in 
tegenstelling tot genetische mutaties, kunnen epigenetische 
veranderingen ook gericht optreden als onderdeel van een 
intern proces (b.v. wondgenezing) of als aanpassing op een 
omgevingsfactor (b.v. eetgedrag). 
Doordat epigenetische processen betrokken zijn bij 
de wijze waarop de cel de genen gebruikt, is het ook te 
verwachten dat epigenetische veranderingen een rol spelen 
bij het ontstaan van ziekten. Aangetoond is dat de genen die 
celdeling en groei controleren epigenetisch volledig ontregeld 
zijn in tumoren, en ook in de hartspier zijn epigenetische 
verschillen gevonden tussen cellen in gezonde gedeelten en 
gedeelten die door een hartinfarct zijn aangetast. Of dit soort 
epigenetische verschillen oorzaak of gevolg zijn van de ziekte 
is nog onduidelijk. Wel is het zo dat een opeenstapeling 
van willekeurige en gerichte epigenetische veranderingen 
gedurende het leven algemeen wordt gezien als een 
belangrijke factor in het proces van veroudering en het 
ontstaan van ouderdomsziekten zoals ouderdomsdiabetes 
(diabetes type 2), hoge bloeddruk, hart- en vaatziekten (HVZ) 
en kanker.
Epigenetisch onderzoek naar hart- en vaatziekten
Er is veel interesse in onderzoek naar de relatie tussen 
epigenetische mechanismen en de ontwikkeling van ziekten, 
zoals ouderdomsziekten, waarbij embryonale omgeving, 
leefomgeving en levensstijl belangrijke risicofactoren in 
zijn. Onderzoek hiernaar in mensen geschiedt veelal via 
populatiestudies, waarvan er verschillende typen zijn. Er 
zijn talloze klinische studies die zich specifiek richten op 
onderzoek naar het effect van (nieuwe) medicatie op het 
risico om binnen enkele jaren de ziekte te ontwikkelen. Ook 
zijn er grootschalige populatiestudies die de levensloop, 
inclusief ziekte en gezondheid, van een grote groep 
individuen of families gedurende langere tijd onderzoeken. 
Er zijn zelfs enkele historische cohortstudies die zich 
concentreren op een specifieke gebeurtenis in het verleden, 
zoals een hongersnood, en de gevolgen daarvan voor de 
gezondheid gedurende het leven. Voor de meeste humane 
studies is biologisch materiaal van de deelnemers, vaak 
DNA uit bloed, goed beveiligd opgeslagen in zogenaamde 
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biobanken. Door technologische vooruitgang is epigenetisch 
onderzoek in humane cohorten, epigenetische epidemiologie 
genoemd, mogelijk geworden. 
Op termijn zal epigenetische epidemiologie meer 
inzicht verschaffen in de manier waarop de epigenetische 
verschillen tussen mensen bijdragen aan het ontstaan van 
ouderdomsziekten. Dit proefschrift vormt een eerste stap in 
het onderzoek naar de rol van epigenetische processen bij 
de ontwikkeling van hart- en vaatziekten (HVZ), en bevat 
twee aspecten. Ten eerste bestuderen en beschrijven we 
biologische eigenschappen van epigenetische informatie 
voor een set HVZ kandidaat genen, genen waarvan de 
betrokkenheid bij HVZ bekend is of vermoed wordt. We 
onderzochten voor deze genen de lange termijn effecten van 
ondervoeding voor de geboorte op epigenetische informatie 
(Hoofdstuk 3) en de veranderlijkheid van epigenetische 
informatie gedurende de volwassen periode (Hoofdstuk 4). 
Vervolgens onderzochten we of epigenetische informatie met 
betrekking tot de prentaal gevoelige set genen het risico op 
hart- en vaatziekte beïnvloedt (Hoofdstuk 5). 
Embryonale omgeving beïnvloedt epigenetische informatie
Epigenetische veranderingen als gevolg van of 
aanpassing aan omgevingsfactoren kunnen gedurende 
het hele leven voorkomen. Echter, doordat omvangrijke 
epigenetische herstructureringen cruciaal zijn bij de 
embryonale ontwikkeling wordt dit proces gezien als een 
periode waarin epigenetische informatie erg gevoelig is 
voor omgevingsinvloeden zoals bijvoorbeeld voedings- of 
rookgedrag van de moeder (zie Figuur 1, Introductie). Dit 
geldt in feite ook voor de rijping van de geslachtcellen. 
Verschillende bevolkingsonderzoeken observeerden een 
relatie tussen slechte omstandigheden vroeg in het leven 
en het risico op ouderdomsziekten zoals HVZ, diabetes type 
2 en hoge bloeddruk op latere leeftijd. Deze observaties 
leidden tot formulering van de Developmental Origins of 
Health and Disease (DOHaD) hypothese die stelt dat een deel 
van het risico op hart- en vaatziekten bepaald wordt door 
omstandigheden van voor en vlak na de geboorte. Verder 
heeft onderzoek in proefdieren aangetoond dat blootstelling 
voor de geboorte aan bijvoorbeeld te weinig voedsel of 
voedsel van slechte kwaliteit leidt tot subtiele epigenetische 
veranderingen die samengaan met een hoger risico op deze 
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ziekten. Dit soort resultaten toont aan dat epigenetische 
aanpassing een geloofwaardig moleculair mechanisme is 
voor de DOHaD hypothese. Echter, doordat proefdieren vrij 
kort leven in vergelijking met mensen is wel nog onduidelijk 
hoe blijvend dit soort veranderingen zijn over een periode 
van tientallen jaren. 
Eerder onderzoek van ons heeft aangetoond dat de 
epigenetische informatie voor een HVZ kandidaat gen 
blijvend veranderd kan zijn bij ouderen die prenataal 
blootgesteld waren aan de Hongerwinter van 1944-1945. 
We onderzochten of dit bij andere kandidaat genen ook het 
geval kon zijn (Hoofdstuk 3). We vonden dat 6 van de 15 
onderzochte genen ook gevoelig waren voor ongunstige 
omstandigheden tijdens het begin van de zwangerschap. 
Hierbij viel op dat de richting van de epigenetische 
verandering niet voor elk gen gelijk was, in tegenstelling tot 
wat je zou verwachten bij een epigenetische beschadiging. 
Voor sommige genen was de methylatie toegenomen, bij 
andere afgenomen ten opzichte van broers en zusters 
die niet prenataal waren blootgesteld aan de ongunstige 
omstandigheden. Verder was er voor 5 van de 6 genen 
een andere of geen epigenetische verandering te zien bij 
blootstelling aan de Hongerwinter tijdens het einde van 
de zwangerschap. Dit wijst erop dat de timing van de 
blootstelling medebepalend is voor het al of niet optreden 
van de verandering. Ook was het zo dat voor 3 van de 6 
genen het effect specifiek in één geslacht voorkwam of veel 
sterker was ten opzichte van het andere geslacht. Al deze 
observaties wekken de indruk dat er blijvende epigenetische 
aanpassingen plaatsvinden in het DNA van cellen als gevolg 
van blootstelling aan omstandigheden voor de geboorte. 
Epigenetische veranderingen tijdens het ouder worden
De resultaten uit de Hongerwinter studies waren 
gevonden in individuen van 60 jaar oud (Hoofdstuk 3). 
De mogelijkheid tot epigenetische veranderingen blijft 
echter gedurende het hele leven bestaan, waardoor we 
ons afvroegen in hoeverre epigenetische instabiliteit over 
een dergelijke periode doorwerkt op de HVZ kandidaat 
genen. Willekeurige epigenetische veranderingen, zowel 
spontane (bijvoorbeeld door een kopieerfoutje) als die ten 
gevolge van een schadelijke blootstelling (bijvoorbeeld 
een niet dodelijke vergiftiging), zijn meestal neutraal 
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van aard. Een ongecorrigeerde opeenstapeling ervan, 
“epigenetic drift” genoemd, kan op termijn wel leiden tot 
minder goed functionerende cellen en weefsels. Algemeen 
wordt aangenomen dat het vermogen om willekeurige 
epigenetische foutjes te corrigeren tijdens de veroudering 
vermindert.
We onderzochten in hoeverre epigenetische informatie 
voor deze HVZ kandidaat genen verandert gedurende de 
volwassenheid in een groep eeneiige tweelingen van 18 jaar 
tot 88 jaar oud (Hoofdstuk 4). We vonden een toename van 
epigenetische verschillen (variatie) met het ouder worden, 
zowel tussen niet de verwante individuen als binnen de 
eeneiige tweelingparen, die in principe genetisch identiek 
zijn. Dit duidt op een opeenstapeling van epigenetische 
veranderingen gedurende het leven. Of de veranderingen 
het gevolg zijn van externe omgevingsfactoren zoals 
beroep en leefstijl of dat het om willekeurige epigenetische 
veranderingen gaat was niet te achterhalen. Wel viel op dat 
niet elk kandidaat gen evenveel epigenetische veranderingen 
onderging, voor sommige genen was de epigenetische 
variatie niet veel groter in de oudste groep vergeleken met 
de jongvolwassenen, terwijl voor andere genen die variatie 
praktisch verdubbeld was. Verder viel op dat er zelfs in de 
oudste groep nog tweelingparen waren die epigenetisch 
nauwelijks van elkaar verschilden. Dit alles duidt erop dat 
epigenetische variatie verandert gedurende het leven, 
maar dat niet elk gen even sterk verandert en dat sommige 
individuen nauwelijks veranderen.
Epigenetische informatie is geassocieerd met risico op 
hartinfarct
In navolging van het onderzoek in proefdieren naar 
de betrokkenheid van epigenetische mechanismen in de 
relatie tussen omstandigheden voor de geboorte en het 
risico op HVZ (DOHaD hypothese) vroegen we ons af of de 
epigenetische veranderingen als gevolg van de hongerwinter 
(Hoofdstuk 3) ook betrokken kunnen zijn bij de ontwikkeling 
van HVZ. Uit verschillende onderzoeken zijn aanwijzingen 
gekomen dat individuen die voor de geboorte blootgesteld 
waren aan de Hongerwinter een hoger risico hebben op het 
ontstaan van HVZ. De Hongerwinter familiestudie is echter 
door haar unieke karakter (zie Box 1 Introduction) aan de 
kleine kant voor dit soort epidemiologisch onderzoek. Verder 
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hebben de blootgestelde individuen nog niet de leeftijd 
bereikt waarop de meeste mensen voor het eerst serieuze 
HVZ problemen ervaren, waardoor een degelijke vergelijking 
van hun epigenetische profiel met dat van niet blootgestelde 
individuen binnenkort pas een reële mogelijkheid is. 
 We onderzochten in een klinische studie in hoeverre de 
epigenetische informatie voor de zes HVZ kandidaat genen 
die gevoelig bleken voor omstandigheden voor de geboorte 
(Hoofdstuk 3), betrokken is bij het risico op het krijgen van 
een hartinfarct op latere leeftijd (Hoofdstuk 5). We vonden 
dat epigenetische informatie op 2 van deze genen verschilde 
tussen vrouwen die gedurende de vervolgperiode van drie 
jaar een hartinfarct kregen en vrouwen met een vergelijkbaar 
HVZ risico die hiervan gevrijwaard bleven. Voor mannen 
vonden we geen verschillen. Verder vonden we dat diegenen 
met het epigenetische verschil op beide genen het hoogste 
risico hadden op een hartinfarct. Het epigenetische verschil 
was niet te verklaren door andere HVZ risicofactoren zoals 
zwaarlijvigheid en de bloedspiegels van het cholesterol. Dit 
alles duidt erop dat epigenetische informatie een nieuwe 
indicator voor het risico op hart- en vaatziekten kan zijn, die 
wellicht deels afhangt van omstandigheden voor de geboorte.
Praktische strategieën voor een nieuw onderzoeksveld
Naast het biologische aspect bevat dit proefschrift 
ook een tweede, meer methodologisch aspect, waarin we 
praktische strategieën beschrijven voor het uitvoeren van 
epigenetisch onderzoek op humane cohortstudies. Dit 
nieuwe onderzoeksveld wordt epigenetische epidemiologie 
genoemd en is volop in ontwikkeling. Recent is er een 
aantal projecten gelanceerd om biobanken die specifiek 
ontworpen zijn voor epigenetisch onderzoek op te zetten met 
materiaal uit meerdere toegankelijke weefsels zoals bloed, 
wangslijmvlies, en opperhuid. Het opzetten van biobanken 
kost echter veel tijd en middelen, waardoor epigenetisch 
epidemiologische studies vooralsnog zijn aangewezen 
op het materiaal van de bestaande biobanken die veelal 
ontworpen zijn voor genetisch onderzoek. Ondanks dat zulk 
epigenetisch onderzoek technisch uitvoerbaar is, zijn er een 
aantal praktische complicaties die samenhangen met de 
dynamische eigenschappen van epigenetische informatie. 
Waar een genetische bepaling informatie geeft over de 
genetische code in elke cel van het lichaam gedurende 
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het hele leven, is dit voor een epigenetische bepaling niet 
vanzelfsprekend. Ook is het aantal toegankelijke weefsels 
van levende mensen voor epidemiologisch onderzoek 
beperkt, en hebben die toegankelijke weefsels (zoals bloed 
en wangslijmvlies) vaak een beperkte rol bij het ontstaan van 
ziekte. Dit houdt in dat onduidelijk is welke epigenetische 
onderzoeksvragen beantwoord kunnen worden middels 
epidemiologisch onderzoek en voor welke vragen celculturen 
en diermodellen noodzakelijk zijn.
Tijdens de totstandkoming van de huidige biobanken is bij 
het verzamelen van het genetisch materiaal geen rekening 
gehouden met een mogelijke toepassing in epigenetisch 
onderzoek. We onderzochten in hoeverre en onder welke 
voorwaarden de enorme collecties biologisch materiaal in 
deze biobanken, meestal DNA uit bloed, geschikt is voor 
epigenetisch onderzoek (Hoofdstuk 2). Hiervoor beschreven 
we eerst de normale variatie en patronen van epigenetische 
informatie voor 16 HVZ kandidaat genen aan de hand 
van DNA uit bloed van 30 gezonde individuen tussen 21 
en 73 jaar oud (Hoofdstuk 2). Daarna vonden we dat een 
substantieel deel van deze kandidaat genen voldoet aan de 
voorwaarden voor gebruik in epigenetische epidemiologie 
(Hoofdstuk 2). Op geschikte genen is de variatie in 
epigenetische informatie tussen personen stabiel gedurende 
de vervolgperiode van een studie (Hoofdstuk 2). Verder wordt 
de epigenetische variatie niet beïnvloed door persoonlijke 
verschillen in de samenstelling van het bloed in de vele typen 
(witte) bloedcellen (Hoofdstukken 2 en 4). Genen die aan 
deze criteria voldoen kunnen gebruikt worden als indicatoren 
voor een schadelijke blootstelling en het risico op ziekten 
(Hoofdstukken 3 en 5). 
Het koppelen van een epigenetisch mechanisme aan 
de ontwikkeling van een ziekte vereist ook kennis over 
epigenetische informatie in het (interne) weefsel waarin 
de ziekte ontstaat. Omdat bloed als weefsel niet direct 
betrokken is bij het ontstaan van veel ziekten dient de 
epigenetische informatie in bloed wel representatief te zijn 
voor het aan ziekte gerelateerde weefsel. In een verkennende 
genoomwijde studie op autopsiemateriaal (bloed, skelet 
spier, onderhuids vet, buikholte vet, lever, nier, alvleesklier 
en milt) vonden we dat epigenetische informatie in bloed 
gedeeltelijk representatief kan zijn voor deze interne weefsels 
(Hoofdstuk 6). In de meeste gevallen leek de overeenkomst 
Binnenwerk_opmaak.indd   225 5-12-2014   13:22:24
226
in epigenetische variatie afhankelijk te zijn van de combinatie 
van meetpunt en weefsels. Grondige genoomwijde herhaling 
van al deze experimenten op grotere populaties met 
monsters van meerdere toegankelijke weefsels zal op termijn 
van alle kandidaat genen de geschiktheid voor epigenetisch 
epidemiologisch onderzoek aantonen.
De toekomst van epigenetische epidemiologie
In dit proefschrift hebben we een eerste verkennende 
stap gezet in het epidemiologische onderzoek naar de rol 
van epigenetische processen bij de ontwikkeling van HVZ. 
We vonden dat het dynamische aspect van epigenetische 
informatie wel beperkingen oplegt aan de praktische 
uitvoering en interpretatie van dit type onderzoek, maar het 
niet onmogelijk maakt (Hoofdstukken 2 – 6). Zo vonden we 
kandidaat genen waarvan de epigenetische variatie in twee 
weefsels stabiel is over een periode van 20 jaar (Hoofdstuk 
2). De opvolgperiode van de meeste klinische studies is veel 
korter dan dit, wat inhoudt dat deze kandidaat genen als 
epigenetische indicator kunnen dienen voor het risico op 
ziekten (Hoofdstuk 5). Verder vonden we dat blootstelling 
aan de extreme omstandigheden van de Hongerwinter 
tijdens de embryonale ontwikkeling blijkt te leiden tot een 
permanente beschadiging of aanpassing van epigenetische 
informatie op sommige kandidaat genen (Hoofdstuk 
3). In een tweede studie vonden we dat epigenetische 
informatie op dit soort kandidaat genen ook een indicator 
kan zijn van het risico op HVZ (Hoofdstuk 5), een ziekte 
waarvan het ontstaan dikwijls in verband gebracht is met 
omstandigheden vroeg in het leven (DOHaD hypothese). 
Ook voor minder extreme omstandigheden tijdens de 
zwangerschap, zoals bijvoorbeeld roken of verminderde 
functie van de placenta, is gevonden dat epigenetische 
veranderingen een gevolg kunnen zijn. In dit proefschrift 
vonden we dat juist epigenetisch onderzoek geschikt 
blijkt om via een combinatie van verschillende studies in 
kaart te brengen wat de uiteindelijke gevolgen van deze 
omstandigheden op latere leeftijd zijn (Hoofdstukken 3 – 5).
De resultaten in dit proefschrift kunnen ook van 
waarde zijn voor het aanleggen van nieuwe biobanken 
of het uitbreiden van bestaande biobanken om er meer 
epigenetische vragen mee te kunnen beantwoorden. 
Het is voor grotere populatiestudies onhaalbaar om elk 
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celtype van een weefsel apart te meten, en dat hoeft voor 
de meeste kandidaat genen ook niet (Hoofdstuk 2). Wel 
is het van belang dat er per individu gegevens zijn over 
de aantallen van de belangrijkere celtypen in bloed, om 
rekening te kunnen houden met de invloed van onderlinge 
verschillen in de cellulaire compositie die aan epigenetische 
verschillen tussen mensen ten grondslag kunnen liggen 
(Hoofdstukken 2 en 4). Verder geven onze resultaten 
aan dat via het verzamelen van meerdere toegankelijke 
weefselmonsters meer epigenetische informatie te ontrafelen 
is over ontoegankelijke, maar ziekte gerelateerde weefsels 
(Hoofdstuk 6). Bij het verzamelen van informatie over de 
deelnemers lijkt het waardevol om informatie over dieet 
en leefomstandigheden in de vroege kindertijd (Hoofdstuk 
3), aan het beroep gerelateerde omgevingsfactoren, of 
aan de gekozen leefstijl te vragen. Verder komt uit dit 
proefschrift sterk naar voren dat er behoefte is aan databases 
waarmee de genoomwijde epigenetische variatie tussen 
personen, tussen de weefsels binnen een persoon en de 
veranderlijkheid van deze variatie binnen een weefsel over 
de tijd geraadpleegd kan worden. Er wordt op dit moment 
veel geïnvesteerd in het creëren van zulke databases 
waardoor het te verwachten is dat dit soort informatie in de 
nabije toekomst steeds beter voorhanden is. 
Desalniettemin zal niet elke epigenetische vraag middels 
humane populatiestudies beantwoord kunnen worden. Het 
zou ook teveel zijn dit te verwachten. Dit proefschrift toont 
echter aan dat met aanpassing van bekende (klassieke) 
epidemiologische studieontwerpen en het zorgvuldig 
combineren van populatiestudies er epigenetisch onderzoek 
mogelijk is waarin omstandigheden en ziekten over een 
heel leven aan elkaar kunnen worden gekoppeld. Als daarbij 
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